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ABSTRACT+Myeloid! cells! are! a!major! component! of!most! forms! of!malignant! tumour.!The!plasticity!of!such!cells!means!that!they!can!alter!their!phenotype!in!response!to!changes!in!the!tumour!microenvironment,!including!the!pronounced!ones!that!take!place!after!chemotherapy.!Tumour!cell!death,!as!well!as!the!various!cytokines!and!chemokines!released!by!cells!in!tumours!after!such!treatments,!are!now!known!to!alter!both!the!recruitment!and!function!of!myeloid!cells.!Recent!studies!have!shown!that! monocytes! recruited! into! tumours! during/following! chemotherapy! can!promote!tumour!chemoresistance!and!metastasis.!The!data!presented!in!this!thesis!suggest!that,!following!chemotherapy,!tumourSassociated!macrophages!(TAMs)!may!increase! their! expression! of! the! neutrophilSrecruiting! chemokines,! CXCL1,! CXCL2!and!CXCL5,!and!possibly!stimulate!the!intratumoural!accumulation!of!neutrophils.!Responding! to! these! CXC! chemokines! (and! possibly! other! secreted! factors! in!chemotherapyStreated!tumours),!neutrophils!may!then!upregulate!their!expression!of!such!inflammatory!cytokines!as!TNFα,!CCL2!and!CCL3.!Furthermore,!data!from!in#
vitro! invasion!assays! suggest! that!neutrophilSderived!TNFα! is! capable!of! inducing!tumour! cell! invasiveness.! Notably,! the! number! of! tumourSinfiltrating! neutrophils!was!significantly!increased!after!chemotherapy!in!3!of!the!4!mouse!tumour!models!used.! Furthermore,! in! all! 4! tumour!models! there! were! significantly!more! TNFα+!neutrophils!after!chemotherapy!compared!to!control!tumours.!Combined!treatment!with!chemotherapy!and!SB!265610,!a!CXCR2!antagonist!that!inhibits!CXCL1,!CXCL2!and! CXCL5! signalling,! successfully! reduced! both! the! number! of! these! tumourSinfiltrating,!TNFα+!neutrophils,!and!the!overall!level!of!immunodetectable!TNFα!in!tumours!after!chemotherapy.!Although!TNFα!is!known!to!be!capable!of!supporting!tumour!growth,!angiogenesis!and!metastasis,!it!remains!to!be!seen!whether!such!an!increase! in! neutrophil! TNFα! expression! contributes! significantly! to! the! postSchemotherapy! regrowth! of! either! primary! or! metastatic! tumours.! This! could! be!achieved! by! giving! chemotherapy! to! mice! in! which! TNFα! has! been! selectively!knocked! out/down! in! neutrophils.! Data! presented! here! suggest! that! combining!chemotherapy! with! CXCR2! inhibitors! like! SB! 265610! to! inhibit! the! above!neutrophilSmediated! events! could! improve! patient! tumour! responsiveness! to!chemotherapy!and!reduce!tumour!relapse.! !
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1+INTRODUCTION+
1.1+BASICS+OF+THE+IMMUNE+SYSTEM+The!body!is!protected!from!invading!pathogens!by!the!immune!system,!a!complex! network! of! cells,! humoral! factors,! tissues! and! organs.! It! consists! of!adaptive! and! innate! immunity.! ! Both! rely! on! cells! called! ‘white! blood! cells’! or!‘leukocytes’,!including!monocytes,!macrophages!and!neutrophils.!These!cells!are!professional! phagocytes! and! key! to! the! processes! of! inflammation! and! tissue!repair.!They!share!a!common!lineage!in!early!stages!of!myeloid!cell!development,!and! are! derived! mainly! from! haematopoietic! stem! cells! (HSCs)! in! the! bone!marrow!(Fig+1.1).!Under!some!conditions,!bone!marrowSderived!HSCs!can!also!accumulate! at! extramedullary! sites,! such! as! the! spleen,! which! can! also! then!become!an!important!site!for!monocyte!production![1].!
1.2+ORIGINS+OF+MACROPHAGES+AND+NEUTROPHILS+Macrophages!and!neutrophils!are!classically!categorised!as!belonging! to!the!haematopoietic!stem!cell!(HSC)!lineage!in!the!bone!marrow,!and!a!temporal!sequence!of!progenitor!cells!that!ultimately!lead!to!macrophage!and!neutrophil!differentiation! has! been! described! [2S5].! However,! in! recent! years! gathering!evidence! has! challenged! former! understanding! [6],! rewriting! the! ontology! of!myeloid! cells! at! least! in! mice.! The! mononuclear! phagocyte! system! (MPS)! –! a!family!of!cells!that!includes!monocytes,!macrophages!and!dendritic!cells![7]!–!has!been! shown! to! derive! from! at! least! three! sources! (Fig+ 1.1).! Firstly,! resident!macrophages!of!the!central!nervous!system!called!‘microglia’!were!identified!as!arising! from! yolk! sac! progenitors! in! mice,! and! thus! were! an! ontogenically!distinct! population! in! the!MPS! [8].! In! contrast,! murine! Langerhans! cells! –! the!dendritic!cells!of!the!epidermis!–!were!shown!to!derive!mainly!from!progenitors!in!the!foetal!liver,!with!only!a!minor!contribution!from!the!yolk!sac![9].!!Furthermore,! a! key! study! demonstrated! that! the! transcription! factor,!Myb,! which! is! essential! in! bone! marrow! haematopoiesis,! is! functionally!irrelevant! in! yolk! sac! macrophages! and! for! several! F4/80hi! yolk! sacSderived!tissue!macrophage!populations! that!persist! in! adult!mice! [10].! In! this!way,! the!
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major!F4/80hi!resident!macrophage!populations! in! liver,!skin,!spleen,!pancreas,!brain! and! lung,!were! identified! as! arising! from! yolk! sac! progenitors! (Fig+ 1.1).!Additionally,! kidney! (Kupffer)! macrophages! and! lung! (alveolar)! macrophage!populations! were! found! to! include! F4/80lo! cells,! but! also! some! F4/80hi! cells,!suggesting! a!mixed! origin! from! both! the! bone!marrow! and! yolk! sac! [10].! The!smaller! F4/80lo! macrophage! population! and! classical! dendritic! cells! are!continually!seeded!by!bone!marrow!haematopoiesis.!Taken!together,!these!data!



























suggest! that! murine! macrophages! originate! from! three! sources,! and! further!studies!are!needed!to!better!understand!the!role!of!circulating!Ly6C–!monocytes,!given! that! murine! Ly6C–! monocytes! do! not! seem! to! be! important! for! seeding!adult!tissues!with!macrophages![6].!In!support!of!this,!the!loss!of!the!analogous!‘resident’! monocyte! population! in! humans! –! supposedly! important! for! rapid!response! to! infection! (see! section+ 1.2.2.2)! –! appears! to! have! little! effect! on!patient!susceptibility!to!infection![12].!
1.2.1+MONOCYTE+AND+NEUTROPHIL+RELEASE+INTO+THE+BLOOD+Mobilisation! of! monocytes! from! the! bone! marrow! into! the! blood! is!controlled,! in! part,! by! CSC! chemokine! receptor! type! 2! (CCR2)! expressed! on!monocytes,!in!addition!to!activating!and!recruiting!them!from!the!blood!to!sites!of! inflammation! [13,!14].!The!CCR2! ligands! that!direct! these!processes! include!such!CSC!chemokine!ligands!as!CCL7!and!CCL2![13].+Neutrophil! production! and! release! into! the! blood! –! a! process! called!granulopoiesis! S! is! also! regulated! by! soluble! cytokines! like! granulocyteScolony!stimulating! factor! (GSCSF),! which! regulates! neutrophil! numbers! in! the! blood![15].! Neutrophils! leave! the! bone!marrow! as! part! of! steadySstate! homeostasis.!However,! large! pools! of! mature! neutrophils! are! also! retained,! forming! bone!marrow!reserves![16].!During!inflammation,!such!proSinflammatory!cytokines!as!CXCLS1! [16],! CXCLS2! [17],! CXCLS8! [18],! TNFα,! leukotriene! B4! (LTB4)! and!complement!5a!(C5a)![19]!are!increased!in!the!blood,!inducing!a!rapid!release!of!neutrophils!from!bone!marrow!reserves.!!Both!monocytes!and!to!a!lesser!extent,!neutrophils,!express!the!chemokine!receptor!CXCR4,!for!which!one!of!the!ligands!is!stromalSderived!factorS1!(SDFS1!or!CXCL12).!As!its!name!suggests,!SDFS1!was!first!identified!as!a!factor!released!by!stromal!cells!of!the!bone!marrow![20].!The!binding! of! CXCR4! by! SDFS1! is! important! for! the! retention! of! monocytes! and!neutrophils! in! the!bone!marrow,!acting!as!a!negative! regulator!of! their! release![16,! 21].! Once! released! from! the! bone!marrow,! circulating!monocytes!migrate!into! tissues! under! homeostatic! and! inflammatory! conditions.! Under! typical!inflammatory!conditions,!growth! factors,! cytokines!and!any!microbial!products!present!locally!in!the!tissues!induce!phenotypic!changes,!and!the!differentiation!of!monocytes!into!macrophages!and!dendritic!cells.!!
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1.2.2+MACROPHAGE+LINEAGE+AND+MONOCYTE+SUBSETS+! Monocytes! can! be! distinguished! from! other! leukocytes! through! their!expression!of!CD11b,!CsfS1! receptor! (CD115)!and! chemokine! receptor!CX3CR1,!and! lack! of! expression! of! CD15,! CD19,! NkpS46! or! CD3.! Within! the! monocyte!population,!accumulating!evidence!suggests!that!phenotypically!discrete!subsets!exist.! In! mice! and! humans,! two! major! populations! of! monocytes! have! been!described:! inflammatory! and! resident!monocytes,! as! shown! in!Table+ 1.1.! The!resident! population! of! monocytes! patrol! tissue! microvasculatures! for! danger,!while!the!other!describes!the!classical!inflammatory!monocytes!that!accumulate!at! inflammatory!sites,!and!have!a!shorter! lifespan!than!the!resident!population![22,!23].!
1.2.2.1!INFLAMMATORY!MONOCYTES!The! ‘inflammatory’!monocyte!population!are! identified!by!expression!of!CCR2,!which! is! important! for! their!recruitment! to!sites!of! inflammation,!and!of!Gr1,! a! myeloid! differentiation! antigen.! They! also! exhibit! low! expression! of!CX3CR1,! a! chemokine! receptor! that! is! involved! in! monocyte! adhesion! and!migration! [22]! (Table+ 1.1).! Recruited! to! sites! of! inflammation,! these!

















CX3CR1loCCR2+Gr1+!monocytes!have!been!shown!to!specialise!in!the!production!of! proSinflammatory! cytokines! tumour! necrosis! factor! (TNF),! reactive! oxygen!species! (ROS),! nitric! oxide! (NO),! and! type! 1! interferon,! but! marginal! antiSinflammatory! cytokine! interleukin! (IL)S10! in! response! to! bacterial! and! viral!infection,!as!has!been!discussed!elsewhere![24,!25].!This!inflammatory!monocyte!population!also!have!a!shorter!survival!of!approximately!48!hours! [14].! In! line!with! their! production! of! proSinflammatory!molecules,! classical! monocytes! can!differentiate! into! immunostimulatory! dendritic! cells! (DCs),! which! are!professional!antigen!presenting!cells!(APCs)!that!communicate!with!the!adaptive!immune! system.! ! Furthermore,! these! cells! are! also! believed! to! give! rise! to!myeloidSderived! suppressor! cells! (MDSCs),! which! are! important! in! the!resolution!of!acute!inflammation![26].!Similar!monocyte! subsets! have!been!described! in! humans,!whereby! the!more!abundant!inflammatory!or!‘classical’!monocyte!population!are!identified!by!high! expression! of! CD14! (Table+ 1.1),! a! coSreceptor! that! detects! conserved!bacterial!motifs! including! lipopolysaccharide! (LPS)! [27],! and! an! absence! of! Fc!receptor!CD16!expression![28,!29].!Such!CD14++CD16–!classical!monocytes!share!commonalities! in! their! surface! marker! expression! and! gene! expression! with!murine!inflammatory!monocytes![22].!1.2.2.2!RESIDENT!MONOCYTES!Conversely,! ‘resident’! or! ‘nonSclassical’! monocytes! are! characterised! in!mice!by!the!expression!of!CX3CR1,!which!binds!to! its! ligand!CX3CL1![30]!and!is!important! in! recruitment! of! resident!monocytes! into! nonSinflamed! tissue! [22]!(Table+ 1.1).! They! also! exhibit! greatly! reduced! CCR2! and! Gr1! expression,! and!therefore! are! identified! as! CX3CR1hiCCR2–Gr1–! cells! [22].! In! humans,! (low)!expression! of! CD14! and! high! expression! of! CD16! identifies! a! similar,! nonSclassical!subset!of!macrophages![29].!Analogous!to!murine!resident!monocytes,!human! CD14++CD16–! monocytes! are! also! CCR2–! [31]! and! the! CD14+CD16+!monocyte! phenotype! can! additionally! be! defined! by! CX3CR1hi! expression! in!humans! [22].! CD14+CD16+! monocytes! exhibit! patrolling! behaviour! in! blood!vessels! [32]! similar! to! that! shown! in! mice! [23],! whereby! they! roll! along! the!
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surface!of!endothelial!cells!to!allow!for!a!very!rapid!response!to!damage!and/or!infection.!
1.2.3+NEUTROPHIL+LINEAGE+Neutrophils! arise! through! the! process! of! granulopoiesis,! sharing! a!common! myeloid! lineage! with! bone! marrowSderived! monocytes! and!macrophages! [2S5]! (Fig+ 1.1).! Granulopoiesis! involves! the! differentiation! of!granulocyteSmonocyte! progenitors! (GMPs)! into! myeloblasts,! the! first! of! the!granulocyte! precursors,! which! are! capable! of! differentiating! into! neutrophils,!eosinophils! and! basophils! [11,! 33,! 34].! Tracking! the! neutrophil! lineage,!myeloblasts! differentiate! further! into! promyelocytes,! myelocytes! and! then!metamyelocytes,!which!ultimately!mature!into!neutrophils!!(Fig+1.1).!Neutrophils! are! produced! in! the! bone! marrow! at! a! rate! of! ~106! per!second!in!humans!and!circulate!in!the!blood!at!a!concentration!of!between!3!and!6!million!cells!per!millilitre!in!a!healthy!human![35].!They!are!far!more!abundant!than!monocyte/macrophage!phagocytes,!but!have!a!much!shorter! lifespan.#It! is!generally!believed!that!neutrophils!survive!less!than!a!day!in!the!body,!showing!a!halfSlife!of!approximately!8S10!hours!in!mice![36]!and!10!hours!in!humans!![37S39].!Other!studies!have!suggested!that!under!homeostatic!conditions!neutrophils!may! in! fact! live! up! to! 12.5! hours! and! 5.4! days! in# vivo! in! mice! and! humans,!respectively! [40];! however,! the! methodology! used! (2H2OSlabelled! water)! was!later! criticised! since! it! is! likely! to! label! bone! marrow! neutrophils! as! well! as!circulating! cells,! thus! augmenting! the! measure! of! neutrophil! longevity! in! the!blood![41].!Communication!between!the!complex!networks!of!cells,!tissues,!and!organs! that!make!up! the! immune!system! is! required! to!coordinate!an!effective!immune!response.!In!humans,!neutrophil!pools!are!sustained!by!steady!state!granulopoiesis!under! homeostatic! conditions.! Infection! and! inflammation,! however,! triggers!neutrophilia!via!the!release!of!neutrophils! from!pools! in!the!bone!marrow,!and!increases! the! rate! of! neutrophil! generation! in! a! process! termed! ‘emergency’!granulopoiesis! [42].!This! is!partially! stimulated!by!macrophage!and!neutrophil!
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release! of! GSCSF,! CXCL1! and! CXCL8! [43,! 44]! upon! detection! of! infection,!supporting!increased!neutrophil!release!from!the!bone!marrow.!
1.3+INNATE+RESPONSE+TO+INFECTION+After! penetrating! the! skin! and! other! external! defences! (e.g.! mucous!membranes,!gut!lining!etc.),!microbes!must!traverse!the!epithelial!barrier!where!they! will! encounter! components! of! the! innate! immune! system.! Initially,!pathogens! are! recognised! by! the! innate! components! of! the! immune! system.!These! macrophages! and! neutrophils! are! capable! of! discriminating! between!different! types! of! infectious! pathogen,! but! are! not! capable! of! immunological!memory.!Immunological!memory!is!important!for!a!rapid!response!to!previously!encountered! infectious! agents! and! involves! the! specific! arm! of! the! immune!system.!The! outcome! of! microbial! invasion! is! very! much! dependent! upon! the!interaction!between!the!microbe!and!host.! In!cases!where!the!host!generates!a!balanced! immune!response! to!control!and!destroy!microbes,! infectious!disease!can! be! avoided.! Should! the! microbial! attack! mechanisms! favour! the! microbe,!pathogenic!infection!may!occur.!The!host!response!to!the!presence!of!microbes!is!also! governed! by! the! damage! done! to! the! host! through! toxins! and! enzymes,!which!may!lead!to!host!cell!apoptosis!and!necrosis,!or!support!the!transition!to!malignancy![45].!!
1.3.1+PATTERN+RECOGNITION+RECEPTORS+! The! innate! arm! of! the! immune! system! responds! rapidly! to! common!motifs! present! on! microbes! called! ‘pathogenSassociated! molecular! pattern’!!(PAMPs)!using!germlineSencoded!pattern!recognition!receptors!(PRRs).!Some!of!the!most!important!PRRs!are!TollSlike!receptors,!or!TLRs,!of!which!there!are!10!functional! receptors! identified! in! humans! and! 12! in! mice,! and! TLRs! 1S9! are!conserved!between!humans!and!mice![46,!47].!Human!TLRs!1,!2,!4,!5,!6!and!10!are!expressed!on!the!cell!surface,!primarily!binding!to!components!of!microbial!membranes!and!cell!walls,!whereas!TLRs!3,!7,!8!and!9!are!incorporated!into!the!membranes! of! endosomes! and! predominantly! detect! foreign! nucleic! acids.!Additionally,! TLR10! is! only! expressed! in! humans! and! TLR11! only! in! mice.!
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Experimental!models! have! been! used! to! observe! the! effects! of! the! deletion! of!each! TLR! individually! and! to! identify! ligands! of! these! receptors,! including! a!diverse! array! of! protein,! lipoprotein,! lipid! and! nucleic! acid! components! of!microorganisms! [48].! Activation! of! TLRs! on! innate! immune! cells!characteristically! leads! to! the! production! of! such! inflammatory! cytokines! as!TNFα,!ILS1,!ILS6,!and!ILS12![49S51].!! Other!PRRs!that!have!been!identified!include!RIGSISlike!receptors!(RLRs),!which!detect!viral!RNA!species![52],!and!a!large!family!of!receptors!called!NodSlike! receptors! (NLRs)! [53],! which! also! detect! a!wide! range! of! PAMPs! that! are!expressed!on,! or! are!part! of,! infectious! agents.! The! intracellular! signalling! that!results!from!the!binding!of!PRRs,!and!upregulation!of!proSinflammatory!cytokine!expression,!are!the!first!steps!towards!initiating!an!immune!response![54].!
1.3.2+PHAGOCYTOSIS+Phagocytosis! –! the! engulfing! of! cells! –! is! also! a! key! feature! of! innate!immunity.!The!process!was! initially!described!in!1883!by!Ilya!Metchnikoff!who!shared! a! Nobel! prize! for! his! discovery! of! the! cells! that! he! and! his! colleagues!termed!phagocytes![55].!Metchnikoff!noted!that!phagocytes!could:!(i)!rapidly!detect!microbes,!(ii)!phagocytose! foreign! material! like! fungal! spores,! and! (iii)! exert! antimicrobial!activity,! which! he! postulated! was! through! some! sort! of! secretion.! The! main!professional! phagocytes! are! macrophages! (literally! meaning! ‘big! eaters’)! and!neutrophils! [56,! 57].! Their! ability! to! engulf! material! is! not! just! important! for!eradication!of!pathogens,!but!also!for!the!clearing!of!dead!cells!and!debris!as!part!of!normal!tissue!homeostasis!and!conditions!like!wound!healing![58,!59].!!Macrophages! and! neutrophils! are! complementary! and! cooperative!partners,! ingesting! the! invading!microbes! they! encounter! and! coordinating! an!immune! response! against! them.! Their! arsenal! of! antiSmicrobial! mechanisms!includes!the!production!of!reactive!oxygen!and!nitrogen!species!(ROS!and!RNS),!granule! proteins,! and! ironSwithholding! molecules! [60,! 61].! Detection! and!phagocytosis! of! material! by! macrophages! and! neutrophils! also! leads! to! their!production! of! proSinflammatory! cytokines! TNFα,! ILS1,! ILS6,! CXCL2! and! CCL5!
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[62],!through!which!they!recruit!other!inflammatory!cells!to!the!site!of!infection!and!activate!their!antiSmicrobial!functions,!and!then!begin!to!communicate!with!the!specific!(or!adaptive)!arm!of!the!immune!system.!The! highly! specialised! adaptive! system! is! made! up! of! TS! and! BSlymphocytes! that! each! express! a! unique! antigen! receptor.! ! This! receptor!diversity! is! achieved! through! accelerated!mutation! and! recombination! of! gene!segments! that! encode! these! receptors! [63].! The! incredible! array! of! unique!receptorScarrying!T!and!B!cells!helps!protect!against!infection!since,!even!before!they!encounter!any!microbes,!a!receptor!that!can!bind!an!epitope!somewhere!on!the! invading! microbe! already! exists.! Therefore,! when! antigenSpresenting! cells!(APCs)!present!microbial!components,!specific!TS!and!BSlymphocytes!can!bind!to!particular! epitopes! via! their! unique! antigen! receptors! and! initiate! an! adaptive!immune! response.! This! crucial! step! in! an! immune! response! leads! to! the!activation! and! subsequent! clonal! expansion! of! cells! bearing! a! receptor! that!specifically! binds! the! fragment,! and! therefore!will! be! effective! in! targeting! the!invading!pathogen.!The!host!produces! large!quantities!of! effector!and!memory!lymphocytes! that! eliminate! the! invading! microbe! and! protect! against! future!infection![64].!
1.4+NORMAL+PHYSIOLOGICAL+ROLE+OF+NEUTROPHILS+Neutrophils!are!known!to!express!an!abundance!of!PRRs,!which!are!key!to! their! identification! and! phagocytosis! of! microorganisms! as! well! as! their!detection!of!tissue!damage.!!In!humans,!neutrophils!express!TLRs!1,!2,!4,!5,!6,!7,!8,!9,!and!10!–!all!the!TLRs!except!TLR3!–!which!when!activated!lead!to!neutrophil!cytokine!release,!enhanced!phagocytosis!of!opsonised!latex!beads,!and!inhibition!of!ILS8–mediated!chemotaxis![65].!Under! inflammatory!conditions,!activated!neutrophils!are!also!known!to!produce!ROS;!such!proteolytic!enzymes!as!neutrophil!elastase!(NE),!proteinase!3!(PR3)! and! cathepsin! G! [66,! 67];! and! such! antimicrobial! proteins! as!myeloperoxidase,! hydrogen! peroxide! and! chloride! [68],! which! they! store! in!intracellular! granules.! Upon! phagocytosis! of! encountered! microbes,! these!granules! fuse! with! phagosomes! to! form! phagolysosomes,! and! the! resultant!
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exposure! to! proteolytic! enzymes,! antimicrobial! proteins,! acidic! pH,! and! ROS!further!support!the!degradation!and!killing!of!microorganisms.!!These! factors! can! also! be! released! by! active! neutrophils! into! the!extracellular! environment! as! an! alternative! mechanism! for! attacking!microorganisms.!Paradoxically,!however,!this!can!also!lead!to!host!tissue!damage!and!has!been!implicated!in!various!diseases![33].!!Activated!neutrophils!(e.g.!via!TLR!ligands!or!CXCR2!ligands)!are!capable!of!expressing!a!wide!array!of!cytokines![69,!70],!including:!







• Fibrogenic!and!angiogenic!factors;!HGF,!VEGF!and!ILS8!However,! neutrophils! are! well! known! for! their! ability! to! recruit! and!activate!monocytes! at! sites! of! inflammation! [71],! specifically! the! inflammatory!CX3CR1loCCR2+Gr1+! monocyte! subset! in! mice! [72].! Similar! chemotactic! effects!have!been!observed!towards!macrophages!and!T!cells,!mediated!by!neutrophilSderived!CCL2!released!in!skin!wounds![73].!!The! role! of! neutrophils! in! angiogenesis! is! also!well! established.! In! such!sites! as! inflamed! tissues! and! malignant! tissues,! neutrophils! can! promote!angiogenesis,!in!part!driven!by!their!release!of!matrix!metalloproteaseS9!(MMP9)!and! VEGF,! and! release! of! VEGF! from! extracellular! stores! in! the! extracellular!matrix![74,!75].!!
1.4.1+NEUTROPHIL+EXTRACELLULAR+TRAPS+! Besides! phagocytosis! and! cytokine! expression,! neutrophils! also! combat!microorganisms! via! the! production! of! microbial! traps! in! tissues! called!
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‘neutrophil!extracellular!traps’!or!‘NETs’.!By!actively!extruding!chromatin!bound!to!granular!proteins!to!create!an!extracellular!fibrillary!network,!neutrophils!can!immobilise! and! disarm! invading! pathogens! [76].! The! DNA! is! bound! by! such!antimicrobial! factors! as! neutrophil! elastase,! myeloperoxidase! and! histones,!which!–!due!to!their!high!concentration!in!NETs!–!readily!bind,! immobilise!and!kill!microorganisms.!! The!exact!mechanisms!leading!to!the!formation!of!NETs!are!not!currently!known,!but!several!factors!could!be!involved!including!platelet!interaction![77];!the! presence! of! gram! positive! and! gram! negative! bacteria! [76],! or! fungi! [78];!even! the! cytokines! TNFα,! ILS1β! and! ILS8,! through! the! activation! of! NADPH!oxidase!and!myeloperoxidase![79].!
1.5+MACROPHAGE/NEUTROPHIL+CROSSTALK+! Given! their! shared! origin,! it! is! not! surprising! that! macrophages! and!neutrophils!have!many!shared!characteristics,!as!summarised!in!Table+1.2.!
Feature+ Refs.+Phagocytic!capabilities!and!an!arsenal!of!antiSmicrobial!functions!(e.g.!ROS,!RNS)! [80,!81]!Expression!of!similar!transcription!patterns!and!coSexpressed!genes!(e.g.!CSFS1R,!F4/80,!COXS2)! [82,!83]!Similar!cytokine!and!chemokine!secretion!profiles,!common!surface!receptors!and!antigen!expression,!making!them!difficult!to!target!independently!(e.g.!ILS1β,!TNFα,!PRRs,!CD11b,!Ly6C)! [48,!58,!84,!85]!Neutrophils!can!contribute!to!scavenging!of!necrotic!cells!and!debris,!particularly!when!macrophages!are!overwhelmed! [86]!Mobilisation!of!macrophages!and!neutrophils!to!sites!of!infection!follow!a!similar!pattern! [56]!
!
Table+ 1.2+ Shared+ characteristics+ of+ macrophages+ and+ neutrophils.+ Macrophages! and!neutrophils! share! a! common! lineage! in! early! stages! of! development.! This! table! summarises!key! characteristics! shared! by! murine! macrophages! and! neutrophils.! Most,! but! not! all,! are!conserved!in!humans. 
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The!interaction!of!neutrophils!and!macrophages!can!also!occur!–!with!the!former! helping! to! recruit! the! latter! under! some! conditions! like! inflammation.!Neutrophils!are!often!the!first!responders!to!sites!of!infection!and!inflammation,!and! are! capable! of! secreting! factors! that! recruit! macrophages! and! additional!neutrophils,! but! can!also! recruit! other! such! immune! cells! as!T! cells,!mast! cells!and!dendritic!cells.!For!example,!neutrophil!release!of!human!neutrophil!peptide!(HNP)S1! and! 3! –! natural! antibiotic! peptides,! known! as! alphaSdefensins! –! was!shown! to! strongly! attract!macrophages! as! well! as! T! cells! and!mast! cells! [87].!Production!of!these!factors!by!neutrophils!is!important!in!inflammatory!diseases!including!Crohn’s!disease,!inflammatory!cardiac!disease!and!inflammatory!bowel!disease.!!!Furthermore,!such!peptides!also!induce!TNFα!and!ILS1β!expression!in!monocytes!within!the!context!of!Staphylococcus!aureus!infection![88].!! These! neutrophilSderived! chemotactic! molecules! explain! why! a! patient!with! neutrophilSspecific! granule! deficiency! (SGD)! –! characterised! by! a! lack! of!neutrophil! granules! that! are! key! to! their! protein! secretion! –! exhibits! reduced!monocyte! migration! into! Rebuck! skin! windows! (slides! that! are! applied! to!abraded!skin!areas!to!allow!visualisation!of!leukocyte!infiltration)![89];!and!why!neutropenia,! induced!by! injection!of!neutrophilSdepleting!antibody!RB6S8C5!or!1A8,! caused! a! significant! reduction! in! the! mobilisation! of! inflammatory!monocytes! in! mice,! which! could! be! restored! by! local! injection! of! secretions!isolated!from!activated!neutrophils![72].!Additionally,!monocyteSderived!macrophages! from!neutropenic! patients!were!found!to!express!lower!levels!of!cytokines!than!healthy!control!volunteers;!this! included! expression! of! TNFα,! ILS6,! ILS10! and! ILS1RA,! indicating! a!deactivation!of!macrophages!in!the!absence!of!neutrophils![90].!Neutrophils,!and!their! granule! proteins,! are! key! to! the! proper! function! of!monocytes/macrophages![91].!! Interestingly,! tissue! resident!macrophages!at! sites!of! inflammation!have!been!shown!in!mice!to!play!an!important!role!in!the!recruitment!of!neutrophils,!by! releasing! CXCL1! and! CXCL2! chemokines! [92].! Resident! macrophages! were!shown!to!upregulate!CXC!cytokines!via!signalling!dependent!upon!TLR!adaptor!
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proteins,!MyD88!and!TRIF,!both!of!which!are!used!by!TLR4.!Macrophage!TLR4!signalling!was!therefore!found!to!be!responsible!for!the!robust!chemoattraction!of!neutrophils,! leading! to! their!accumulation!at! sites!of! inflammation!or! injury,!which! is! an! essential! early! step! in! the! immune! response.! The! use! of! blocking!monoclonal! antibodies! to! these! chemokines! demonstrated! in# vitro! and! in# vivo!that! neutrophil! chemotaxis!was! dependent! upon! them,! thus! suggesting! that! at!sites! of! inflammation! or! injury,! tissue! macrophages! cause! neutrophil!accumulation!in!a!CXCL1/CXCL2Sdependent!manner+[93].!Importantly,!however,!macrophages! are! also! known! to! stimulate! endothelial! cells! [94];! it! is! possible!therefore!that!the!proSinflammatory!actions!of!macrophages!stimulate!epithelial!cells! to! release! chemokines! via! the! proSinflammatory! actions! of!macrophages,!and!are!themselves!a!major!source!of!neutrophil!chemokines![95].!!! The! production! of! CXCL8! by! human! blood!monocytes! upon! stimulation!with! bacterial! products,! LPS! and! polyhydroxyalkanoate! (PHA),! was! identified![96].!Two!key!responses!of!neutrophils!to!CXCL8Scontaining!conditioned!media!were!observed:!the!release!of!specific!granules/exocytosis,!and!the!induction!of!a!respiratory! burst! (the! swift! release! of! reactive! oxygen! species! to! combat!invading!pathogens!they!encounter).!Human!and!murine!macrophages!have!also!been! found!to!express!CXCL8!under!hypoxic!conditions,!such!as! those! found! in!tumours! [97].! This! correlates! with! the! finding! that,! in! (7! day! old)! rats! where!hypoxia/ischaemia! was! induced! by! occlusion! of! the! left! carotid! artery! and!exposure!to!a!7.7%!oxygen!atmosphere,!increased!numbers!of!neutrophils!were!seen!in!the!infarct!region![98].!! As!previously!mentioned,!neutrophils!do!not!survive!long!in!the!blood!or!following! extravasation! into! tissues! and! their! activation.! A! tightly! regulated!apoptotic!programme!controls!their!survival,!and!thus,!acts!as!a!mechanism!for!resolving! acute! inflammation.! Clearance! of! apoptotic/necrotic! neutrophils! and!associated! debris,! which! is! called! efferocytosis,! is! a! process! in! which!macrophages!play!a!crucial!part!as!expert!scavengers!and!phagocytes![99,!100].!Interestingly,! such! proSinflammatory! factors! as! LPS! and! TNFα! can! not! only!manipulate!the!rate!of!apoptosis!and!promote!the!survival!of!macrophages!and!
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neutrophils!during!infection/inflammation,!but!have!also!been!demonstrated!to!inhibit!efferocytosis!of!neutrophils!by!macrophages![100].!!
1.6+CELLULAR+PLASTICITY+! Cells!of!the!MPS!share!a!common!feature!of!plasticity!–!the!ability!to!adapt!and! change! characteristics! in! different! environments! –! governed! by! the!combinations!of!local!chemical!signals!and!receptor!binding![58,!101].!Plasticity!is! important! for!maintaining!homeostasis,! since! tissue!repair,! regeneration!and!resolution!of! inflammation!require!a!dynamic! interaction!between!multifaceted!immune!cells!and!resident!cells.!!
1.6.1+M1+AND+M2+POLARISATION+OF+MACROPHAGES+! Macrophages!display!considerable!functional!plasticity.!The!conventional!paradigm! has! been! that! macrophages! are! antigenSpresenting! phagocytes! that!secrete! antimicrobial! and!proSinflammatory! factors.!However,! it! is!now!known!that! in! response! to! their! environment! macrophages! can! alter! their! functional!phenotype.! Initially,! two! disparate! macrophage! phenotypes! were! described,!which!–!although!an!oversimplification!of!the!true!phenotypic!diversity!–!provide!a!useful!framework!for!the!study!of!macrophage!plasticity.!!The!nomenclature!M1!and!M2!were!ascribed!to!classically!activated!and!alternatively!activated!macrophages,!respectively.!In!line!with!T!helper!1!and!T!helper!2!type!immune!responses,!the!M1!macrophage!phenotype!can!be!skewed!by! lipopolysaccharide! (LPS)! and! interferon! gamma! (IFNSγ),! and! the! M2!phenotype! by! interleukinS4! (ILS4)! and! interleukinS13! (ILS13)! [101S103],! as!shown!in!Fig+1.2.!In!both!mice!and!humans,!the!proSinflammatory!M1!population!of!macrophages! can! be! broadly! described! as! being! ILS12hiILS10lo,! whereas! the!generally! immunosuppressive! M2! population! are! ILS12loILS10hi! [104S106].! M1!macrophages! have! dominant! microbicidal! and! tumouricidal! functions,! and!conversely,! M2! macrophages! are! involved! in! parasite! clearance,!immunoregulation! in! order! to! supress! hypersensitivity! and! maintain!homeostatic! conditions,! and! can! promote! tissue! remodelling! and! tumour!progression.!!
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! In! addition! to! high! ILS12! and! low! ILS10! expression,! the! human! M1!macrophage!phenotype!is!further!characterised!by!high!expression!of!such!proSinflammatory!molecules! as! TNFα,! ILS1β,! ILS6,! ILS23! and! reactive! nitrogen! and!oxygen!species![107,!108],!and!expression!of!TLRs!2!and!4,!and!CD80!and!CD86,!which! are! important! for! detection! of! pathogens! and! macrophage! direct! and!indirect! killing! activities.! Additionally,! M1!macrophages! express! high! levels! of!major! histocompatibility! complex! (MHC)! I! and! II,! and! express! CCL5,! CCL16,!CXCL9,!CXCL10!and!CXCL11,!which!together!indicate!communication!with!other!cells! and! recruitment! of! other! members! of! the! innate! and! adaptive! immune!system! to! generate! strong! immune! responses! [106].! In!mice! and! humans,! the!transcription! factor! interferon! regulatory! factor! (IRF)! 5!was! shown! to! control!the! upregulation! and! downregulation! of! M1! and! M2! marker! expression! on!macrophages! [109].! High! expression! of! IRF5! is! associated! with! an! M1!macrophage!phenotype.!!Conversely,!M2!macrophages!share!a! low!expression!of! ILS12!and!ILS23,!and! increased! expression! of! scavenger! receptor! and! mannose! receptor! [102,!103].! Importantly,! it!was! established! that!M1!and!M2!macrophage!phenotypes!are! not! simply! due! to! different! activation! states,! but! are! the! outcome! of! two!separate! metabolic! programmes! [110].! Later,! a! more! complex! description! of!macrophage!behaviour!was!suggested,!which!extrapolated!beyond!the!basic!M1!and! M2! phenotypes.! This! acknowledged! the! array! of! phenotypes! that! can! be!adopted!in!response!to!changes!in!their!environment,!suggesting!that!rather!than!the! existence! of! two! distinct! subsets,! macrophages! can! ‘reversibly! and!progressively! change! the! pattern! of! functions! that! they! express’! and! adopt! an!array!of!different!phenotypes![111].!In! line! with! this,! the! M2! population! of! macrophages! has! been! further!divided!into!three!subsets!in!both!mice!and!humans!termed!M2a,!M2b!and!M2c,!depending! upon! their! environmental! stimulation,! as! shown! in! Fig+ 1.2.!!Stimulated!with!the!Th2!cytokines!ILS4!and!ILS13,!macrophages!can!be!polarised!to!an!M2a!phenotype,!whereby!they!express!ILS1ra!to!reduce!ILS1!inflammatory!signalling,! and! antiSinflammatory! cytokine! ILS10.! They! also! express! scavenger!receptor! CD163,! growth! factor! TGFSβ! [102,! 112],! and! cytokines! CCL17,! CCL22!
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and!CCL24,!which!lead!to!recruitment!of!eosinophils,!basophils!and!Th2!cells!and!result!in!a!type!II!response![106].!!!! In!contrast,!the!M2b!phenotype!is!induced!by!LPS!and!immune!complexes!(IC),!and!by!exposure!to!ILS1ra.!M2b!macrophages!retain!their!expression!of!such!inflammatory! genes! as! ILS1,! ILS6! and! TNFα! [106],! as! shown! in! Fig+ 1.2.!Additionally,! M2b! macrophages! are! characterised! by! CCL1! expression,! a!






































































recruitment! factor! for! eosinophils,! Th2! cells,! and! regulatory! T! cells,! through!which!they!promote!a!Th2!response![112].!! Finally,! the! third!population!of!M2!macrophages!are!governed!by! ILS10,!TGFSβ,! and! glucocorticoid! (GC)! hormones! [112],! and! are! named! M2c!macrophages.! These! macrophages! are! characterised! by! CCL16,! CCL18! and!CXCL13!production! in! humans! [113S115],!which! are! known! to! chemoattract! T!lymphocytes,!B!lymphocytes!and!monocytes.!M2c!macrophages!also!express!the!scavenger! receptor,! CD163,! and! CCR2,! which! are! important! for! macrophage!scavenging! and! recruitment/migration! respectively,! and! TLRs! 1! and! 8! [112],!which! bind! bacterial! triacyl! lipopeptides! and! single! stranded! viral! RNA,!respectively![116].!It! is!also!believed!that!M2c!macrophages,! in!response!to!the!presence!of!both!LPS!and!ILS10,!are!capable!of!shedding!cytokine!receptors!to!act!as!functional!decoys!for!chemokines,!thus!dampening!inflammation.!However,!it!is!worth!noting! that!not!all!experts! in! the! field!believe!M2a,!b!and!c! to!be! true!subsets,!regarding!M1!and!M2!as!the!only!true!macrophage!classifications,!and!so!further!experimental!proof!of!macrophage!subsets! is!needed.!Furthermore,!not!all! described! M1! and! M2! features! are! shared! between! mice! and! human!macrophages;!for!example,!production!of!arginase!and!nitric!oxide!(NO)!is!a!key!feature!of!murine!M1!macrophages!but!is!absent!in!human!macrophages![117].!
1.6.2+PLASTICITY+OF+NEUTROPHILS+Neutrophils!also!display!considerable!phenotypic!plasticity.!For!example,!the!stimulation!of!neutrophils!occurs!upon!interaction!with!activated!endothelial!cells!and!their!infiltration!into!inflamed!tissues.!This!activation!has!been!shown!to:!




Together! these! functions! help! eliminate! pathogenic! infection! [118]! via!phagocytosis,!the!release!of!antiSmicrobial!factors,!and!the!attack!by!cytotoxic!T!lymphocytes!(CTL)!and!natural!killer!(NK)!cells.!! As!mentioned,! neutrophils! are! typically! the! first! responders! of! the! host!defence! against! pathogens.! The! soluble! mediators! released! locally! in! the!inflammatory! milieu! include! cytokines! and! chemokines,! which! activate! and!induce!changes!in!leukocytes,!leading!to!their!sequestration!and!adhesion!to!the!vascular!endothelium,!as!reviewed!previously![11].!!!! Neutrophils! bind! to! the! vascular! endothelium,! a! process! that! involves!adhesion! mediated! by! selectin! and! integrin! surface! proteins! [119S121].!Endothelial!cells!at!inflammatory!sites!increase!their!expression!of!such!selectin!proteins! as! ESselectin! and! PSselectin,! which! interact! with! heavily! glycosylated!proteins!on!the!surface!of!neutrophils,!including!PSselectin!glycoprotein!ligandS1!(PSGLS1),!CD44!and!ICAMS1![122].! In!regions!of! inflammation,!endothelial!cells!can!express!ILS8,!which!stays!bound!to!their!cell!surface!and!triggers!activation!of! CXCR1! and! CXCR2! on! neutrophils.! This! activation! also! stimulates! the!formation! of! high! affinity! interactions! with! intercellular! adhesion! molecules!(ICAMs)! on! the! surface! of! inflamed! endothelial! cells,! and! a! cytoskeletal! reSarrangement! that! facilitates! transendothelial! migration! [123].! In! this! way,!chemokine! signalling! and! selectin! signalling! coSoperate! in! the! recruitment! of!neutrophils! into! tissues.! Neutrophils! undergo! extravasation! at! sites! of!inflammation,! whereupon! they! are! polarised! and! primed! for! antimicrobial!action.!Neutrophil!activation!triggers!the!release!of!such!inflammatory!oxidants!ROS!and!RNS,!alongside!an!array!of!cytotoxic!factors,!during!their!short!lifespan!of! approximately! 1S2! days.! Release! of! these! factors! by! large! numbers! of!neutrophils! at! sites! of! infection! and! inflammation! are! crucial! for! fighting!invading!pathogens.!However,!the!uncontrolled!release!of!these!compounds!can!also!lead!to!severe!host!tissue!damage,!which!is!why!under!normal!homeostatic!conditions!this!process!is!tightly!regulated![121].!! Neutrophil! plasticity! acts! as! a! key! negative! regulator! of! inflammation;!under!certain!conditions,!the!proSinflammatory!nature!of!tissue!neutrophils!can!
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be!reversed.!For!example,!the!effects!of!serum!amyloid!A1!(SAA1)!on!neutrophil!phenotype! and! differentiation!were! recently! described! [124].! SAA1! is! a!major!acute! phase! protein! whose! expression! and! plasma! concentration! increases!substantially!during! inflammation!and!tissue! injury.!This!protein!was!shown!to!induce! the! release! of! antiSinflammatory! cytokine,! interleukin! 10,! from! healthy!neutrophils,! acting! as! a! negative! regulator! to! control! the! magnitude! of! the!neutrophil!response.!! Additionally,! SAA1! promoted! the! interaction! between! neutrophils! and!invariant! natural! killer! T! (iNKT)! cells! [124].! In! line!with! the! effects! iNKT! cells!have! on! other! immune! cell! subsets! [125],! the! interaction! between! neutrophils!and! iNKT! cells! suppressed! neutrophilSderived! ILS10! and! increased! proSinflammatory!cytokine! ILS12!expression.! In! this!way,!a!new!mechanism! for! the!modulation! of! inflammatory! processes! was! revealed,! initially! by! the! antiSinflammatory! skewing! effects! of! SAA1,! then! the! downmodulation! of! this! by!crosstalk! of! neutrophils! with! iNKT! cells! [124].! The! fine! balance! of! these!mediatory!loops!is!necessary!to!control!inflammation!and!subsequent!resolution,!maintaining!homeostatic!conditions.!
1.7+THE+IMMUNE+SYSTEM+AND+CANCER+! Tumours!can!occur!in!many!sites!of!the!body,!but!the!surrounding!tissue!–!or! tumour! microenvironment! –! usually! comprises! of! common! cellular!components! including! immune! cells,! blood! and! lymphatic! vessels,! and!fibroblasts,! as! well! as! nonScellular! components! such! as! extracellular! matrix.!Tumour! cells! are! known! to! release! factors! that! can! directly! or! indirectly!reorganise! their! microenvironment,! for! example,! the! recruitment! of!inflammatory!cells![126,!127]!and!orchestration!of!angiogenesis!and!metastasis![128S130].!The! cells!of! the! immune!system!and! the!molecules! they! secrete!are!fundamental! elements! of! the! tumour! microenvironment.! Immune! cells! that!localise!to!the!tumour!include!macrophages,!dendritic!cells,!neutrophils,!natural!killer! cells,! mast! cells,! effector! T! cells,! and! myeloid! progenitors! [131S133],! in!response!to!inflammatory!signals.!
+
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1.7.1+TUMOURXPROMOTING+INFLAMMATION+! The!presence!of!inflammatory!cells!in!tumours!is!not!a!recent!discovery.+In! 1863,! Rudolf! Virchow! observed! leukocyte! infiltrates! in! human! neoplastic!tissues!and!hypothesized!a!link!between!inflammation!and!cancer.!Furthermore,!Virchow! proposed! that! this! ‘lymphoreticular! infiltrate’! might! indicate! cancer!initiation!at!sites!of!chronic!inflammation.!!! In!the! late!19th!century!a!surgical!oncologist,!William!Coley,!noted!a! link!between!inflammation!and!cancer!regression,!which!he!published!in!1891![134].!‘Coley’s! toxins’!were! generated! from!killed! bacterial! species,!which! he! used! to!treat!sarcoma!patients!with!a!deliberate!bacterial!infection,!and!in!some!patients!tumour!regression!was!achieved.!In!those!cases!where!the!cancer!did!regress!it!is!now!believed!to!be!because!of!a!successful!activation!of!cytotoxic!immune!cells,!thus!demonstrating!the!ability!of! the! immune!system!to!eradicate!cancer!when!appropriately! activated.! Coley’s!work,! however,! remains! controversial! and! not!readily!reproducible![135,!136].!! Further! key! observations! were! made! by! Harold! Dvorak,! discoverer! of!vascular!endothelial!growth!factor!(VEGF).!He!first!postulated!that!tumours!were!‘wounds!that!do!not!heal’![137]!after!noting!that!cancers!share!tissueSinfiltrating!cells! with! inflammation,! but! failed! to! resolve! unlike! healing! wounds.! In!accordance! with! this,! chronic! inflammation! without! resolution! will! eventually!lead!to!tissue!damage!and!a!barrage!of!genetic!errors!that!will!inevitably!cause!a!cell!to!become!cancerous![138,!139].!!
1.7.2+MACROPHAGES+IN+CANCER+1.7.2.1!MACROPHAGE!RECRUITMENT!! Monocytes! are! recruited! to! the! tumour! by! such! tumourSderived!chemokines! as! CCL2! [140],! CCL5! [141],! colony! stimulating! factorS1! (CSFS1)![142],! VEGF! [143]! and! AngiopoietinS2! [144].! In! humans,! CCL2! and! CCL5! have!been!most!heavily!implicated!in!monocyte!recruitment!to!tumours,!produced!by!tumour! cells,! endothelial! cells,! neutrophils,! fibroblasts,! and! even! by! infiltrated!TAMs! themselves! [145,! 146].! Higher! expression! of! CCL2! and! CCL5! has! been!shown!to!correlate!with!increased!TAMs!in!tumours!and!forced!CCL2!expression!
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in!B16!melanoma!cells!–!accomplished!via!gene!transfer!–!led!to!increased!levels!of!macrophage!infiltration![140],!implicating!CC!cytokines!as!effective!monocyte!chemoattractants.!Not! only!do!CCL2!and!CCL5!have!monocyte! chemotactic! properties,! but!CCL5! is! also! capable! of! stimulating! monocytes! to! express! a! variety! of! genes!including! ILS1β,!CCL2!and!CCR1,!and!genes! involved! in!matrix!remodelling!and!angiogenesis,!MMP9,!MMP19!and!urokinaseStype!plasminogen!activator!receptor!(uPAR)![147]!(Fig+1.3),!suggestive!of!a!mechanism!through!which!monocytes!are!recruited!and!polarised!in!tumours.!The!potent!chemoattractant!CXCL12!(SDFS1)!also!recruits!monocytes!into!tumours,! more! specifically,! TIE2Sexpressing! monocytes! (TEMs;! see! section+
1.7.2.3).!Within!the!tumour,!both!tumour!cells!and!stromal!cells!are!capable!of!secreting!CXCL12!(identified!on!the!basis!of!cellular!morphology),!and!increases!following! treatment! with! combretastatin! A4! phosphate! (CA4P),! a! vascularSdisrupting! agent! [148].! The! importance! of! CXCL12! in!monocyte! localisation! to!tumours!was!demonstrated! through! the!use!of!AMDS3100!–!an! inhibitor!of! the!CXCL12!receptor,!CXCR4.!TumourSbearing!mice!treated!with!combined!CA4P!and!AMDS3100!had!fewer!TEMs!in!tumours!than!mice!treated!with!CA4P!alone![148],!demonstrating!the!importance!of!the!CXCL12/CXCR4!axis!for!(TIE2Sexpressing)!monocyte!recruitment.!1.7.2.2!TAM!FUNCTIONS!IN!TUMOURS!High! levels! of! tumourSassociated! macrophages! (TAMs)! correlate! with!poor!prognosis! in! the!majority!of!human!tumour! types! including!breast!cancer![149],!nonSsmall!cell!lung!carcinoma![150],!prostate!cancer![151],!bladder!cancer![152],!endometrial!cancer![153],!thyroid!cancer![154]!and!glioma![155].!!! Similarly,!murine!TAMs!have!also!been!shown!to!be!capable!of!promoting!tumour! progression! and! vascularisation! in! Lewis! lung! carcinoma! [156],! and!tumour!progression!and!metastasis!in!spontaneous!PyMT!breast!tumours![157].!These!findings!–!in!both!human!and!mice!–!suggest!that!macrophages!act!mainly!in! a! proStumour! fashion! in! the! tumour! environment,! aiding! various! aspects! of!tumour! survival! and! metastasis! (Fig+ 1.3).! However,! this! is! not! true! of! all!
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tumours,!since!increased!TAM!infiltration!has!also!correlated!with!good!patient!prognosis!in!some!studies!of!human!gastric!carcinoma!and!prostate!cancer![158,!159].!
1.7.2.2.1#TAM#MODULATION#OF#ANGIOGENESIS#TAMs! in! tumours! have! been! shown! to! promote! angiogenesis! in! preSclinical! models.! Human! breast! tumour! (T47D)! spheroids! implanted! into! the!dorsal! skinfold! chamber! in! nude! mice,! with! or! without! infiltrated! TAMs,!demonstrated! a! TAMSdependent! increase! in! angiogenesis! [130].! A! 3Sfold!upregulation!of!VEGF!release!by!macrophageSinfiltrated!spheroids!was!noted!in#
vitro!as!compared!with!unSinfiltrated!tumour!spheroids.!This!correlated!with!in#







































Figure+ 1.3+ TAM+ proXtumour+ functions.! TumourSassociated! macrophages! (TAMs)! are!capable! of! supporting! a! variety! of! tumourSsupporting! mechanisms,! some! of! which! are!summarised! here.! The! release! of! proSangiogenic,! immunosuppressive,! and! proSmetastatic!factors!by!TAMs!in!a!variety!of!tumour!types!has!been!shown.!The!therapeutic!targeting!TAM!recruitment,!or!reSeducating!them!towards!an!M1Slike!phenotype,!has!been!suggested.!ArgI,!arginase!I;!CSFS1,!colonySstimulating! factorS1;!EGF,!epidermal!growth!factor;! IL,! interleukin;!iNOS,! inducible!nitric!oxide!synthase;!MMP,!matrix!metalloprotease;!PTX3,!pentraxin!3;!Treg,!regulatory! T! cell;! uPA(R),! urokinaseStype! plasminogen! activator! (receptor);! VEGF,! vascular!endothelial!growth!factor.+
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macrophages!in!solid!tumours!significantly!enhance!the!process!of!angiogenesis.!Additionally,!a!study!of!macrophage! infiltration!–!using!the!spontaneous!PyMT! murine! breast! tumour! model! –! also! showed! that! TAMs! encourage!angiogenesis! and! malignancy! in! tumours! [160].! In! this! model,! macrophage!migration! into! tumours! was! found! to! precede! vascular! remodelling! and!angiogenesis.! ! Furthermore,! homozygous!Csf1op#mice! that! lack!wildStype! CSFS1!were!used!to!reduce!macrophage!migration!into!tumours,!and!this!reduction!was!shown! to! impede! angiogenesis! and! the! transition! to!malignancy.! Furthermore,!manipulating!early!macrophage! infiltration!by! forced!overSexpression!of!CSFS1,!prompted!vessel!network!formation!in!premalignant!lesions.!This!demonstrates!that! macrophages! can! have! a! direct! angiogenic! effect,! irrespective! of! the!progression!to!malignancy![160].!
1.7.2.2.2#TAM#CONTRIBUTION#TO#IMMUNOSUPPRESSION#! As! TAMs! display! an! M2Slike! phenotype,! their! phagocytic! and! antigenSpresenting! abilities! are! then! suppressed! and! they! can! exhibit! pronounced!immunosuppressive! effects! (Fig+ 1.3).! In! hypoxic! areas! of! tumours,! TAMs!have!been! shown! to! upregulate! the! immunosuppressive! enzymes! inducible! nitric!oxide!synthase!(iNOS)!and!the!M2!marker!arginase!I!(ArgI)!under!the!control!of!hypoxiaSinducible!factorS1α!(HIFS1α)![161].!These!enzymes!profoundly!affect!TScell! proliferative! capacity! and! their! sensitivity! to! stimulation! and! explain!why!inhibition! of! macrophage! infiltration! with! a! CSFS1! receptor/cKIT! inhibitor!(PLX3397)! enhanced! antiStumour! immunity! mediated! by! cytotoxic! TScells!following!chemotherapy![162].!TAMs! and! tumour! cells! have! been! shown! to! secrete! chemokine! CCL22,!which!helps! to!recruit! regulatory!TScells! (Tregs)! into! tumours.! In! line!with! their!known! role! in! suppressing! immune! responses! of! other! cells,! recruited! Tregs!dampened! tumourSspecific! TScell! immunity! [163].! Additionally,! the!immunosuppressive!molecule!prostaglandin!E2!(PGE2)!stimulated!macrophages!to! produce! ILS10! and! pentraxin! 3! (PTX3).! Autocrine! actions! of! these! factors!suppressed! macrophage! phagocytosis! of! tumour! cells! [164],! demonstrating!another!mechanism!by!which!TAM!aid!tumour!immune!escape.!
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1.7.2.2.3#TAM#MODULATION#OF#INVASION#AND#METASTASIS#! Tumour! invasion! and! metastasis! can! also! be! encouraged! by! M2Slike!macrophages! in! the! tumour! (Fig+ 1.3).! By! crossing! a! transgenic!mouse! that! is!prone! to! the! development! of!mammary! tumours! (PyMT!mouse)!with! a!mouse!bearing!a!CSFS1!null!recessive!mutation!(Csf1op),!researchers!developed!a!mouse!susceptible!to!cancer!but!also!in!the!absence!of!CSFS1![157].!In!these!mice,!CSFS1!deficiency! correlated! with! reduced! numbers! of! TAMs! in! tumours! and!deceleration!of! the! late! stages! of! cancer! and! slower!progression! to!metastasis,!suggesting!that!TAMs!–!recruited!by!CSFS1!–!are!important!for!tumour!invasion!and!metastasis.!Further!support!and!clarification,!again!using!the!PyMT!murine!mammary! tumour!model,! came! from! a! study! showing! that! TAM! expression! of!EGF!increased!tumour!cell!invasion!and!the!number!of!circulating!malignant!cells!in!the!blood![165].!Notably,!CD4+!TScellSderived!ILS4!induced!TAM!expression!of!EGF,! which! is! suggestive! of! a! proStumour! phenotype.! Therefore,! CD4+! TScells!appear! to! stimulate! TAMs! to! encourage! tumour! cell! invasion! and! metastasis!from!primary!tumours.!However,!ILS4!stimulates!more!than!just!EGF!expression!by!macrophages;!cathepsin! protease! release! by!TAMs! is! also! induced! by! ILS4! in! PyMT! tumours,!and! at! different! stages! of! malignant! progression,! including! pancreatic! islet!cancers,! mammary! tumours,! and! lung! metastases! [166].! In! particular,! TAMSderived! cathepsin! B! and! S! supported! pancreatic! tumour! growth,! angiogenesis!and!tumour!cell! invasion! in#vivo.!This!confirmed!an!earlier!report!showing!that!macrophageS! and! tumourSderived! cathepsin! B! is! important! in! metastasis! of!PyMT!tumours!to!the!lung![167].!TAMs! may! also! support! tumour! invasion! and! metastasis! via! the!expression! of! urokinase! plasminogen! activator! (uPA)! [168],! a! serine! protease!that! generates! active! plasmin.! It! is! also! involved! in!many! physiological! tissueSremodelling! processes,! making! it! well! suited! to! supporting! invasion! and!metastasis.!!!
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1.7.2.3!TIE2SEXPRESSING!MONOCYTES!! Over! the! last! ten! years! a! subset! of! heavily! M2Sskewed!monocytes/macrophages! has! been! identified.! These! cells! express! the! receptor!TIE2,! and! as! such,! were! called! TIE2Sexpressing! monocytes! or! TEMs.! Within!tumours,! TEMs! are! distinct! lineage! of! proSangiogenic! monocytes! that! are!recruited! predominantly! by! angiopoietinS2! –! a! ligand! of! TIE2! –! released! by!activated! endothelial! cells! and! angiogenic! vessels! [144,! 169].! In! contrast,!tumourSassociated!macrophages!(TAMs)!are!recruited!to!tumours!through!such!factors!as! colonySstimulating! factor! (CSF)S1! [170],!CCL2! [140],!CCL5! [171]!and!VEGF![172],!and!orchestrate!aspects!of!cancer!growth!and!progression!including!angiogenesis,!immunosuppression!and!metastasis![173].!! TEMs!are!highly!proSangiogenic![174],!stimulated!in!part!by!angiopoietinS2! in! the! tumour!microenvironment,! but!notably,! they’re! also!proSangiogenic! in!circulation,! suggesting! this! is! an! innate! feature! of! TEMs! [175].! In! comparison!with! TIE2–! monocytes,! TEMs! were! found! to! express! higher! levels! of! proSangiogenic! genes! MMP9,! VEGF,! COXS2! and! WNT5A! in! the! circulation,! and!increased! expression! of! thymidine! phosphorylase! and! cathepsin! B! upon!stimulation!with!angiopoietinS2,!commonly!present!in!tumours![175].!Currently!identified! mechanisms! behind! their! proSangiogenic! effects,! and! potential! for!TEMStargeted! therapy,! have! been! extensively! reviewed! [176S178],! and! their!contribution!to!tumour!angiogenesis!has!been!shown!to!be!nonSredundant! in!a!murine!glioma!model![174].!! The! gene! signature! of! murine! TEMs! was! compared! and! contrasted! by!gene! array! with! that! of! murine! TAMs,! splenic! CD11b+Gr1+! cells,! circulating!inflammatory! monocytes,! circulating! resident! monocytes! and! tumourSderived!endothelial! cells! in! PyMT! tumours! [26].! TEMs! and! TAMs! were! identified! as!CD11b+CD31low/−!cells!after!showing!that!the!majority!of!CD11b+!cells!were!also!F4/80+,! and!distinction!between!TEMs!and!TAMs!was!made!based!upon!a!GFP!reporter,!since!the!mice!received!bone!marrow!transplants!from!Tie2SGFP!mice!(GFP!expression!under!the!control!of!the!TIE2!promotor).!TEMs!and!TAMs!were!unsurprisingly!shown!to!express!similar!gene!expression!profiles,!although!some!genes! were! expressed! at! different! levels! in! line! with! TEMs! being! more! proS
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angiogenic,! and! less! proSinflammatory! than! their! Tie2–! counterparts! from! the!same! tumours.! Interestingly,! it! was! also! found! that! TEMs! shared! similar!expression! patterns! with! the! resident! monocyte! population,! suggesting! that!some!may! become!TEMs.! Additionally,! inflammatory!monocytes!may! be! set! to!become!TAMs!in!the!context!of!a!tumour.!Macrophages!in!tumours!clearly!play!an!important!role!in!several!aspects!of!tumour!progression!and!metastasis.!Reducing!macrophage!infiltration,!or!‘reSeducating’!macrophages! back! to! an!M1Slike! phenotype! [179],!may!prove! to! be!therapeutically!beneficial.!
1.7.3+NEUTROPHILS+IN+CANCER+Neutrophils!and!their!myeloid!precursors!–!although!less!well!described!than!their!close!relative,!the!macrophage!–!also!contribute!towards!many!aspects!of!tumour!progression,!as!will!now!be!discussed.!1.7.3.1!TAN!RECRUITMENT!! Neutrophils! are! recruited! by! such! tumourSderived! factors! as! CXCL1,!CXCL2! [180]! and! CXCL8! [181],! and! can! count! for! a! significant! fraction! of!intratumoural! inflammatory! cells! in! several! human! and!murine! cancers! [181S184].! Accordingly,! in! a!murine! lung! cancer! xenograft!model,! blocking!CXCR2! –!the! receptor! for! these! chemokines! –! with! a! small! molecule! inhibitor!(AZ10397767;!AstraZeneca)![185]!resulted!in!reduced!neutrophil!intratumoural!TAN! accumulation.! This! verifies! the! importance! of! these! chemokines! in! the! in#
vivo! tumour! setting.! In! addition! to! CXC! cytokines,! tumourSderived! MIF!(macrophage! migration! inhibitory! factor)! may! also! recruit! neutrophils! into!tumours!and!activate!them![186].!! In!the!context!of!a!tumour,!polarisation!of!CD11b+Ly6G+!cells,!or!tumourSassociated! neutrophils! (TANs),! can! be! altered! by! tumourSrelated! inflammation!from!an!N1!phenotype!(similar!to!macrophage!M1)!to!an!N2!phenotype!(similar!to! M2)! [146].! Furthermore,! the! addition! of! a! TGFSβ! receptor! inhibitor!successfully!reSprogrammed!TANs!from!N2!to!N1.!Likewise,! tumourSinfiltrating!monocytic! MDSCs! showed! M1S! and! M2Slike! polarisations,! regulated! by!(autocrineSacting)!TGFSβ! [187].! Blockade!of!TGFSβ! signalling! via! an! antiSTGFSβ!
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antibody!was! successful! at! restoring!monocytic!MDSC! ability! to! express! nitric!oxide!(NO),!indicative!of!a!more!M1Slike!phenotype.!!! As! mentioned! previously! (see! section+ 1.4.1),! neutrophils! can! release!chromatin! bound! to! granular! proteins! to! form! neutrophil! extracellular! traps!(NETs).! There! is! gathering! evidence! to! support! a! role! of! NETs! in! tumour!progression! also,! including! the! trapping! of! circulating! tumour! cells! to! support!the! formation! of! metastases! [188].! NETosis! is! also! thought! to! be! a! key!contributor!to!cancerSassociated!thrombosis![189].!
1.7.4+MYELOIDXDERIVED+SUPPRESSOR+CELLS++A!myeloid!progenitor!cell!population,!named!myeloidSderived!suppressor!cells! or! MDSCs,! play! an! important! part! in! resolution! of! inflammation,! tumour!immune!escape,! transplantation!and! trauma![190].!Under!normal!physiological!conditions!haematopoietic!stem!cells!(HSCs)!differentiate!into!immature!myeloid!cells! (iMCs)! in! the! bone!marrow,!which! typically!migrate! to! peripheral! tissues!and!further!differentiate!into!macrophages,!dendritic!cells!and!granulocytes!(Fig+
1.1)!under!the!direction!of!soluble!factors.!!However,! the! inflammatory!milieu!contains!growth!factors!that!promote!iMC!expansion!and!can!also!hinder!their!more!regular!course!of!differentiation,!leading! to! the! development! of! a! subpopulation! of! iMCs! known! as!MDSCs.! The!molecular! mechanisms! responsible! for! MDSC! development! are! not! well!understood,! but! a! recent! poster! and! review! aptly! summarise! the! current!understanding! of! MDSC! polarisation! and! reprogramming! [191,! 192].! Murine!MDSCs! have! been! divided! into! two! major! groups:! monocytic! (Ly6G−Ly6Chigh)!MDSC! and! granulocytic! (Ly6G+Ly6Clow)! MDSC,! both! with! immunosuppressive!capabilities! [193,!194].!Similar!classifications!have!also!been!broadly!described!in!humans![195].!Analogous!to!macrophage!M1!and!M2!phenotypes,!granulocytic!MDSCs/neutrophilic! cells! have! also! been! described! to! have! two! opposing!polarisations,!predominantly!mediated!by!TGFSβ.!!1.7.4.1!CONTRIBUTION!OF!MDSCS!TO!TUMOUR!PROGRESSION!! Due! to! their! initial! discovery! in! tumours,! the! bulk! of! the! information!available! on! MDSCs! relates! to! their! role! in! cancer;! they! have,! however,! been!
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implicated! in! autoimmunity! and! transplantation! success! as! well.! Avoiding!immune!destruction!is!one!of!the!ten!hallmarks!of!cancer!recently!described!by!Hanahan!and!Weinberg![196],!and!therefore,!tumours!survival!and!progression!relies!on!the!suppression!of!antiStumour!immune!responses.!Production!of!TGFSβ! by! MDSCs! suppresses! the! activity! of! tumourSinhibiting! cytolytic! CD8+! T!lymphocytes,!which!can!be!stimulated!by!the!cytokine!ILS13!through!the!binding!of! receptor! ILS13Rα2! on!MDSCs.! In! line!with! the! finding! that! tumour! necrosis!factor! alpha! (TNFα)! is! partially! responsible! for! MDSC! ILS13Rα2! expression,!neutralisation! of! TNFα!was! shown! to! restore! the! cytolytic! activities! of! CD8+! T!cells! and! reduce!metastatic! nodule! formation! in! a!murine! colon! cancer!model![197].! These! findings! support! the! idea! that! TGFSβ! and! TGFSβR! are! potential!targets!for!the!manipulation!of!MDSCs!in!cancer!and!other!diseases![191].!!!Several! lines! of! evidence! suggest! that! within! the! tumour!microenvironment,! MDSCs! act! in! an! M2Slike,! proStumour! manner! [198].! The!adoptive!transfer!of!MDSCs!in!murine!tumour!models!was!linked!to!an!increase!in!tumour!growth!and!angiogenesis![199,!200].!Notably,!the!administration!of!an!antiSGrS1! antibody! to! deplete! GrS1+! cells! in! mice! bearing! tumours! caused! a!significant! inhibition! of! tumour! growth! and! metastasis,! and! an! increase! in!survival![201S203].!Similarly,!depletion!of!MDSCs!in!tumourSbearing!mice!using!gemcitabine,! allStransSretinoic! acid,! and! inhibitors! of! phosphodiesteraseS5,!increased!overall!survival,! impeded!tumour!progression!and!resistance! to!antiScancer!therapies![204S206].!! MDSCs! exert! their! immunosuppressive! effects! in! part! through! cross!communication!with!T!cells,!reducing!their!ability!to!mount!an!immune!response!against! presented! antigens.! They! produce! ROS,! RNS! and! arginase! 1! (ARG1),!which! act! independently! or! together! to! reduce! the! association! of! CD3Sζ! (zeta)!chain!with!the!rest!of!the!T!cell!receptor!(TCR)!complex,!inhibit!the!proliferation!of!T! cells,! and! increase!T! cell! apoptosis! [207S209].! In!doing! so,!MDSCs!are!key!regulators! of! inflammation,! bringing! about! resolution! and! preventing!autoimmunity.!!However,!their!ability!to!suppress!immune!responses!also!makes!them!useful!allies!of!tumours,!allowing!tumours!to!remain!effectively! ‘invisible’!to! the! immune! system.! In! a! clinical! study,! circulating! MDSCs! were! more!
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abundant! in! cancer! patients! at! all! stages,! relative! to! the! healthy! control! group![210].! There! was! a! significant! relationship! between! increased! numbers! of!circulating!MDSCs!and!increasing!clinical!cancer!stage.!Observations!in!stage!IV!patients!revealed!that!individuals!with!extensive!metastatic!tumour!burden!had!significantly! higher! numbers! of! MDSCs! than! patients! with! limited! tumour!burden,!measured! both! as! a! percentage! and! as! an! absolute! number! of!MDSCs![210].! As! previously! mentioned,! inflammatory! conditions! promote! the!differentiation! of!MDSC! from! iMCs.! Interestingly,! treatment!with! doxorubicin–cyclophosphamide! chemotherapy,! which! induces! further! inflammation,! was!shown! to! cause! an! induction! in! circulating!MDSCs! in! patients!with! early! stage!breast!cancer![210].!This!was!also!associated!with!increased!metastatic!burden,!indicating! that! chemotherapySinduced! inflammation! may! be! a! contributing!factor! to! tumour! metastasis! in! patients! with! cancer,! with! a! potential! role! for!MDSCs!in!this!process.!Therefore,!understanding!the!mechanisms!behind!MDSCSdriven!tumour!progression!and!subversion!of!the!immune!system!is!imperative.!Given!the!propensity!of!MDSCs!to!aid! tumour!progression!and! immune!escape,!the! presence! of! increased! numbers! of! MDSCs! following! chemotherapy! is!undesirable,! and! they! may! also! reduce! the! effectiveness! of! concurrent!immunotherapies.!!Further!studies!on!the!recruitment!of!the!different!populations!of!myeloid!cells! into! tumours! may! lead! to! new! therapies! that! aim! to! block! their!accumulation,!or!to!reSeducate!these!cells!towards!an!antiStumour!phenotype!in!the! tumour!environment,!overcoming! the! tumours! immunomodulating!defence!mechanisms.!Such!therapies!could!be!used!alone,!or!in!combination!with!existing!treatments!such!as!chemotherapy.!
1.8+CHEMOTHERAPY+TREATMENT+OF+CANCER+! Common! treatments! for! cancer! include! surgery,! chemotherapy,!radiotherapy,!hormonal!therapy,!biological!therapy,!stem!cell!and!bone!marrow!transplants! (depending! on! the! type! of! cancer)! [211],! of! which,! chemotherapy!and! its! effects!on! the! immune! system!will! be! the! focus!here!due! to! the! results!
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• AntiStumour!antibiotics!In!brief,!alkylating!agents!(for!example,!cyclophosphamide!and!cisplatin)!add!alkyl!groups!to!guanine!bases.!The!alkyl!groups!cause!irregular!base!pairing!and!generate!crossSlinks!between!the!strands!of!DNA,!which!inevitably!disrupts!cellular! division! [214].! Topoisomerase! inhibitors! (for! example,! etoposide! and!doxorubicin)! cause! damage! to! the!DNA;! they! prevent! the! proper! regulation! of!DNA!by!topoisomerases,!which!are!crucial!for!the!binding!of!DNA!back!together!after! it! has! been! cut.! Therefore,! cells! affected! by! these! inhibitors! accumulate!breaks!in!one!or!both!strands!of!DNA,!eventually!leading!to!cell!death![215].!!AntiSmetabolites,! however,! exert! their! effects! by! mimicking! DNA! bases!and! other! necessary!metabolites,! incorporating! themselves! into!molecules! and!
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disrupting! their! proper! function.! For! example,! fluorouracil’s! (5SFU)! primary!mode! of! action! is! as! a! pyrimidine! antagonist! that! blocks! the! synthesis! of!pyrimidineScontaining! nucleotides! in! DNA! and! RNA! [216].! Similarly,! this!disruption!of!proper!DNA!synthesis!during!cell!replication!ultimately!leads!to!cell!death.! As!the!name!suggests,!plant!alkaloids!are!a!type!of!treatment!that!derive!from!various!plants,!and!are!also!cellScycle!specific.!The! taxanes,!paclitaxel!and!docetaxel,!are!semisynthetic!molecules!derived!from!the!bark!and!needles!of!yew!trees.! Their! mode! of! action! is! to! inhibit! mitosis! by! stabilising! microtubules,!preventing! them! from! depolymerising! –! a! process! which! is! required! during!normal! cell! division.! Both! compounds! are! used! routinely! for! the! treatment! of!breast,! ovarian,! and! lung! cancer,! as! well! as! for! metastatic! disease! and! in!combination!with!other!antiScancer!therapies![217].!! As! mentioned! above,! treatment! with! chemotherapy! causes! significant!necrotic! cell! death! in! tumours! [218],! which! can! further! contribute! towards!inflammatory!conditions!in!the!tumour.! !Myeloid!cells!are!recruited!to!tumours!by! a! variety! of! inflammatory! chemokines,! including! CCL2! [140],! CCL5! [141],!CXCL1!and!CXCL2![180]!and!CXCL8![181].!Due!to! the!results!described! in! later!chapters,!the!CXC!motif!chemokines!will!now!be!focussed!on!here.!
1.9+CXC+CHEMOKINES++The! CXC! chemokines! were! first! identified! as! a! secretory! product! of! a!human!malignant!melanoma! cell! line,! Hs0294,! which! had! autocrine!mitogenic!effects! [219].! CXCL8/IL8!was! the! first! CXC! cytokine! to! be! identified,! following!which,! growthSrelated! oncogene! (GRO)!α,! GROβ! and!GROγ!were! identified! and!later!changed!for!the!nomenclature!CXCL1,!CXCL2!and!CXCL3,!respectively.!This!naming! reflects! their! characteristic! two!NSterminal! cysteines! (C)! separated! by!another!amino!acid!(X),!forming!a!cysteineSXScysteine!motif,!as!shown!in!Fig+1.4+
B+ and+ C.! Other! important! CXC! molecules,! with! regards! to! neutrophil!chemoattraction! and! activation,! include! CXCL5! (epithelialSderived! neutrophilSactivating! peptide! 78,! or! ENAS78)! and! CXCL8! (ILS8).! There! are! a! total! of! 17!described!CXC!molecules!in!mammals!S!they!can!be!split!into!two!groups:!those!
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with! the! amino! acid! sequence! glutamic! acidSleucineSarginine! (ELR+)! prefacing!the!CXC!motif,!and!those!without!(ELRS).!The!ELR+!cytokines!hCXCL1,!2,!3,!5,!6,!7!and!8,!have!between!40S90%!homology!in!their!amino!acid!sequence!in!humans.!
[221][221][221][221][220][219][218][217][217][216][215][214][214][214][214][214],!214][214][214].! !ELR+! CXC! cytokines! bind! to! the! receptors! CXCR1! and! CXCR2,! and! have!potent! chemotactic! and! activatory! effects! on! neutrophilic! granulocytes.! CXCR1!and! CXCR2! are! most! abundant! and! coSexpressed! on! neutrophils.! However,!CXCR1!and!CXCR2!are!also!present!on!monocytes/macrophages!and!endothelial!cells! [222],! and! one! or! both! of! the! receptors! present! on! cytokineSactivated!dendritic!cells![223],!basophils,!T!lymphocytes,!NK!cells![224],!mast!cells![225],!and!more!recently!shown!expressed!on!some!nonSimmune!cells![226].!! By!measuring!calcium!flux! in!human!embryonic!kidney!cells! transfected!with!the!genes!encoding!CXCR1!or!CXCR2,!the!binding!of!ELR+!CXC!molecules!to!the!two!receptors!was!analysed![227,!228].!Importantly,!the!studies!showed!that!
Figure+ 1.4+ Schematic+ representations+ of+ CC+ and+ CXC+ cytokine+ structure,+ and+ of+ CXC+





























the!ligand!CXCL1!induced!calcium!influx!more!efficiently!in!CXCR2S!than!CXCR1Stransfected! cells,! suggesting! the! CXCR2! is!more! sensitive! to! the! ligand! CXCL1.!The!same!was!also!found!to!be!true!for!cytokines!CXCL2!and!CXCL5.!In!addition,!CXCR1!showed!equal!or!greater!responsiveness! to!other!ELR+!cytokines!CXCL8!and!CXCL6,!whereas!CXCR2!was!more!responsive!to!the!ligand!CXCL7![227,!228].!!
1.9.1+CXC+CHEMOKINES+IN+CANCER+! Chronic!exposure!of!cells!to!a!cytokineSrich!milieu!has!been!implicated!in!several!aspects!of!tumour!formation!and!progression,!through!the!recruitment!of!macrophages! and! T! cells! and! their! extended! activation,! atypical! angiogenesis,!and! damage! to!DNA! caused! by! locally! produced!ROS! [229,! 230].! In! fact,!many!roles!for!chemokines!and!their!receptors!have!been!described!in!different!types!of!cancer![231].!Proteomic! analysis! of! a! weakly! invasive! (RT112)! and! a! highly! invasive!(T24)!bladder!carcinoma!cell!line!identified!CXCL1!as!regulating!the!invasion!of!bladder!cancer!cells![232].!In#vitro,!CXCL1!was!able!to!enhance!cell!invasion!and!modulated!the!expression!of!proSinvasive!MMP13,!and!in#vivo,!CXCL1!correlated!with!higher!pathologic!stages! in!bladder!cancer!and! levels!of! the!chemokine! in!urine!samples!were!significantly!higher!in!patients!with!invasive!bladder!cancer!than! nonSinvasive! cancer.! CXCL1! was! found! to! be! an! independent! predictive!marker!of!invasive!phenotype!in!bladder!cancer![232].!!Similarly,! CXC! cytokines! can!modulate! tumour! angiogenesis.! In! general,!CXC!cytokines!with!an!ELR!motif!are!potent!angiogenic!factors,!and!those!lacking!the! motif! have! angiostatic! effects! in! the! presence! of! ELR+! cytokines! or! basic!fibroblast!growth!factor!(bFGF)![233,!234].!Therefore,!the!ELR!motif!appears!to!promote! angiogenesis! –! confirmed! by! the! finding! that! removal! of! the! ELR!sequence!in!CXCL8!inhibited!its!normal!angiogenic!effects!–!and!showed!that!the!different!classes!of!CXC!cytokines!have!antagonistic!effects.!Angiogenesis!is!also!indirectly! induced! by! CXCL1,! via! the! recruitment! of! VEGFSASexpressing!neutrophils!in!mice![235].!! Chemokine! analysis! of! human! gastric! tumours! showed! that! CXCL5! is!overexpressed! in! late! stage! disease,! and! that! strong! CXCL5! expression!
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corresponded! with! increased! microvascular! density! [236].! Similarly,! CXCL5!overexpression!is!indicative!of!poor!prognosis!in!patients!with!pancreatic!cancer,!and! is! possibly! due! to! its! activation! of! extracellular! signalSregulated! kinase!(ERK),! protein! kinase! B! (Akt),! and! signal! transducer! and! activator! of!transcription!(STAT)!in!human!endothelial!cells,!stimulating!angiogenesis![237].!In! hepatocellular! carcinoma,! CXCL5! expression! was! increased! in! more! highly!metastatic! HCC! cell! lines! in# vitro! and! in! tumour! samples! from! patients! with!recurrent! HCC! versus! controls! [238].! Animal! studies! showed! that! increased!CXCL5!in!HCC!cells!enhanced!tumour!growth,!lung!metastasis,!and!accumulation!of! neutrophils! in! tumours.! The! overexpression! of! CXCL5! alone,! or! given! in!combination! with! intraStumoural! neutrophils,! was! found! by! multivariate!analysis! to! be! an! independent! indicator! of! overall! survival! and! cumulative!recurrence![238].!! !These! findings,! and! others! [231],! demonstrate! the! importance! of!chemokine! signalling! in! tumour! progression,! and! suggest! that! inhibition! of!!chemokines! or! their! receptors! concurrent! with! chemotherapy! may! benefit!therapy.!
1.9.2+CXCR2+INHIBITORS+Inhibitors! of! both! CXCR1! and! CXCR2! have! been! developed! by! several!companies,! and! a! selection! of! the! better! characterised! inhibitors! are! shown! in!




























































































antagonist! AZ10397767! (AstraZeneca)! was! used! in! a! murine! lung! carcinoma!xenograft! model! to! study! the! effects! of! neutrophil! function! in! tumours! [185].!Inhibition! of! CXCR2! with! AZ10397767! was! sufficient! to! significantly! reduce!neutrophil! infiltration! and!was! associated!with! a! reduction! in! tumour! growth,!suggesting!that!this!inhibitor!may!have!potential!as!an!antiScancer!therapy.!The!CXCR2!inhibitor!SCHS527123!(ScheringSPlough)!inhibits!both!CXCR1!and!CXCR2.!However,! it! has! a!much!higher! affinity! for! CXCR2! and! is! therefore!therapeutically! CXCR2Sselective.! Using! human! colorectal! cancer! cells,! SCHS527123! was! shown! to! reduce! ILS8Sdependent! proliferation! of! cancer! cells,! as!well! as! reducing! cell! migration! and! invasion,! and! increasing! malignant! cell!apoptosis! in#vitro# [240].! Furthermore,! study! of! this! inhibitor! in#vivo! in!murine!colorectal!cancer!xenograft!models!confirmed!that!SCHS527123!treatment!could!reduce! tumour! growth! as! well! as! microvessel! density! in! comparison! with!vehicleStreated! mice.! Similar! results! were! shown! in! another! colorectal! cancer!xenograft! model! where! SCHS527123! enhanced! cancer! cell! apoptosis! and!inhibited!angiogenesis,!leading!to!reduced!metastasis![241].[239,!242S260]!1.9.2.1!COMBINED!CHEMOTHERAPY!AND!CXCR2!INHIBITION!The!use!of!CXCR2!inhibitors!in!combination!with!chemotherapy!has!also!been! investigated! in! preSclinical! trials! (Table+ 1.3).! A! CXCL8SCXCR2! autocrine!network! that! reduces! sensitivity! of! prostate! cancer! cells! to! apoptosisSinducing!therapy![261]!was!inhibited!by!the!CXCR2!antagonist!AZ10397767.!Inhibition!of!CXCR2! signalling! led! to! increased! cancer! cell! apoptosis! by! reSsensitising! these!cells! to! therapy.! Additionally,! CXCR2! inhibition! has! also! been! investigated! in!combination! with! docetaxel! chemotherapy! for! the! treatment! of! breast! cancer![242],! where! combined! docetaxel! and! reparixin! significantly! reduced! tumour!growth!in!comparison!with!docetaxel!alone.!Notably,! Acharyya! and! colleagues! [126]! used! the! inhibitor! to! disrupt! a!newly! described,! proStumoural! paracrine! network,! where! tumour! cellSderived!CXCLs! 1! and! 2! enhanced! S100A8/9! production! by! CD11b+GrS1+! MDSCs.! In!tumourSbearing! mice,! blocking! the! activation! of! CXCR2! and! the! ensuing!S100A8/9! expression! by! MDSCs! increased! the! effectiveness! of! chemotherapy!
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and! reduced!metastatic! burden.! Therefore,! the! therapeutic! benefits! of! treating!cancer! patients! with! combined! chemotherapy! and! CXCR2! inhibition! are! being!increasingly! realised.! Benefits! include! reduced! tumour! growth,! angiogenesis,!immune! escape,! tumour! cell! invasion! and! metastasis,! and! enhanced!responsiveness!to!doxorubicin,!cyclophosphamide!and!paclitaxel!chemotherapy![126,!262,!263].!
1.10+TUMOUR+NECROSIS+FACTOR+ALPHA+! The! cytokine,!TNFα,! is! a!key!modulator!of! inflammation.!Predominantly!produced! and! released!by!monocytes,!macrophages! and!neutrophils! of!M1/N1!polarisation,! TNFα! can! also! be! generated! by! such! cells! as! endothelial! cells,! T!lymphocytes!and!mast!cells.!At! the! time! it!was!named! ‘tumour!necrosis! factor’,!this! molecule! was! identified! as! a! macrophageSsecreted! product! that! caused!necrosis! of! tumours! [264].!However,! it! has! since!been! shown! that,! at! different!concentrations!and!in!certain!environments,!this!molecule!can!have!very!diverse!functions.! ! In! the! process! of! host! defence! against! infection,! TNFα! expression!plays! a! protective! role! by! recruiting! phagocytes,! stimulating! their! oxidative!respiratory!burst!and!release!of! lysosomal!enzymes![265].!However,! it!has!also!been!proven!to!be!harmful!to!the!body!–!in!autoimmunity,!cancer!and!toxic!shock!–!when!its!expression!becomes!deregulated![266,!267].!!! TNFα!binds!to!the!receptors!TNFRI!and!TNFRII,!which!have!very!different!expression;!whereas!TNFRI! is! thought! to! be! expressed! on! all! cell! types! except!erythrocytes,!TNFRII! is!more!restricted!to!haematopoietic!cells!and!endothelial!cells.!Although!both!receptors!can!be!activated!by!membraneSintegrated!TNFα,!the! TNFRI! receptor! can! also! be! triggered! by! soluble! TNFα.! As! a! negative!regulator,!both!TNFα!receptors! can!be! shed! from! the! cell! surface!and!compete!for!free!ligands.!
1.10.1+TUMOUR+NECROSIS+FACTOR+ALPHA+IN+THE+TUMOUR+ENVIRONMENT+1.10.1.1!TUMOUR!CELLSDERIVED!TNF!ALPHA!!! The!fact! that!plasma!levels!of!TNFα!were!higher! in!patients!with!poorer!prognosis! in! pancreatic! cancer! [268],! renal! cell! carcinoma! [269],! chronic!
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lymphocytic! leukaemia! [270]! and! in! metastatic! breast! cancer! [271],! and! that!malignant! cells! can!produce!TNFα! themselves! [272],! are! strong! indicators! that!TNFα!has!functions!that!are!beneficial!to!tumour!survival!and!progression.!!! With!the!development!of!a!TNFαSknockout!mouse,!tumour!growth!in!the!absence!of!TNFα!could!be!studied.!Treatment!of!mice!with!a!carcinogen!to!induce!skin! tumours! showed! that! TNFα−/−!mice!were! resistant! to! the! development! of!both!benign!and!malignant! tumours! [273],! supporting! the! connection!between!inflammation!and!carcinogenesis.!Interestingly,!in!this!model!of!skin!cancer,!lack!of! TNFα! did! not! affect! the! time! to!malignant! progression,! implying! that! TNFα!may! be! required! for! early! stages! of! carcinogenesis! but! not! the! later! stages! of!tumour!progression.!! Indeed,! constitutive! expression! of! TNFα! is! also! a! feature! of! epithelial!ovarian!cancer!cells,!where!it!supports!the!expression!of!other!factors!important!for!peritoneal!cancer!proliferation!and!metastasis,!such!as!the!chemokines!CCL2!and! CXCL12,! the! cytokines! ILS6! and! macrophage! migrationSinhibitory! factor!(MIF),!and!proSangiogenic!molecule!VEGF![274].!1.10.1.2!TNFΑ!PRODUCTION!BY!OTHER!CELLS!! As!mentioned!above,!TNFα! is! also! released!by!monocytes,!macrophages!and! neutrophils.! Production! of! TNFα! by! epithelial! and! inflammatory! cells!activates! nuclear! factor! kappa! B! (NFSkB)! –! a! key! signalling! molecule! and!hallmark! of! inflammation! –! in! hepatocytes,! contributing! to! inflammationSassociated!liver!cancer![275].!Similar!findings!were!reported!using!a!transgenic!mouse!model!of!gastric!cancer![276]!and!a!chemicallySinduced!colorectal!cancer!model! [277],! where! myeloid! cellSderived! TNFα! promoted! tumourigenic!signalling! in! cancer! and! mucosal! cells.! Prolonged! expression! of! high! levels! of!TNFα!may!also!explain!the!link!between!chronic!inflammation!and!cancer,!as! it!has!been!shown! to! cause!DNA!damage! in!Trp53–/–!malignant! cells! [278]!and! in!normal!lung!epithelial!cells![279],!in!part!via!the!upregulation!of!ROS.!!Another! aspect! of! tumour! progression! modulated! by! TNFα! is! the!induction! of! epithelialSmesenchymal! transition! (EMT)! –!which! is! linked! to! the!induction!of! an! invasive!phenotype!–! in! colon! cancer! spheroids! [280].! In!EMT,!
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epithelial! cells! lose! polarity! and! break! contact! with! adjacent! cells! and!extracellular!matrix!(ECM),!undergoing!cytoskeletal!remodelling!to!enable!their!characteristic! migratory! phenotype! [281].! Cells! undergoing! EMT! gain! such!mesenchymal! markers! as! fibronectin,! vimentin,! smooth! muscle! actin! and! NScadherin,! and! lose! such! markers! as! EScadherin! and! αS! and! γScatenin! that! are!associated!with!epithelial!cells![282].!In!the!context!of!cancer,!tumour!cell!EMT!is!associated!with!cancer!progression!and!is!a!key!mechanism!behind!tumour!cell!invasion! and! metastasis! [281],! and! macrophage! secretion! of! TNFα! led! to! an!acceleration! of! TGFSβSinduced! EMT,! implicating! macrophages! and! TNFα! in!supporting!tumour!cell!invasion!and!metastasis![280].!!
1.10.2+TNFΑXBASED+ANTIXCANCER+THERAPY+! Initially,!when!TNFα!was! identified!as!having!antiStumour! functions!and!much! less! was! known! about! its! proStumour! roles,! human! recombinant! TNF!(rTNF)!was!injected!systemically!as!a!form!of!cancer!therapy,!with!the!hopes!of!inducing! haemorrhagic! tumour! necrosis.! However,! higher! doses! of! rTNF!were!associated!with!severe!side!effects,!including!headache,!rigors,!hypotension!and!pulmonary! oedema,! and! in! several! cases,! tumour! progression! [283].! Notably,!however,! lower! doses! of! rTNF!were! better! tolerated! and! showed! partial! antiScancer!effect![284].!! With! increasing! evidence! that! implicates! TNFα! in! the! promotion! of!tumour! development! rather! than! their! destruction,! the! focus! of! TNFαSbased!cancer!therapies!shifted!towards!blocking!TNFα!in!cancer.!AntiSTNFα!antibodies!were! effective! in! reducing! tumour! metastasis! in! a! murine! fibrosarcoma!metastasis!model![285],!not!only!demonstrating!the!role!of!TNFα!in!controlling!metastasis,! but! that! TNFα! inhibition! had! therapeutic! effect,! at! least! in!murine!cancer.!! To! determine! the! effects! of! TNFα! on! human! pancreatic! ductal!adenocarcinoma! (PDAC)! cells,! the! invasive! growth! of! three! cell! lines! following!treatment!with!TNFα!was!assessed,!and!was!shown!to!be!significantly!increased!both! in#vitro! and! in#vivo! [286].! Furthermore,! TNFα! treatment! of! orthotopically!xenotransplanted! PDAC! tumours! in! mice! significantly! increased! tumour! cell!
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• Degradation!of!the!extracellular!matrix!The!general!consensus!of!most!experts!in!the!field!of!TNFα!biology!is!that!TNFα! antagonist! therapy! is! effective! and! safe,! and! a! useful! addition! to! the!arsenal!of!antiScancer!therapies![288,!289],!but!requires!more!understanding!of!the!relative!importance!of!tumour!cell!and!stromal!TNFα!contributions!in!human!cancers,! and! the! identification! of! the! subgroups! of! cancer! patients! for! which!TNFα!antagonism!will!be!most!beneficial.!!!!!
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1.11+MACROPHAGES+AND+NEUTROPHILS+IN+THE+
CHEMOTHERAPYXTREATED+TUMOUR+ENVIRONMENT+! Evidence! is!accumulating! for! the! function!of! tumourSassociated! immune!cells!being!altered!during!chemotherapy!treatment![126,!162,!212,!290,!291],!as!shown!in!Fig+1.5.!!
1.11.1+MYELOID+CELLS+AFFECT+RESPONSE+TO+CHEMOTHERAPY+! In#vitro,! cervical! and!ovarian! cancer! cell! lines! treated!with! cisplatin!and!carboplatin!were!able!to! induce!an!M2!phenotype!in!coScultured!monocytes,!as!seen!by! their! increased! expression! of! ILS10! and! activation! of! STAT3! signalling![291].!The!mechanism!of!the!response!involved!tumour!cell!NFSκB!signalling!and!tumour!cellSderived! ILS6!and!PGE2,!suggesting! that!use!of!COXSinhibitors!or! ILS6R!inhibitors!simultaneously!with!chemotherapy!may! impede!the!development!of! chemoresistance.! Evidence! that! myeloid! cells! can! adopt! a! proStumour!phenotype!particularly!after!chemotherapy!is!also!supported!in#vivo.!In!a!mouse!mammary! (MMTVSPyMT)! tumour! implant!model,! the!effects!of! paclitaxel! (PTX)! treatment! were! investigated.! This! resulted! in! mammary!epithelial! cells! upregulating! CSFS1! and! ILS34,! ligands! of! the! CSFS1! receptor!CSF1R! [162].! Consequently,! increased!macrophage! infiltration! into! the! tumour!was! observed! and! inhibition! of! CSF1RSsignalling! reduced! PTXSinduced!macrophage! accumulation,! slowed! primary! tumour! growth,! decreased!angiogenesis! and! metastasis,! and! an! initiation! of! antiStumour! CD8+! TScell!responses.!! Similarly,! myeloid! cells! accumulated! in! PyMT! tumours! in! response! to!doxorubicin! therapy,! but! regulated! by! the! chemokine! receptor! CCR2! [212].! A!comparison! of! PyMT! tumours! grown! in! Ccr2+/−! or! Ccr2−/−! mice! that! lack! host!CCR2,! showed! that! its! absence! was! associated! with! a! significantly! improved!response.!Tumours!relapsed!significantly!later!in!Ccr2−/−!mice!when!treated!with!either!doxorubicin!or! cisplatin! chemotherapy,! and!were!of! a! lower!histological!grade!than!controls.!
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! Further! support! of! the! chemotherapySinduced! macrophage! proStumour!phenotype,! also! in! the! PyMT!model,! came! from! another! study! confirming! that!PTXSinduced! accumulation! of! macrophages! in! tumours,! and! that! macrophage!release!of!cathepsin!proteases!protected!the!tumour!against!PTX,!etoposide!and!doxorubicin![290].!As!expected,!concurrent!cathepsin!inhibition!with!PTX!in#vivo!made! both! primary! and!metastatic! tumours! more! susceptible! to! treatment.! A!summary!of!these!findings!can!be!seen!in!Fig+1.5.!
1.11.2+A+PARACRINE+NETWORK+BETWEEN+TUMOUR+AND+MYELOID+CELLS+PROMOTES+
TUMOUR+GROWTH+AND+METASTASIS+! A! recent! study! in! a! mouse! mammary! tumour! model! has! shown! that!communication!between!tumour!cells,!neutrophils!and!endothelial!cells!supports!





































tumour!chemoresistance!and!metastasis!(Fig+1.6)![126].!Hyperactivation!of!the!4q21! region! in! some! breast! tumours! [292],! which! leads! to! excessive!transcription! of! CXCLs! 1! and! 2! (as! well! as! CXCLs! 3S8),! was! shown! to! recruit!CD11b+Gr1+!myeloid!cells!(possibly!neutrophils)!into!the!tumour.!PyMT!tumour!cells! and! LM2! cells! (metastatic! breast! cancer! cells! derived! from! the!MDASMBS231!parental! line)!were!treated!with!shRNA!hairpins!to!knockdown!CXCL1!and!CXCL2.! When! injected! into! mice,! CXCL1/2! knockdown! specifically! in! tumour!cells! was! shown! to! significantly! reduce! CD11b+Gr1+! cell! infiltration,! which!correlated!with! the! finding! that!CXCR2! receptor! expression!was!highest! in! the!CD11b+Ly6G+! population! (Ly6G! is! together! with! Ly6C! a! component! of! the!myeloid!differentiation!antigen!GrS1)!in!PyMT!tumours![126].!! Gene!expression!analysis!showed!that!genes!upregulated!in!human!breast!tumours!and!metastases!in!association!with!CXCL1,!include!the!survival!factors,!S100A8!and!S100A9.!These!proteins!–!associated!with!chronic!inflammation!and!cancer! –! were! highly! expressed! by! CD11b+Gr1+! cells,! and! the! growth! and!metastasis! of! mammary! tumours! were! significantly! reduced! in! mice!
Figure+ 1.6+TumourXderived+ CXCL1/2+ recruits+ S100A8/9Xexpressing+ granulocytic+ cells+
to+ the+ tumour+ and+ promotes+ metastasis.+Murine! breast! cancer! cells! express! CXCL1! and!CXCL2! that! recruit!CD11b+Gr1+! cells! to! the! tumour.! Subsequently,!CD11b+Gr1+! cells! release!S100A8! and! S100A9! in! the! tumour! environment,! thereby! supporting! tumour! growth! and!metastasis.! Treatment! with! chemotherapy! upregulates! TNFα! release! by! endothelial! cells!which!further!amplifies!CXCL1!expression!by!tumour!cells.!Adapted!from![287].!
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transplanted!with!S100A9S/S!bone!marrow,! in!comparison!with! their!S100A9+/+!counterpart![126].!! Notably,!the!paracrine!loop!between!tumour!cell!secretion!of!chemokines!CXCL1! and! CXCL2,! their! recruitment! of!myeloid! cells! to! the! tumour,! and! their!subsequent!expression!of!S100A8/9!to!support! tumour!growth!and!metastasis,!was! present! in! control! tumourSbearing! mice.! Treating! these! mice! with!doxorubicin! and! cyclophosphamide! chemotherapy! caused! a! significant!upregulation! of! CXCL1/2! in! tumours,! as! well! as! an! increase! in! S100A9Sexpressing!cells.!The!mechanism!behind!the!amplification!of!the!paracrine!loop!by! chemotherapy! was! discovered! to! be! due! to! an! upregulation! of! TNFα! by!stromal! cells! –! including! endothelial! cells,! unidentified! bone! marrowSderived!cells,!and!smooth!muscle!cells!–!as!a!direct!effect!of!chemotherapy.!!Such! findings! led! to! the! hypothesis! that! inhibition! of! CXC! chemokine!signalling! alongside! chemotherapy! may! have! a! synergistic! effect,! preventing!recruitment! of! CD11b+Gr1+! cell! accumulation! in! the! tumour! after! therapy! and!their!subsequent!support!of!tumour!growth!and!metastasis.!Indeed,!inhibition!of!the! CXCR2! receptor! using! the! antagonist! SB! 265610! (Tocris! Bioscience)! that!binds! the! ligands! CXCL1! and! CXCL2,! concurrent! with! doxorubicin! and!cyclophosphamide! therapy,! significantly! reduced! both! tumour! growth! and!metastasis,!as!summarised!in!Fig+1.6.![293]!! These! studies! clearly! show! that! myeloid! cells! dominate! tumour!responsiveness! to! chemotherapy! since! they! can! blunt! the! chemotherapeutic!response.!The!evidence!discussed!here!–!in!mammary!tumour!models!and!with!different!chemotherapies!–!indicates!that!combined!targeting!of!the!tumour!and!its!microenvironment!is!important.!!
1.12+CONCLUSION+TumourSinfiltrating! myeloid! cells! are! an! important! component! of! most!solid! tumours.! They! accumulate! in! tumours! in! response! to! the! release! of!chemokines! by! tumour! cells! and! other! myeloid! cells! present! in! the! tumour.!Myeloid! cells! display! great! phenotypic! plasticity! in! response! to! changes! to! the!
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local! environment,! which! has! implications! in! a! wide! range! of! inflammationSassociated! disorders! and! cancers.! Extra! layers! of! complexity! are! continually!added! to! the! classical! view! that! macrophages! and! neutrophils! are! hostSprotecting!cells!that!combat!disease,!demonstrating!that!within!the!macrophage!and!neutrophil!cell!types!exist!phenotypically!distinct!subsets.!!Since!chemotherapy!can!cause!changes!in!the!tumour!microenvironment!–! including! cell! death! by! apoptosis/necrosis,! and! in! some! cases! exacerbating!tumour!inflammation![210]!–!this!is!likely!to!have!an!effect!on!the!polarisation!of!intratumoural! macrophages! and! neutrophils.! Although! the! polarisation! and!function!of!myeloid!cells! in!chemotherapyStreated!tumours! is!becoming!a! topic!of!interest!(Fig+1.5),!few!studies!have!investigated!macrophage!gene!expression!specifically! in! the! chemotherapyStreated! tumour! environment.! Similarly,!although! some! studies! have! investigated! tumourSassociated! neutrophil,! and!N1/N2!neutrophil!gene!expression![75,!146,!294,!295],!very!little!is!known!about!human! neutrophil! gene! expression! in! the! chemotherapyStreated! tumour!environment,!or!their!crosstalk!with!macrophages.!
1.13+HYPOTHESIS+! My!hypothesis!is!that!following!chemotherapy,!the!harsh!conditions!in!the!tumour!microenvironment!will! lead! to! an! alteration! of!myeloid! cell! activation!and/or!polarisation,!such!that!these!cells!accumulate!in!the!tumour!and!increase!their!tumour!promoting!activity.!
1.14+AIMS+! The!aims!of!this!thesis!were!to:!
• Investigate! what! effects! chemotherapyStreatment! of! the! tumour!environment! has! on! macrophage! gene! expression! using! microarray!technology!!
• Study! the! crosstalk! between!macrophages! and! neutrophils! via! cytokine!release,! and! how! this! affects! neutrophil! gene! expression! and! function!within! spheroidSbased! model! of! a! chemotherapyStreated! tumour!microenvironment.!
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Reagent+ Supplier+4SHydroxy!Cyclophosphamide!(Cyclophosphamide)! Santa!Cruz!Biotechnology!Inc,!Heidelberg,!Germany;!Santa!Cruz!Biotechnology!(Shanghai)!Co.!Ltd,!Shanghai,!China!AB!serum!(human)! SigmaSAldrich!Inc,!Poole,!Dorset,!UK;!SigmaSAldrich!Pte!Ltd,!Singapore!Acetic!acid! BDH!Ltd,!Poole,!Dorset,!UK;!Fisher!General!Scientific!(SEA)!Pte!Ltd,!Singapore!Agarose!type!V! SigmaSAldrich!Co.!Ltd,!Poole,!Dorset,!UK!Bovine!serum!albumin!(BSA)! SigmaSAldrich!Co.!Ltd,!UK;!SigmaSAldrich!Pte!Ltd,!Singapore!Cell!TrackerTM! Life!Technologies!Ltd,!Paisley,!UK;!Life!Technologies!Holdings!Pte!Ltd,!Singapore!Cyclophosphamide! See#4JHydroxy#Cyclophosphamide#DAPI! Molecular!Probes,!Life!Technologies,!Paisley,!UK!Dimethylsulphoxide!(DMSO)! SigmaSAldrich!Inc,!Poole,!Dorset,!UK;!SigmaSAldrich!Pte!Ltd,!Singapore!DMEM! BioWhittaker!UK!Ltd,!Wokingham,!UK;!Life!Technologies!Holdings!Pte!Ltd,!Singapore!Docetaxel!(Taxotere®)! SigmaSAldrich!Co.!Ltd,!UK;!Singlab!Technologies!Pte!Ltd,!Tocris!Biosciences,!Singapore!Ethanol! Fisher!Scientific!Ltd,!Leicestershire,!UK;!Fisher!General!Scientific!(SEA)!Pte!Ltd,!Singapore!FicollSPaque™!PLUS! Amersham!Biosciences,!Buckinghamshire,!UK;!Amersham!Biosciences,!Singapore!
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HetaSep™!! STEMCELL!Singapore!Pte!Ltd,!Singapore!Iscove's!Modified!Dulbecco's!Medium!(IMDM)! BioWhittaker!UK!Ltd,!Wokingham,!UK;!Life!Technologies!Holdings!Pte!Ltd,!Singapore!LSGlutamine!! BioWhittaker!UK!Ltd,!Poole,!Dorset,!UK;!Life!Technologies!Holdings!Pte!Ltd,!Singapore!Methanol! Fisher!Scientific!Ltd,!Leicestershire,!UK;!Fisher!General!Scientific!(SEA)!Pte!Ltd,!Singapore!Paclitaxel!(Taxol®)! SigmaSAldrich!Co.!Ltd,!UK!Paraformaldehyde! SigmaSAldrich!Co.!Ltd,!Poole,!Dorset,!UK;!Fisher!General!Scientific!(SEA)!Pte!Ltd,!Singapore!PhosphateSbuffered!saline!(PBS)! SigmaSAldrich!Co.!Ltd,!Poole,!Dorset,!UK;!SigmaSAldrich!Inc,!Singapore!Power!SYBR®!Master!Mix! Life!Technologies!Holdings!Pte!Ltd,!Singapore!Prolong!Gold!AntiSfade!reagent! Molecular!Probes,!Life!Technologies,!Paisley,!UK!Propidium!iodide! SigmaSAldrich!Co.!Ltd,!Poole,!Dorset,!UK!ToPRO®S3! Life!Technologies!Holdings!Pte!Ltd,!Singapore!Triton!x100! SigmaSAldrich!Co.!Ltd,!Poole,!Dorset,!UK!
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TRIzol®!! Life!Technologies!Holdings!Pte!Ltd,!Singapore!Trypsin/EDTA!(0.04%/0.03%)! BioWhittaker!UK!Ltd,!Wokingham,!UK;!Life!Technologies!Holdings!Pte!Ltd,!Singapore!TweenS20! BDH!Laboratories!Suppliers,!Poole,!Dorset,!UK!Vacutainer®!tubes!! BD!Biosciences,!Singapore!
+
2.1.2+MATERIALS+
Material+ Supplier+25cm2!and!75cm2!tissue!culture!flasks! Greiner!BioSOne!Ltd,!Gloucestershire,!UK;!Corning!Singapore!Holdings!Pte!Ltd,!Singapore!6Swell,!12Swell!and!24Swell!tissue!culture!plate! Greiner!BioSOne!Ltd,!Gloucestershire,!UK;!Corning!Singapore!Holdings!Pte!Ltd,!Singapore!Cover!slips! BDH!Ltd,!Poole,!Dorset,!UK!Glass!microscopic!slides! BDH!Ltd,!Poole,!Dorset,!UK!iQ™!96SWell!PCR!Plates! BioSRad!Laboratories!Pte!Ltd,!Singapore!Transwell®!Permeable!Supports! Corning!Holding!GmbH,!Wiesbaden,!Germany;!Corning!Singapore!Holdings!Pte!Ltd,!Singapore!
+
2.1.3+MONOCLONAL+(M)+AND+POLYCLONAL+(P)+ANTIBODIES+AND+ANTISERA+
Antibody+(clone)+ Supplier+Rat!m!antiSCD11b! BioLegend!UK!Ltd,!London,!UK!Rat!m!antiSmouse!F4/80! Serotec,!Oxford,!UK!Rat!m!antiSmouse!Ly6G!(1A8)! BioLegend!UK!Ltd,!London,!UK!Rat!m!antiSmouse!TNFα!FITC!(LEAF™!purified)! BioLegend!UK!Ltd,!London,!UK!Rabbit!p!antiSactive!Caspase!3! Abcam!Plc,!Cambridge,!Cambridgeshire,!UK!Rabbit!p!antiSCD31! BD!Biosciences,!Erembodegem,!Belgium!Rabbit!p!antiSGRO!alpha!! Abcam!Plc,!Cambridge,!Cambridgeshire,!UK!FcR!Blocking!Reagent! Miltenyi!Biotec,!Surrey,!UK!Mouse!m!antiSCXCR2! Abcam!Plc,!Cambridge,!Cambridgeshire,!UK!Mouse!m!antiShuman!TNFα! Abcam!Plc,!Cambridge,!Cambridgeshire,!UK!
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(LEAF™!purified)!Goat!m!antiSrat!AlexaFluor®!555! Molecular!Probes,!Life!Technologies,!Paisley,!UK!Goat!m!antiSrat!AlexaFluor®!633! Molecular!Probes,!Life!Technologies,!Paisley,!UK!Goat!m!antiSrabbit!APC! R&D!Systems!Europe!Ltd,!Abingdon,!UK!
+
2.1.4+COMMERCIAL+KITS+
Kit+ Supplier+CD16!Microbeads,!Human! Miltenyi!Biotec!Asia!Pacific!Pte!Ltd,!Singapore!HumanHTS12!v4!Expression!BeadChip!Kit! Illumina!Singapore!Pte!Ltd,!Singapore!Human!CXCL1/GRO!alpha!Quantikine!ELISA!Kit!! Singlab!Technologies!Pte!Ltd,!R&D!Systems!Inc,!Singapore!RNeasy!Mini!and!Rneasy!Micro!Kits! QIAGEN!Singapore!Pte!Ltd,!Singapore!RNaseSfree!DNase!Set! QIAGEN!Singapore!Pte!Ltd,!Singapore!Superscript!II! Life!Technologies!Holdings!Pte!Ltd,!Singapore!TaqMan®!Reverse!Transcription!Reagents! Life!Technologies!Holdings!Pte!Ltd,!Singapore!TargetAmp!NanoSg!BiotinSaRNA!Labelling!kit! Illumina!Singapore!Pte!Ltd,!Singapore!
++
2.1.5+INSTRUMENTATION+
Instrument+ Supplier+2100!Bioanalyzer! Agilent!technologies!Bead!Array!Scanner!500!GTX! Illumina!CFX96!Touch™!RealSTime!PCR!Detection!System! BioSRad!Laboratories!Pte!Ltd,!Singapore!Confocal!Microscope!Zeiss!LSM!510! Zeiss,!Hertfordshire,!UK!
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FACSAria!II!4Slaser! BD!Biosciences,!Singapore!FACSCalibur!Flow!Cytometer! BD!Biosciences,!Cowley,!Oxford,!UK!FACSCanto!II!Flow!Cytometer! BD!Biosciences,!Singapore!Infinite®!200!PRO!series! Tecan!Asia!Pte!Ltd,!Singapore!NanoDrop!Spectrophotometer2000! Thermo!Scientific,!Wilminton,!USA;!Fisher!Scientific!Pte!Ltd,!Singapore!Spectrophotometric!plate!reader! Anthos!Labtec!Instruments,!GmbH,!Wals,!Austria!!
2.1.6+SOLUTIONS+
Phosphate+buffered+saline+(PBS)+Add! 5! PBS! tablets! to! 1L! dH2O! (0.01!M! phosphate! buffer,! 0,0027!M! potassium!chloride!and!0.137!M!sodium!chloride),!pH!to!7.4!and!store!at!room!temperature.!!
Phosphate+buffered+saline+with+tween+20+(PBST)+Add!500μL!tween!20!to!1L!PBS.!!







2.1.7+PRIMERS+Primers! were! validated! by! members! of! the! research! group,! or! were!published! already! in! the! literature;! validation! included! the! construction! of! a!standard!curve!from!experiments!using!varying!template!concentrations,!as!well!as!specificity!verification!by!melt!curve!and!gel!analysis.!




2.2.1+CELL+CULTURE+2.2.1.1!MAINTAINING!CELL!LINES!! Adherent!A549!human!lung!adenocarcinoma!cells!(ATCC)!were!cultured!in! 75cm2! culture! flasks! in! DMEM! (10%! FCS! and! 2mM! LSGlutamine).! When!passaging! cells,! DMEM! was! removed! and! the! cells! were! washed! with! HBSS!(without! Ca2+! and! Mg2+).! Subsequently,! 3mL! of! trypsin/EDTA! solution! were!added! to! each! flask! and! kept! at! 37oC!until! cells! could! be!detached!with! gentle!agitation.!Five!millilitres!of!DMEM!(with!10%!FCS)!were!then!added!to!neutralise!the! trypsin/EDTA!solution.!Cells!were!pelleted!by!centrifuging!at!400!x!g! for!5!minutes,! resuspended! in! fresh! DMEM! and! counted! using! a! CSChip!haemocytometer!(Neubauer!improved).!For!standard!culture,!cells!were!seeded!at! a! density! of! 1! x! 106! per! flask! and! passaged! when! approximately! 80%!confluent.!2.2.1.2!CRYOPRESERVATION!OF!CELL!LINES!Cells!were! stored! in! cryopreservation! vials,! each! aliquot! containing! 2! x!106!cells!resuspended!in!1mL!cryopreservation!medium.!Vials!were!kept!on!ice!and!quickly!moved!to!a!freezing!container!to!control!the!cooling!of!cells!to!S80oC!overnight.!Vials!were!subsequently!kept! in! liquid!nitrogen!for!storage.!To!thaw!cells,!vials!were!placed! in!a!37oC!waterbath!until!almost! fully!defrosted,!before!being! added! to! 9mL! DMEM! (containing! 10%! FCS,! 2mM! LSGlutamine! and! preSwarmed!to!37oC).!The!cells!were!then!pelleted!by!centrifugation!at!400!x!g!for!5!minutes,!resuspended!in!10mL!DMEM!(containing!FCS!and!LSGlutamine!and!preSwarmed! to! 37oC)! and! transferred! to! a! 75cm2! tissue! culture! flask.! The! culture!medium! was! replaced! after! 2! hours! to! remove! debris! and! cells! that! had! not!attached.!2.2.1.3!ISOLATION!OF!HUMAN!MONOCYTES!FROM!PERIPHERAL!BLOOD!! Peripheral! blood! monocytes! were! isolated! from! waste! Buffy! coats!provided! by! the! National! Blood! Service,! Sheffield,! or! from! blood! cones,!Singapore.! Blood!was!diluted!1:1!with!HBSS! (without!Ca2+! or!Mg2+)! and!30mL!diluted! blood! were! layered! on! top! of! 20mL! FicollSPaque.! This! was! then!
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centrifuged!at!1200!x!g! for!20!minutes!with!brake!set! to!0.!The!monocyteSrich!layer! was! collected! and! placed! into! a! 50mL! centrifuge! tube,! which! was! preScoated! with! HBSS! (without! Ca2+! or! Mg2+)! and! preSchilled! on! ice.! Cells! were!pelleted! by! centrifuging! at! 400! x! g! for! 5! minutes! and! then! washed! by!resuspending! in! HBSS! (without! Ca2+! or! Mg2+)! and! centrifuging! again.! The!remaining! erythrocyte! contamination! was! then! removed! by! resuspending! the!cell! pellet! in! 5mL! red! blood! cell! lysis! solution! for! 5! minutes.! At! which! point,!45mL!of!HBSS!(without!Ca2+!or!Mg2+)!were!added!and!centrifuged!at!400!x!g!for!5!minutes.!For!gene!expression!studies,!the!monocytes!were!further!purified!by!magnetically! isolating! CD14+! cells! using! CD14! MicroBeads,! according! to! the!manufacturer’s! instructions.!Monocytes!were! resuspended! in!5mL! IMDM!(with!10%! human! serum! and! 2mM! LSGlutamine)! and! counted.!Monocyte! purity! has!been! tested! previously! by! members! of! this! research! group! by! measuring! the!number!of!CD14Sexpressing!cells!by!flow!cytometry,!and!was!determined!to!be!95S98%.!2.2.1.4!GENERATING!MONOCYTESDERIVED!MACROPHAGES!! FreshlySisolated! monocytes! were! seeded! into! tissue! culture! plates! at! a!density!of!2!x!106!per!well!of!a!6Swell!plate,!or!the!equivalent!for!12S!and!24Swell!plates,!in!IMDM!(with!10%!human!serum!and!2mM!LSGlutamine).!After!allowing!monocytes! to! adhere! for! 1! hour,!medium! and! unattached! cells! were! removed!and! replaced!with! fresh! IMDM.!Monocytes!were! differentiated! into!monocyteSderived!macrophages! (MDMs)!by! their!adherence! to! culture!plates!and!culture!for!7!days.!Medium!was!changed!for!fresh!IMDM!every!2!days.!2.2.1.5!ISOLATION!OF!HUMAN!NEUTROPHILS!FROM!PERIPHERAL!BLOOD!Human!neutrophils!were! isolated! from!peripheral! blood!by!diluting! the!blood! 1:1! with! wash! buffer! and! layering! on! an! equal! volume! of! Ficoll,! before!centrifugation!at!1200!x!g!for!20!minutes!with!brake!set!to!0!and!temperature!set!to!4oC.!Subsequently,!plasma!and!mononuclear!cell!layers!were!removed!and!the!erythrocyteSrich! pellet! was! collected.! Erythrocytes! were! crossSlinked! using!HetaSep!to!enhance!sedimentation,!where!1!part!HetaSep!was!added!to!5!parts!blood! and! mixed! gently.! The! blood/HetaSep! mixture! was! then! left! at! room!temperature! until! the! plasma:RBC! interface! was! at! approximately! 50%! of! the!
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total! volume,! according! to! the!manufacturer’s! instructions.! The! leukocyteSrich!supernatant!was!then!collected!and!washed!in!wash!buffer,!before!pelleting!the!cells!by!centrifugation!at!120!x!g!for!10!minutes.!A!CD16!Microbead!Kit!was!then!used,!according!to!the!manufacturers! instructions,!to!select! for!neutrophils!and!remove!eosinophil!contamination.!Neutrophils!were!>95%!pure,!as!determined!by! cytospin! and/or! flow! cytometry.! Freshly! isolated! neutrophils! are! shown! in!
Fig+2.1.!!
+
2.2.2+COXCULTURE+OF+MDMS+AND+CHEMOTHERAPYXTREATED+TUMOUR+CELLS+! A549!cells!were!treated!with!10µM!paclitaxel!or!docetaxel!for!96!hours!in!75cm2! culture! flasks! in! IMDM.! As! a! control,! an! equal! volume! of! the! vehicle!(DMSO)!was!also!used.!The!media!and!soluble!factors!were!collected!(including!dead/detached! cells)! and! adherent! cells! were! detached! with! Trypsin/EDTA,!diluted!in!IMDM,!and!pelleted!by!centrifugation!at!400!x!g!for!5!minutes.!Tumour!cells!were!then!resuspended!to!a!concentration!of!1!x!106!per!mL!in!the!collected!conditioned!media!with! tumourSsecreted! factors.! A! total! of! 2! x! 106! cells!were!either! placed! directly! on! top! of! MDMs! in! 6! well! plates,! or! for! Transwell!experiments,!were!added!to! the!upper!chamber!of!a!Transwell!plate!(pore!size!0.3µm)!where!MDMs!were!in!the!lower!chamber.!Cells!were!then!coScultured!for!5!hours.!For!direct!coScultures!(Figs+3.2!and!3.3)!a!short!treatment!(5!minutes)!with!Trypsin/EDTA!was!used! to!detach! the! tumour! cells! so! that! they! could!be!























washed!off,! and! the!MDMs! could!be! collected! since! they! remain! attached! after!this!short!treatment!–!this!method!was!shown!in!Fig+2.2+to!produce!a!>95%!pure!population!of!macrophages,!and!has!been!reported!previously![296].!
!
2.2.3+CULTURE+OF+NEUTROPHILS+FOR+16+HOURS+IN+CONDITIONED+MEDIA+FROM+
MACROPHAGEXINFILTRATED+SPHEROIDS+! For! the! analysis! of! neutrophil! gene! expression,! freshlySisolated!neutrophils!were!seeded!at!a!density!of!5!x!106!per!well!of!a!6Swell!plate!in!2mL!of!conditioned!media.!Neutrophils!were!then!kept!at!37oC!for!16!hours!to!allow!changes! in! their! gene! expression.! Subsequently,! neutrophils! and! media! were!collected!and!centrifuged!to!pellet!the!cells.!The!supernatant!was!removed,!and!neutrophils!were!resuspended!and!lysed!in!500µL!TRIzol,!before!proceeding!to!RNA!extraction!steps.!
Figure+2.2++A+5Xminute+trypsin+treatment+is+sufficient+to+detach+A549+cells+ following+coX
culture+ with+ monocyteXderived+ macrophages.+ SevenSday! monocyte! derived! macrophages!(MDMs)!were! labelled!with! CellTracker!green!dye,! then! coScultured!with!A549!cells! that!had!been! treated!with! docetaxel! (10µM)! for! 96! hours.! A! 5Sminute! treatment! with! trypsin/EDTA!solution! at! 37oC! was! sufficient! to! remove! A549! cells,! leaving! a! (>95%)! pure! population! of!conditioned! MDMs,! as! determined! by! flow! cytometry! based! on! CellTracker! labelling.! (A)!Unlabelled! macrophages! (red! circle)! are! negative! for! CellTracker.! (B)! CellTracker! efficiently!labels!99%!of!MDMs! (red! circle)!with!only!1%! of!MDMs! not! labelling! (blue! circle).! (C)!A549!cells!(unlabelled;!blue!circle)!can!be!selectively!detached!by!a!5Sminute!trypsin!treatment!and!discarded,!leaving!a!98%!pure!population!of!labelled!MDMs!(red!circle).!
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2.2.4+TUMOUR+SPHEROIDS+2.2.4.1!CULTURING!TUMOUR!SPHEROIDS!To!make!tumour!spheroids,!100µL!of!a!1.5%!agarose!solution!(in!DMEM!without!serum!or!LSGlutamine)!were!added!to!each!well!of!a! flatSbottomed!96Swell!plate!using!a!multichannel!pipette.!After!allowing!agarose!solution!to!set!at!room!temperature,!1.5!x!104!cells!were!added!to!each!well! in!IMDM!(with!10%!human!serum!and!2mM!LSGlutamine)!in!a!volume!of!200µL.!IMDM!was!used!to!accommodate!the!human!monocytes!that!were!to!be!added!later,!and!the!agarose!coating!of!wells!provided!a!nonSadherent,!curved!surface!(due!to!the!meniscus),!on!which!spheroids!could!form.!The!cells!were!then!kept!at!37oC!and!monitored!for! the! formation! of! spheroids! and! a! necrotic! core! (see! Fig+ 2.3).! Half! of! the!medium!was!removed!and!replaced!with!fresh!medium!every!2S3!days.!
2.2.4.2!MONOCYTE!INFILTRATION!AND!CHEMOTHERAPY!TREATMENT!OF!TUMOUR!SPHEROIDS!! Spheroids! were! grown! for! 8S12! days,! at! which! point! almost! all! had!developed! a! necrotic! core,! which! were! visible! when! using! a! 10x! bright! field!microscope.! To! each! spheroid,! 1! x! 105! freshlySisolated! peripheral! blood!monocytes! were! added,! which! had! been! labelled! with! CellTracker! Green,!according! to! the! manufacturer’s! instructions,! detailed! in! brief! in! section+
2.2.10.1.!At! the! same! time,! chemotherapy!groups! received!docetaxel! such! that!the!final!concentration!in!each!well!was!10µM.!It!should!be!noted!that!the!in#vitro!spheroid!assays!conducted!here!could!be!adapted!to!investigate!the!response!of!
Figure+ 2.3+ A549+ human+ lung+ adenocarcinoma+ spheroids:+ Light+ microscopic+ images.+A549!spheroids!at!3,!6,!10!and!14!days.!N,!necrosis;!V,!viable!rim.!Scale!bar!=!100µm.!Figure!provided!by!Dr.!Simon!Tazzyman!in!Professor!Lewis’s!group,!Sheffield.!






existing,!resident!TAMs!to!chemotherapyStreated!tumour!cells!in!the!context!of!a!3D! tumour!mass.! ! For! this,!monocytes!would! be! allowed! to! first! infiltrate! into!A549!spheroids!(and!differentiate! into!TAMs!S! if,! indeed,! this!occurs! in! tumour!spheroids)! before! the! spheroids! were! exposed! to! docetaxel.! Additionally,!spheroids! could! be! treated! with! docetaxel! first,! and! then! coScultured! with!monocytes!–!in!order!to!model!the!possible!effects!of!a!docetaxel!treated!tumour!microevironment! on! gene! expression! by! new,! tumourSinfiltrating! monocytes.!This!is!discussed!further!in!section+3.5.!
+2.2.4.3+COLLECTION+OF+CONDITIONED+MEDIA+FROM+CHEMOTHERAPYXTREATED+
TUMOUR+SPHEROIDS+INFILTRATED+WITH+MONOCYTES+Monocytes!were!allowed!to!infiltrate!and!differentiate!for!48!hours,!after!which,!spheroids!and!media!were!collected!using!a!P1000!pipette!with!a!cut!tip,!and! placed! in! 15mL! centrifuge! tube.! Throughout! the! process! tubes!were! kept!cool!on!ice.!Once!spheroids!had!settled!to!the!bottom!of!the!tube,!all!the!medium!was! removed! and! placed! in! a! new! 15mL! centrifuge! tube.! Any! remaining! cells!were!removed!by!centrifugation!at!500!x!g!for!10!minutes,!and!filtration!through!a!0.22µm!pore!size!syringe!filter.!
2.2.5+RNA+EXTRACTION+2.2.5.1!RNA!EXTRACTION!FROM!MONOLAYERSCULTURED!MACROPHAGES!AND!NEUTROPHILS!! Macrophage!and!neutrophil!total!RNA!was!isolated!using!TRIzol!and!RNA!was! purified! using! the! RNeasy! Mini! kit,! according! to! the! manufacturers’!instructions.! Throughout! the! RNA! extraction! and! cDNA! synthesis! procedures,!samples! were! kept! on! ice,! RNaseSfree! pipette! tips,! RNaseSfree! water,! and!nuclease! microtubes! were! used.! Briefly,! macrophages! and! neutrophils! were!placed!on!ice!and!lysed!and!scraped!with!TRIzol.!The!cell!lysate!was!transferred!to! microtubes! and! homogenised! by! adding! chloroform! and! inverting! several!times!to!mix.!Samples!were!centrifuged!and!the!RNAScontaining!aqueous!phase!collected.!Seventy!percent!ethanol!was!added!to!the!solution!and!then!pipetted!into!RNeasy!spin!columns!and!centrifuged!to!collect! the!RNA!in!the!columns.!A!DNase! step! was! included! at! this! point! to! eliminate! DNA! contamination!
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(according!to!the!manufacturer’s!instructions).!Columns!were!then!washed!with!buffer!RW1!and!RPE!and!purified!RNA!was!collected!in!new!2mL!microtubes!by!centrifugation,!eluting!in!40µL!of!RNaseSfree!water.! Isolated!RNA!was!stored!at!!!!S80oC.!2.2.5.2!RNA!EXTRACTION!FROM!SORTED!MYELOID!CELLS!! For! gene! expression! analysis! of! FACS! sorted! myeloid! cells! the! same!procedure!was!used!as!described!above!with!the!following!changes:!
• An!RNeasy!Micro!kit!was!used!to! isolate!total!RNA!from!sorted!myeloid!cells,!according!to!the!manufacturer’s!instructions.!
• Cell! numbers! between! experimental! groups! were! normalised! before!isolating!total!RNA.!!
• RNA!was!eluted!in!14µL!RNaseSfree!water.!
2.2.6+SYNTHESIS+OF+CDNA+AND+REALXTIME+PCR+ANALYSIS+2.2.6.1!CDNA!SYNTHESIS!!! For!cDNA!synthesis,!0.5S1.0µg!RNA!were!used!to!reverse!transcribe! into!cDNA! using! the! TaqMan! Reverse! Transcription! Reagents,! according! to! the!manufacturer’s!instructions.!Sample!concentration!was!estimated!by!measuring!the!A260/280!ratio!using!a!Nanodrop!1000.!In!brief,!RNA!was!diluted!in!RNaseSfree! water! to! a! volume! of! 15.4µL! in! nucleaseSfree!microtubes! and! added! to! a!mixture!containing!the!following!reagents:!
Reagents+ Per+sample+10x!Buffer! 4µL!25mM!MgCl2! 8.8µL!dNTPs! 8µL!Oligo!dT!primers! 2µL!RNase!Inhibitors! 0.8µL!Reverse!Transcriptase! 1µL!
Total:+ 24.6µL++! !
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Samples!were!then!heated!in!a!thermocycler!as!instructed!in!the!TaqMan!Reverse!Transcription!Reagents!kit,!and!cDNA!stored!at!S20oC.!In!the!case!of!RNA!from!FACS!sorted!macrophages!where!RNA!yield!was!low,!all!RNA!was!used!in!a!reverse! transcription! reaction,! using! the! Superscript! II! kit! according! to!manufacturer’s!instructions.!2.2.6.2!REALSTIME!PCR!! RealStime! PCR! was! done! using! the! SYBR! Green! detection! method! and!using! a! CFX96! realStime! PCR! detection! system.! Primer! concentrations! were!determined!experimentally!and!were!used!at!a!concentration!of!100!–!350nM.!In!each!well!of!a!96Swell!PCR!plate,!2µL!cDNA!were!added,!and!8µL!of!the!following!mixture!of!reagents:!
Reagents+ Per+well+Primer! 3µL!Distilled!water! 5µL!SYBR!Green! 10µL!
Total:+ 18µL++! Once!all!the!reagents!were!added,!PCR!plates!were!centrifuged!to!collect!samples!at!the!bottom!of!the!well.!A!CFX96!realStime!PCR!detection!system!was!then!used!with!the!following!thermocycler!settings:!
Initial+hold+ 45+cycles+of…+ + Melt+curve+
95oC!for!5!min! 95oC!for!15s! 55oC!for!30s! 72oC!for!45s! ! 55oC!to!95oC!in!increments!of!0.5oC!every!10s!! The! 2SΔΔCt! method! was! then! used! to! calculate! foldSchange! in! gene!expression,!normalised!to!endogenous!controls,!and!the!primer!melt!curves!were!consulted!to!confirm!proper!primer!binding.!!2.2.7!Microarray!analysis!! Analysis! of! macrophage! gene! expression! was! carried! out! using! the!HumanHTS12!v4!Expression!BeadChip!Kit!on!the!Illumina!array!platform!by!the!Bioinformatics! Core! Facility! at! Singapore! Immunology! Network,! A*STAR,!Singapore.!See!section+3.3!for!more!information.!
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2.2.8+ELISA+A! CXCL1! (GroSalpha)! ELISA! was! used! to! measure! levels! of! CXCL1! in!conditioned!media!collected!from!various!spheroidSbased!coScultures.!This!was!carried! out! according! to! the! manufacturer’s! instructions,! using! conditioned!media!that!had!been!diluted!1:2!or!1:3!in!fresh!IMDM.!
2.2.9+FUNCTIONAL+ASSAYS+2.2.9.1!NEUTROPHIL!MIGRATION!ASSAY!! To!observe!neutrophil!migration!freshlySisolated!neutrophils!were!added!to!the!upper!well!of!a!Transwell!plate.!Into!the!lower!well,!conditioned!medium!was! added! and! plates!were! incubated! at! 37oC! for! 3! hours.! Following! this,! the!numbers!of!migrated!neutrophils!(in!the!lower!wells)!were!counted.!!2.2.9.2!INVASION!ASSAY!A549! human! lung! adenocarcinoma! cells! were! added! to! the! upper!chamber! of! a! Transwell! plate! that! had! been! preScoated! with! a! thin! layer! of!Matrigel! to! represent! the! extracellular! matrix.! Conditioned! media! were! then!placed!in!the!lower!chamber!and!the!plate!was!kept!at!37oC!for!18!hours!to!allow!tumour!cells! to!actively! invade! through!the!Matrigel.!Subsequently,!all!medium!was! removed! from! the! upper! and! lower! chambers! and! unSinfiltrated! tumour!cells!were!also! removed!using! a! cotton!bud! to! scrape! the!upper! surface!of! the!Matrigel.! The! invaded! tumour! cells,! on! the! lower! face! of! the! Transwell! insert,!were!fixed!in!iceScold!methanol!and!stained!using!crystal!violet.!Cells!were!then!lysed!in!acetic!acid!and!the!absorbance!(595nm)!of!this!solution!was!measured!in!triplicate!using!a!spectrophotometer.!
2.2.10+FLOW+CYTOMETRY+2.2.10.1!CELLTRACKER!LABELLING!! FreshlySisolated!monocytes!were! labelled!with!CellTracker!Green!before!adding! to! tumour! spheroids! to! facilitate! their! reSisolation! by! FACS! sorting.!!Monocytes!were!incubated!in!2.5µM!CellTracker!Green!in!preSwarmed!IMDM!for!30!minutes!at!37oC.!Following!this,!monocytes!were!pelleted!by!centrifugation!at!400! x! g# for! 5! minutes! and! resuspended! in! fresh,! preSwarmed! IMDM! and!
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incubated! for!a! further!30!minutes!at!37oC.!Monocytes!were!washed!one!more!time! in! IMDM! to! ensure! complete! removal! of! excess! CellTracker! Green!fluorescent!probe.!2.2.10.2!ANALYSIS!OF!NECROSIS!AND!APOPTOSIS!! Flow! cytometry!was! used! to! investigate! the! induction! of! apoptosis! and!necrosis! in! tumour! cells! by! the! chemotherapeutic! docetaxel.! The! media! from!chemotherapyStreated!tumour!cells!were!collected!(to!collect!any!dead/detached!cells)! and! the! remaining! adherent! cells! were! detached! using! a! 5Sminute!treatment! with! trypsin/EDTA! solution.! The! collected! conditioned! media! were!used! to! neutralise! the! trypsin/EDTA! solution,! and! cells! were! pelleted! by!centrifugation! at! 400! x! g! for! 10! minutes.! The! tumour! cells! were! then!resuspended! in!100µL!FACS!buffer!and!5µL!of!FITCSconjugated!antiSAnnexin!V!antibody!were!added!for!15!minutes!in!the!dark!at!room!temperature.!Cells!were!subsequently! washed! in! wash! buffer! and! resuspended! in! 300µL! FACS! buffer.!Immediately! before! analysis,! 5µL! propidium! iodide! (PI)! were! added! and!vortexed!thoroughly.!Tumour!cell!apoptosis!and!necrosis!was!recorded!using!a!FACSCalibur!flow!cytometer!and!data!were!analysed!in!CellQuest!Pro.!
2.2.11+FLUORESCENCE+ACTIVATED+CELL+SORTING+OF+MACROPHAGES+FROM+TUMOUR+
SPHEROIDS+! MacrophageSinfiltrated! tumour! spheroids! were! washed! thoroughly! in!HBSS!(without!Ca2+!or!Mg2+).!Spheroids!were!then!pipetted!dynamically!several!times! in! order! to! remove! nonSinfiltrated! myeloid! cells,! which! was! done! in! a!volume!of!1mL!HBSS!using!a!P1000!with!a!cut!tip.!The!total!volume!was!made!up!to!10mL!with!HBSS!and!spheroids!were!left!briefly!to!settle!to!the!bottom!of!the!tube.!HBSS!(containing!nonSinfiltrated!cells)!was!removed!carefully!leaving!only!macrophageSinfiltrated! spheroids! in! the! bottom! of! the! tube,! and! this! washing!process!repeated!a!further!2!times.!! Spheroids! were! then! resuspended! in! 3mL! trypsin/EDTA! solution! for! 5!minutes! and! pipetted! until! they! formed! a! single! cell! suspension.! The!trypsin/EDTA! solution! was! then! neutralised! with! IMDM! (with! 10%! human!serum! and! 2mM! LSGlutamine),! centrifuged! at! 400! x! g! for! 5! minutes! and!
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resuspended! in! FACS! buffer.! A! viability! dye! (ToPROS3)! was! added! and! the!sample!filtered!through!a!35µm!filter!to!remove!aggregated!cells.!Samples!were!kept!on!ice!and!viable,!CellTracker!GreenSpositive!macrophages!were!sorted!and!collected! in! IMDM! (with! 10%! heatSinactivated! human! serum! and! 2mM! LSGlycine).!The!macrophages!were!then!centrifuged!at!450!x!g!for!10!minutes!and!resuspended!in!TRIzol!for!RNA!analysis.!
2.2.12+IMMUNOFLUORESCENCE+2.2.12.1!MURINE!TUMOUR!MODELS!Four!murine!tumour!models!were!used!to!investigate!the!in#vitro!findings!discussed! in!Chapter+ 3! and!Chapter+ 4+ in! an! in# vivo! setting.! Control! tumours!were!not! sizeSmatched,! except! for! LLC! tumours,! and! all! tumours!were! fixed! in!4%!paraformaldehyde!for!5!min!once!thawed,!with!the!exception!PyMT!tumours!that!were!fixed!at!time!of!collection.!In!brief,!the!four!tumour!models!that!were!used!were!(for!more!information!see!section+5.3):!!
PyMT+
+ Transgenic! PyMT! (FVB)! murine! breast! tumours,! grown! as! orthotopic!transplants,! were! kindly! provided! by! Dr.! Joan! Massagué! (Memorial! SloanSKettering!Cancer!Center,!USA).!This! included!mice! that!were! treated!with!dual!doxorubicin! and! cyclophosphamide! chemotherapy,! mice! receiving! the! SB!265610! compound! (CXCR2Sspecific! inhibitor)! in! combination! with!chemotherapy,!and!relevant!controls.!
LLC+ Mice!were!implanted!with!LLC1!murine!Lewis!lung!carcinoma!tumours!by!Dr.! Hughes! in! the! lab! of! Prof.! Claire! Lewis.! Mice! were! treated! with!cyclophosphamide! (150mg/kg)! every! 48! hours! for! a! total! of! 3! injections,! and!culled!48!hours!after!the!last!dose!of!chemotherapy.!Control!tumours!were!sizeSmatched.!!
+
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4T1+ Mice!were!injected!with!syngeneic!4T1!metastatic!breast!cancer!tumours,!and! treated! with! paclitaxel.! Frozen! sections! of! tumours! from! these! mice,! and!control! 4T1! tumours,! were! provided! by! Prof.! De" Palma" (École" Polytechnique"Fédérale( de( Lausanne,( Switzerland)( for( other( studies,( and( were( used( here( to(investigate!intratumoural!neutrophils!in!paclitaxel!treated!murine!breast!cancer.!!
ASVXB+ASVSB! transgenic! mice! that! develop! spontaneous! hepatocellular!carcinoma!were! given! either! vehicle! or! the! chemotherapeutic! agent! etoposide,!and! tumours! were! removed! and! frozen.! These! studies! were! also! done! by! Dr.!Russell!Hughes!in!the!laboratory!of!Prof.!Claire!Lewis.!! Tumour! biopsies! were! cut! into! pieces! and! tissue! was! snapSfrozen! by!placing! into! labelled! microfuge! tubes! and! immersed! for! at! least! 1! minute! in!liquid! nitrogen.! Samples! were! then! transferred! to! S80oC! for! storage.! For!sectioning,!frozen!tumour!samples!were!placed!on!plastic!disposable!mounts!and!covered!in!optimum!cutting!temperature!compound!(OCT),!and!then!returned!to!S80oC.!2.2.12.2!IMMUNOFLUORESCENT!STAINING!OF!FROZEN!TUMOUR!SECTIONS!! Frozen!tumours!were!cut!into!10µm!thick!sections!using!a!cryotome!and!then! placed! on! microscope! slides! before! being! stored! at! S80oC.! Slides! were!allowed! to! warm! up! to! room! temperature! and! then! flooded! with! 4%!paraformaldehyde! (PFA)! for! 5! minutes! to! fix! the! sections,! except! for! PyMT!tumours!since! these! tumours!had!been! fixed! in!PFA!previously.!Following! this,!PFA!was!removed!and!slides!were!washed!for!5!minutes!with!30mM!glycine!in!PBS!at!pH!7.5,!to!quench!PFA!fixation.!Subsequently,!slides!were!washed!in!PBST!for!5!minutes!before!marking!a!ring!around!the!tumour!section!with!a!PAP!pen!(SigmaSAldrich! Inc,!Poole,!Dorset,!UK)!and! flooding!with!blocking!buffer! for!20!minutes.! Blocking! buffer! was! then! tapped! off! and! primary! and! secondary!antibodies!were!applied!(in!the!dark)!according!to!the!times!and!concentrations!
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detailed!in!sections+4.3+and!5.3.!A!list!of!antibodies!used!can!be!found!in!section+
2.1.3.!! After! each! antibody! application! slides! were! washed! thoroughly! for! 15!minutes! in!PBST! in! slide! staining! racks! and!agitated!gently!on! a! rocker,!which!was! important! for! removing! background! signal! of! some! antibodies.! After! the!final!wash!slides!were!counterstained!with!300nM!DAPI!for!2!minutes,!washed!in!PBST,!and!then!protected!with!Prolong!Gold!AntiSfade!reagent!and!a!coverslip.!Samples!were!then!analysed!on!a!Zeiss!LSM!510!confocal!microscope.!2.2.12.3!SEMISQUANTITATIVE!ANALYSIS!BY!ZSSTACK!! ZSstack! images! of! tumour! sections! were! taken! in! order! to! determine! a!semiSquantitative!measure!of!protein!expression.!For!each!group!11!images!were!taken! throughout! the! sample! at! 40x! magnification! in! 4! regions/fieldsSofSview!(FOV)!of!the!tumour,!and!the!mean!and!SEM!calculated!from!4!different!tumours.!Images!were! then! analysed! in! ImageJ! software,! and! the! fluorescence! intensity!throughout!the!tumour!section!(i.e.!all!11!images!in!the!z!axis)!of!the!particular!channelSofSinterest!was!quantified!and!added!together,!using!a!method!based!on!a!previously!reported!analysis! [148],! to!provide!a!value!of!overall! fluorescence!intensity! in! that! FOV.!To! achieve! this,! the! following!macro!was!used! in! ImageJ!software:!
Macro++run("8Sbit");!run("Invert!LUT");!run("Enhance!Contrast...",!"saturated=0.4");!setAutoThreshold("Default");!//run("Threshold...");!setThreshold(4,!255);!run("Convert!to!Mask");!! The! Measure! function! was! used! to! obtain! a! semiSquantitative!measurement!of!signal! fluorescence! intensity,!which!was!then!recorded!for! the!
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comparison!of!expression!between!different!treatment!groups.!The!4!FOV!were!averaged!and!the!mean!and!SEM!of!these!values!from!4!donors!are!presented.!





3.1+INTRODUCTION+Considerable!evidence!exists!for!tumourSassociated!macrophages!(TAMs)!playing!an!important!role!in!tumour!progression,!from!the!promotion!of!tumour!initiation,!growth!and!metastatic!spread![149,!297,!298].!The!tumourSpromoting!functions! of! TAMs! include! their! secretion! of! a! wide! array! of! cytokines! and!chemokines!within!the!tumour!environment,!for!crosstalk!with!other!cell!types.!The!chemokines!CSFS1,!CCL2,!CXCL12!(SDFS1)!and!angiopoietinS2!(AngS2)!are! important! for! monocyte! recruitment! in! multiple! types! of! tumour,! and!modulation! of! these! proteins! and! their! receptors! in! mouse! models! not! only!changes!TAM!intratumoural!accumulation,!but!often!affects!tumour!progression![127,! 140,! 162,! 175,! 299S303].! ! Furthermore,! in! cancer! patients,! high! levels! of!these! chemokines! also! correlate! with! increased! TAM! numbers! and! poor!prognosis![304S307].!This!is,!in!part,!because!TAMs!contribute!significantly!to:!
• Immunosuppression,! through! their! secretion! of! such! factors! as! ILS10![164],! ! TGFSβ! [308],! PGE2[309]! and! the! Treg! chemoattractant! CCL22![163].!
• Angiogenesis,!via!their!release!of!a!wide!array!of!factors!including!VEGF![310],!MMPS9![303]!and!PlGF![311]!expression.!
• Invasion! and! metastasis,! via! the! release! of! such! factors! as! cathepsins![166,!167],!and!urokinase/plasminogen!activator!(uPA)![168].!As! mentioned! previously! (see! section+ 1.11.1),! the! involvement! of!macrophages! in! tumour! responsiveness! to! chemotherapy! has! also! become! a!focus!of!study.!!A!number!of!studies!have!shown!that!TAMs!are!chemoprotective!in! some!mouse! tumour!models! [162,! 212,! 290,! 291,! 298]! (see!Fig+ 1.5).! These!have!proposed!a!variety!of!mechanisms!by!which!TAMs!help!to!protect!tumour!
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recruitment!and!activation![162],!the!secretion!of!MMP9![212],!ILS10![291],!and!cathepsins! B! and! S! [290].! Notably,! the! exact! role! of! TAMs! in! chemotherapyStreated! tumours! varies! between! different! types! of! tumour! as! well! as! with!different!modes!of!chemotherapy![312].!However,!the!chemoprotective!roles!of!TAMs!in!spontaneous!MMTVSPyMT!murine!breast!cancers!have!been!reported!in!mice! treated! with! paclitaxel! [162,! 290]! or! doxorubicin! [212,! 290].! It! has!therefore!been!suggested!that!agents!which!block!TAM!accumulation![162,!313,!314]! or! reSeducate! them! towards! a! ‘classical’,! or!M1,! antiStumour!macrophage!phenotype![315]!may!prove!to!be!therapeutically!beneficial.!!In! addition,!macrophages!may!modulate! the! tumour!microenvironment!by! regulating! the! recruitment! of! other! inflammatory! cells,! such! as! neutrophils![300],! which! is! known! to! occur! at! sites! of! inflammation.! ! For! example,!macrophages!stimulated!with!LPS,!or!LPS!plus!PHA,!release!CXCL1,!CXCL2![93],!and! CXCL8! [96],! which! attract! and! activate! neutrophils.! Likewise,! neutrophils!can! also! signal! the! recruitment! of! monocytes! and! macrophages! to! sites! of!inflammation! [87,! 89],! which! together! lead! to! the! rapid! accumulation! of! such!innate!immune!effector!cells!as!cytotoxic!T!cells,!B!cells!and!natural!killer!cells!at!these!sites.!! !Chemotherapy!can!also!cause!the!release!of!inflammatory!chemokines!by!cancer! cells.! For! example,! docetaxel! can! activate! NFSκB! signalling! in! human!prostate!cancer!cells!in#vitro#[316],!and!paclitaxel!treatment!of!the!PyMT!cell!line!can!increase!messenger!RNA!(mRNA)!levels!of!colonySstimulating!factor!(CSF)S1![162].!Similarly,!chemotherapy!induces!upregulation!of!inflammatory!molecules!from! nonStumour! cells;! combined! treatment! with! doxorubicin! and!cyclophosphamide! induced! the! release! of! inflammatory! cytokine,! TNFα,! from!endothelial!cells,!bone!marrowSderived!cells!and!smooth!muscle!cells![126].!In! this! chapter,! the! early! in# vitro! responses! of! macrophages! following!exposure! to!docetaxelStreated! lung! carcinoma!cells!were!explored.! !Microarray!analysis! and! realStime! polymerase! chain! reaction! (RTSPCR)! identified! various!important! changes! in! chemokine! gene! expression! that!were! then! confirmed! in!different!coSculture!models,!and!also!by!RTSPCR.!!
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For! in# vitro! studies,! A549! lung! adenocarcinoma! cells! were! used.! Lung!cancer! is! the! most! common! cause! of! cancer! death! in! the! UK! in! 2010! [317],!accounting!for!almost!35,000!deaths!in!2010!alone.!The!vast!majority!(87%)!of!lung! cancers! are! nonSsmall! cell! lung! cancer! (NSCLC)! [317],! and! so! A549! cells,!which!derive!from!the!tumour!of!a!patient!with!NSCLC,!were!selected!for!use!in!the!experiments!described!in!Chapter+3+and!Chapter+4.!Additionally,!these!cells!were! selected! based! on! their! ability! to! form! 3D! spheroids,! which! has! been!reported! in! previous! publications! [185,! 300].! One! of! the!most! commonly! used!chemotherapies! for! the! treatment! NSCLC! in! patients! is! the! taxane! drug,!docetaxel!(Taxotere®)![318],!which!is!used!clinically!either!as!a!single!agent!or!in!combination!with!other!such!drugs!as!cisplatin!or!carboplatin.!Docetaxel!was!selected!for!the!treatment!of!A549!cells!to!emulate!the!chemotherapyStreatment!of!lung!tumours,!albeit!in!a!basic!and!simplified!model.!
3.2+AIMS+! To! characterise! changes! in! gene! expression! in! macrophages! following!their!exposure!to!chemotherapyStreated!tumour!cells!in#vitro.!
3.3+METHODS+Human!A549!nonSsmall!cell!lung!cancer!cells!were!cultured!as!described!in!section+2.2.1.1.!Human!monocytes!were!isolated!from!waste!Buffy!coats!from!healthy!blood!donors,!according! to! the!protocol!detailed! in!section+ 2.2.1.3.!To!generate! monocyteSderived! macrophages,! monocytes! were! cultured! in! tissue!culture!plates! for!7!days! in! IMDM,! supplemented!with!10%!human! serum!and!2mM! LSGlutamine,! as! described! in! and! section+ 2.2.1.4.! Additionally,! A549!tumour! spheroids! were! grown! in! IMDM! in! agaroseScoated! 96Swell! plates,! as!described! in!section+ 2.2.4.! To! induce! cell! death,!A549! cells!were! treated!with!docetaxel,! for! which! the! vehicle! was! dimethyl! sulphoxide! (DMSO).! DocetaxelStreated!A549!cells!were!then!coScultured!with!macrophages!in!three!different!coSculture!systems!to!address!three!different!experimental!questions:!1. Direct! coSculture! –! where! docetaxelStreated! A549! tumour! cells! were!added!to!wells!of!MDMs!cultured!in!6Swell!plates!(see!section+2.2.2).!This!
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was! to! observe! changes! in! the! levels! of! macrophage! messenger! RNA!(mRNA)! when! they! encounter! docetaxelStreated! A549! cells.! This! setup!was! also! used! for! the! initial! microarray! analysis! of! the! most! highly!regulated!genes!in!coScultured!macrophages.!2. Transwell! coSculture! –! whereby! macrophages! and! docetaxelStreated!tumour! cells! were! physically! separated! by! a! porous! membrane! (see!
section+ 2.2.2).!MDMs!were! cultured! in! the! lower!wells,! and! docetaxelStreated! A549! cells! were! added! to! upper! wells.! This! allowed! the!investigation!of!the!proportion!of!the!macrophage!response!that!was!due!to!paracrine!signalling!via!soluble!factors.!3. Spheroid!coSculture!–!where!freshlySisolated!monocytes!were!added!to!8S12!day!A549!spheroids,!and!coScultured!for!48!hours!to!allow!monocyte!infiltration.!Docetaxel,!or! its!vehicle!DMSO,!were!also!added!to!the!A549!spheroids! at! the! same! time.! ReSisolation! of!monocytes/myeloid! cells! by!fluorescenceSactivated! cell! sorting! (see! section+ 2.2.11)! allowed! the!investigation! of!myeloid! cell! gene! expression! in! docetaxelStreated!A549!spheroids,! in! comparison! with! DMSOStreated! spheroids,! to! confirm! the!gene! expression! changes! identified! by!microarray! and! the! first! two! coScultures!in!a!more!complex,!3D!model.!More!specifically,! for!direct!coSculture,!2!x!106!docetaxelStreated!(10µM,!96!hours!in!IMDM)!A549!cells,!including!their!secreted!factors,!were!placed!onto!7Sday! MDMs! (initial! starting! number! 2! x! 106! per! well)! in! 6Swell! plates.! For!control,! A549! cells! were! treated! with! an! equivalent! volume! of! the! docetaxel!vehicle!DMSO!and!all!other!parameters!were!kept!the!same.!These!tumour!cells!and!MDMs!were!coScultured!for!5!hours!at!37oC,!following!which!all!media!and!detached!cells!(mainly!tumour!cells)!were!removed,!and!1mL!trypsin/EDTA!was!added! to! each! well.! A! 5Sminute! treatment! with! trypsin/EDTA! at! 37oC! was!sufficient! to! detach! the! docetaxelStreated! tumour! cells! but! still! leave! MDMs!attached!(see!Fig+ 2.2),!as!suggested!previously! [296].!Conditioned!MDMs!were!then! lysed! in! 1mL! TRIzol,! scraped! with! a! cell! scraper! and! collected! on! ice! in!microtubes!for!RNA!extraction.!The!same!conditions!were!used!for!Transwell!coSculture!experiments,!with!the!exceptions!that!MDMs!were!cultured!in!the!lower!
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well!of!a!6Swell!Transwell!plate! (pore!size!0.3µm),!and!docetaxelStreated!A549!cells! and! their! conditioned!media!were!added! to! the!upper!well.! Following! coSculture!for!5!hours,!the!upper!wells!(containing!tumour!cells)!were!removed!and!the! media! in! the! lower! wells! were! also! removed.! As! before,! 1mL! TRIzol! was!added,! conditioned!MDMs!were! scraped!and!collected!on! ice! in!microtubes! for!RNA!extraction.!For! spheroidSbased!studies! (see!section+ 2.2.4),!A549! tumour!spheroids!were! grown! for! 8S12! days! until! a! necrotic! core! was! visible! under! the! light!microscope.! FreshlySisolated!human!monocytes!were! labelled!with!CellTracker!green!dye!(see!section+2.2.10.1)!and!then!washed!several!times!in!fresh!IMDM!to!remove!all!CellTracker!dye! from!the!medium.!Subsequently,!1!x!105! labelled!monocytes!were!then!added!to!each!spheroid.!Docetaxel!was!also!added!so!that!the! concentration! in! the! cell!media!was! 10µM,! or! an! equivalent! volume! of! the!docetaxel! vehicle! DMSO! was! added! to! control! groups.! Monocyte! and! A549!spheroids!were! then! cultured! at! 37oC! for! 48! hours! to! allow! the!monocytes! to!infiltrate! the! tumour! spheroids.! These! myeloid! cells! were! reSisolated! from!spheroids!by!FACS!for!gene!expression!analysis!(see!sections+2.2.5.2,!2.2.10.1!and!2.2.11).!!More! specifically,! unSinfiltrated! myeloid! cells! were! removed! from!spheroids!by!placing!spheroids!into!a!new!centrifuge!tube,!topping!up!to!15mL!with!fresh!IMDM,!allowing!spheroids!to!settle!to!the!bottom!of!the!tube!and!then!removing! as!much! of! the!media! as! possible! using! a! stripettor! (Corning)! and! a!P1000! pipette.! The! spheroids! were! reSsuspended! in! 1mL! IMDM! and,! using! a!P1000!pipette!with! a! cut! tip,! the! spheroids!were!pipetted! firmly!up! and!down!repeatedly! to! dislodge! remaining! myeloid! cells! sticking! to! the! spheroid.!Following!this,!14mL!IMDM!was!added!to!the!1mL!IMDM,!and!then!all!media!and!suspended!cells!were!removed,!leaving!just!the!myeloid!cellSinfiltrated!spheroids!in! the! bottom! of! the! tube.! To! dissociate! the! spheroids,! 1mL! preSwarmed!trypsin/EDTA!solution!was!added,!and!the!cells!were!kept!at!37oC!for!5!minutes.!A!P1000!pipette!was!used! to!pipette! the!cells!up!and!down!repeatedly!and!get!the!A549!cells!and!myeloid!cells!into!a!single!cell!suspension.!The!cells!were!then!pelleted! by! centrifugation! at! 400! x!g! for! 5!minutes! and! reSsuspended! in! FACS!
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buffer.!Subsequently,!5µL!of!the!viability!dye!7SAAD!was!added!and!incubated!on!ice!for!15!minutes.!The!samples!were!then!taken!immediately!for!FACS!to!collect!the!viable,!CellTracker!dyeSlabelled!myeloid!cells.!The!gating!strategy!involved:!1. Gating!out! the!debris! in! the! sample!based!on! forward!scatter! (FSC)!and!side!scatter!(SSC)!profiles.!2. Using! SSCSwidth! against! SSCSheight,! as! well! as! FSCSwidth! against! FSCSheight,!to!eliminate!doublets.!!3. Selecting!viable!cells!by!gating!around!the!7SAADSAPC!negative!cells.!4. Selecting! myeloid! cells! by! gating! around! the! CellTracker! greenSFITC!positive!cell!population!(originally!monocytes).!!Cell!sorting!was!done!using!FACSAria!II!4Slaser!(BD),!run!by!the!FACS!core!facility! at! Singapore! Immunology! Network! (SIgN,! Singapore).! The! sorted! cells!were! collected! in! 15mL! centrifuge! tubes! kept! at! 4oC.! Cells! were! pelleted! by!centrifugation!at!500!x!g#for!10!minutes,!before!removing!the!FACS!buffer!and!reSsuspending!in!500µL!TRIzol!for!RNA!extraction.!The! purpose! of! this! spheroidSbased! myeloid! cell! gene! expression!experiment!was!to!observe!whether!the!identified!changes!in!macrophage!mRNA!levels! are! also! replicated! in! tumourSinfiltrating! myeloid! cells! in! a! 3D! tumour!spheroid!model.!The!benefit!of!using!this!model!is!that!spheroids!contain!certain!characteristics! that! are! more! representative! of! in# vivo! conditions,! including!hypoxic! core! regions,! drug!diffusion! gradients! and!3D! structure! that! facilitates!infiltration! of! immune! cells! [319,! 320].! However,! this! model! lacks! the! full!complexities!of!in#vivo!tumours!such!as!the!presence!of!vasculature.!!As!stated!above,!monocytes!were!added!to!A549!spheroids!for!48!hours!in! the!spheroid!coSculture!model.! It! is! likely! that! they!will! start! to!differentiate!into! macrophages! as! they! encounter! the! tumour! mass,! the! spheroidSderived!factors! in! the!media,! and! as! they! infiltrate! into! the! A549! spheroids.! However,!monocyteSderived!macrophages!are!generally!considered!to!differentiate!in#vitro!over!a!period!of!5S7!days![321,!322],!and!thus!at!48!hours!these!cells!are!unlikely!to!be!fully!differentiated!macrophages.!Therefore,!they!will!be!referred!to!in!this!thesis!as! ‘myeloid!cells’.!These!cells!could!be! isolated!and!compared!to! freshlyS
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isolated!monocytes!and!7Sday!cultured!macrophages!to!determine!whether!they!share!more!characteristics!with!monocytes!or!with!differentiated!macrophages.!Such! characteristics! as! increased! cytoplasmicStoSnuclear! ratio! and! greater!numbers! of! mitochondria! and! lysosomes! –! measured! using! MitoTracker! and!LysoTracker! dyes! –! could! be! analysed,! as! reported! previously! [323].!Additionally,! the!expression!of!carboxypeptidase!M!could!be!measured!by! flow!cytometry,! which! is! associated! with! monocyte! to! macrophage! differentiation![324].!!Following! coSculture! of! docetaxelStreated! A549! cells! and!monocytes/macrophages! in! these! three! coSculture! systems,! an! enzymeSlinked!immunosorbent! assay! (ELISA)! was! used! to! observe! whether! the! changes! in!macrophage! mRNA! were! also! seen! at! the! protein! level! for! the! CXCL1! gene.!Conditioned! media! from! the! myeloid! cell! and! A549! spheroid! coScultures!described! above!were! collected! and! used! in! an! ELISA! for! CXCL1! (see! section+
2.2.8),!according!to!the!manufacturer’s!instructions.!Gene! expression! using! total! RNA! isolated! from! monocyteSderived!macrophages! from! coSculture! experiments,! and! of! myeloid! cells! from! tumour!spheroids,!was!done!using!RNeasy!Mini!Kit! (Qiagen)!and! the!RNeasy!Micro!Kit!(Qiagen)!respectively,!according!to!the!manufacturer’s!instructions!(summarised!in!section+2.2.5).!The!quality!and!quantity!of!isolated!RNA!were!assessed!with!a!Nanodrop!1000!using! the!absorbance!readings!at!260nm!and!280nm.!Between!0.5S1.0µg!RNA!were!used!for!a!reverse!transcription!reaction,!with!the!exception!of! FACSSsorted!myeloid! cells! from! tumour! cells,!where! all! of! the! isolated! RNA!from!at!least!1!x!105!cells!was!used!in!a!reverse!transcription!reaction.!Although!the! concentration! and! purity! of! RNA! in! these! FACSSsorted! samples! were! not!checked,! subsequent! RTSPCR! reactions! were! examined! for! correct! primer!binding!according!to!the!generated!meltcurves,!and!that!βSactin!had!a!threshold!cycle!(Ct)!value!of!fewer!than!22!cycles.!Extracted! RNA! was! used! to! scan! the! transcriptional! profile! of! MDMs!exposed!to!docetaxelStreated!A549!cells!by!microarray!(see!section+2.2.7).!This!was!done!with!the!Human!HTS12_V4!Expression!BeadChip!kit!(Illumina),!which!
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was!used!here!to!investigate!the!expression!of!over!47,000!transcripts!by!human!macrophages.!The!array!identified!a!list!of!differentially!expressed!genes!(DEGs)!between! macrophages! exposed! to! docetaxelStreated! A549! cells! and!unconditioned! macrophages! cultured! in! media! alone,! based! on! 5! identical!experiments.!!More! specifically,! 7Sday!MDMs!were! coScultured!with! docetaxelStreated!A549!cells,!and!macrophage!RNA!was!isolated!as!described!in!detail!above.!The!RNA! was! then! given! to! the! Bioinformatics! Facility! (SIgN,! Singapore)! for!processing,!starting!with!determining!the!RNA!quality!and!quantity!using!a!2100!Bioanalyzer!(Agilent).!The!RNA!integrity!number!(RIN)!was!calculated!using!the!ratio! of! 18s/28s! –! as! well! as! any! peaks! present! between! 18s! and! 28s! and!between!5s!and!18s!–!to!check!how!degraded!the!RNA!was,!and!returned!a!RIN!value!of!8.!The!RNA!was!amplified!and!biotinylated!using!the!TargetAmp!NanoSg!BiotinSaRNA!Labelling!kit!(Epicentre,!Illumina)!to!generate!biotinylated!cRNA,!as!per!the!manufacturer’s!instructions,!and!a!Direct!Hybridization!Assay!was!done!according! to! the! protocol! provided! by! Illumina! [325].! Subsequently,! the!microarray!chip!was!scanned!using!a!Beadarray!Scanner!500GX!(Illumina).!The!expression! values! were! then! extracted! (without! background! subtraction)! in!GenomeStudio! with! Illumina! annotation! Human! HTS12_V4_0_R2_15002873_B.bgx.! These! values! were! then! quantileSnormalized! to!give! samples! an! even! distribution,! and! then! log2Stransformed.! An! analysis! of!differentially! expressed! genes! (DEGs)! was! done! using! Limma! (Bioconductor)![326],! an! open! source! package! for! R! software.! DEG! analysis! was! done! with!normalized!and!log2Stransformed!data,!and!identified!2,466!DEGs.!The!software!MultiExperiment!Viewer!(TM4)!was!used!for!the!generation!of!heatmaps.!Since!primary!cells!were!used!(human!monocyteSderived!macrophages),!the!variation!between! donors!was! quite! high;! therefore,! the! heatmap! in!Fig+ 3.2! shows! fold!change!in!expression!between!treatment!groups.!! Extracted! RNA! was! also! used! to! study! the! expression! of! coScultured!macrophages,! and!expression!of!myeloid! cells! isolated! from! tumour! spheroids,!by! realStime! PCR;! RNA! was! isolated! as! described! above.! For! MDM! and!chemotherapyStreated! tumour!cell! coScultures! (direct! coSculture!and!Transwell!
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coSculture),! TaqMan! Reverse! Transcription! Reagents! were! used! to! reverse!transcribe! macrophage! RNA! into! cDNA,! according! to! the! manufacturer’s!instructions,! and! summarised! in!section+ 2.2.6.1.! For!RNA! isolated! from!FACSSsorted! myeloid! cells! using! the! RNeasy! Micro! Kit! (in! a! volume! of! 14µL),! the!Superscript! II! kit! (Life! Technologies)! was! used,! according! to! manufacturer’s!instructions,! as! it! delivers! a! higher! cDNA! yield! than! the! TaqMan! Reverse!Transcription! Reagents! kit! (determined! previously! inShouse).! All! cDNA! was!stored!at!S20oC.!For! RealStime! PCR,! cDNA! samples! were! analysed! by! SYBR®! green!(Applied! Biosystems)Sbased! quantitative! PCR,! as! described! in! section+ 2.2.6.2.!Primer! concentrations! were! determined! experimentally! and! used! at! between!100!and!300nM,!and!meltcurves!were!analysed!to!check!proper!primer!binding.!Gene!expression!was!normalised!to!a!βSactin!housekeeping!gene!using!the!2SΔΔCt!method.! Samples! were! run! in! duplicate! (i.e.! 2! wells! for! each! sample/gene!combination),! and! the! data! from! a! minimum! of! 3! experimental! repeats! were!collected.!!
3.4+RESULTS+
3.4.1+OPTIMISING+THE+INDUCTION+OF+TUMOUR+CELL+DEATH+BY+DOCETAXEL+A549! human! lung! carcinoma! cells! were! exposed! to! various!concentrations!of!the!taxane!chemotherapy,!docetaxel,!for!24,!48,!72!and!96h!in#
vitro.! The! cells,! both! attached! and! in! suspension,! were! then! analysed! by! flow!cytometry! for! markers! of! apoptosis! and! necrosis,! using! an! antiSAnnexin! V!antibody! to!detect!apoptotic!cells,!and!propidium! iodide!(PI)! to!detect!necrotic!cells.! The! percentage! of! apoptotic! and! necrotic! cells! were! compared! between!docetaxelStreated!and!vehicle!(DMSO)Streated!A549!cells,!shown!in!Fig+3.1.+The! cell! death! by! apoptosis! and! necrosis! were! highest! at! the! 96Shour!timeSpoint.!Differences! in! the! drug! concentration! used!had!negligible! effect! on!A549!apoptosis!and!necrosis,!especially!at! the!24S72!hour! timeSpoints! (see!Fig+
3.1),!but!an! increase! in! the!percentage!of!necrotic! cells!was!observed!between!5µm! and! 10µm! at! the! 96! hour! timeSpoint,! and! so! a! treatment! of! 10µm! for! 96!
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hours! was! selected! for! future! experiments.! This! treatment! induced!approximately!70%!apoptosis!and!50%!necrosis!in!A549!tumour!cells.!!
3.4.2+EARLY+RESPONSE+OF+MACROPHAGES+TO+DOCETAXELXTREATED+TUMOUR+CELLS+Following! chemotherapy,! monocytes! recruited! into! tumours! may! be!activated! to! change! their! gene! expression! by! tumourSderived! factors.! Possible!early! changes! in! macrophage! expression! following! exposure! to! docetaxelSinduced!apoptotic!or!necrotic!A549!cells!(i.e.!within!5h)!were! first! investigated!using!a!Human!HTS12!v4!microarray!(Illumina).!A!list!of!the!top!100!upregulated!and! 100! downregulated! differentially! expressed! genes! (DEGs,! i.e.! those! genes!that!show!a!statistically!significant!increase!or!decrease)!between!macrophages!exposed! to! docetaxelStreated! A549! cells,! and! unconditioned! macrophage!controls! in! fresh! IMDM,! is! shown! in! Supplementary+ Table+ 1.+ This! analysis!identified!2,466+DEGs! in!macrophages!exposed!to!docetaxelStreated!A549!cells,!of!which!1,385!genes!were!upregulated!and!1,081!were!downregulated.!Many!of!these! genes! coded! for! cytokines,! chemokines,! surface! molecules! and!miscellaneous!molecules!involved!in!tumour!promotion.!Since!studying!all!these!
Figure+3.1+Induction+of+apoptosis+and+necrosis+in+A549+cells+by+exposure+to+docetaxel+in+





















































































































































































































































































































genes!is!out!of!scope!of!this!work,!the!cytokine/chemokine!genes!were!focussed!on! because! this! group! of!molecules! has! been! implicated! in! the! recruitment! of!stromal! cells! into! tumours! [126,! 145,! 185],! which! are! important! regulators! of!tumour! growth,! angiogenesis,! immune! escape! and! metastasis.! The! ELR+! CXC!cytokines,! CXCL1,! CXCL2! and! CXCL5,! were! found! to! be! highly! upregulated! in!macrophages! conditioned! by! docetaxelStreated! A549! cells! (Fig+ 3.2).! These!chemokines! are! known! to! be! major! chemoattractants! and/or! activators! of!neutrophils.! Additionally,! three! other! chemokine! genes,! CCL2,! CCL7! and! CCL8,!were!downregulated!in!conditioned!macrophages.!! The! upregulation! of! CXCL1,! CXCL2! and! CXCL5!mRNA!was! confirmed! in!the! identical! coSculture! experiments,! by! realStime! polymerase! chain! reaction!(RTSPCR)!(Fig+3.3+and+3.4).!These!experiments!also!included!a!comparison!of!!
Figure+ 3.2+ Macrophages+ regulation+ of+ cytokine+ mRNA+ following+ coXculture+ with+


















gene!expression!in!MDMs!cultured!for!5!hours!in!the!docetaxel!vehicle!DMSO,!as!well!as!MDMs!exposed!for!5!hours!with!viable!tumour!cells!(i.e.!A549!cells!that!were!cultured!for!96!hours!in!IMDM!containing!an!equivalent!volume!of!DMSO).!These! results! demonstrated! that! the! induction! of! these! genes! is! not! just! a!response!to!chemotherapy,!since!docetaxel!alone!was!not!sufficient!to!upregulate!macrophage!mRNA!levels!greater!than!2Sfold!above!control!macrophages!(MDMs!that! were! cultured! for! 5! hours! in! IMDM! and! the! docetaxel! vehicle! DMSO).!Similarly,!MDMs!exposed!to!viable!tumour!cells!(A549!cells! treated!with!DMSO!for!96!hours)!did!not!upregulate!CXCL1,!CXCL2!or!CXCL5!gene!expression!very!highly!(less!than!4Sfold)!in!comparison!with!control!macrophages.!Fig+3.3!shows!that!MDMs! upregulated! these! chemokine! genes! significantly! (p! <! 0.05)! higher!
Figure+3.3+RealXtime+PCR+confirms+an+upregulation+of+CXCL1,+CXCL2+and+CXCL5+mRNA+






























following!exposure!to!docetaxelStreated!A549!cells,!as!compared!to!macrophages!exposed! to! viable! (DMSOStreated)! A549! cells.! These! in# vitro! data! suggest! that!when!human!lung!tumours!are!exposed!to!docetaxel,!macrophage!expression!of!CXCL1,!CXCL2!and!CXCL5!may!be!upregulated.!The!differences!between!the!data!in!Fig+3.3+and+ 3.4!could!be!due!to!the!fact! that,! in! the! latter!experiments,!macrophages!and!docetaxelStreated! tumour!cells! were! physically! separated! in! a! Transwell! system,! thereby! limiting!interaction! between! the! cell! types! to! soluble! factors! only! and! no! physical!interaction.!Therefore,!it!appears!that!macrophage!upregulation!of!CXCL1!and,!to!an! extent! CXCL2,!may! be! heavily! dependent! on! interaction! via! soluble! factors,!whereas! CXCL5! induction! involves! cellScell! contact! as! well! as! soluble! factor!stimulation!for!increased!induction.!
+
Figure+ 3.4+ Macrophages+ upregulate+ CXCL1,+ CXCL2+ and+ CXCL5+ mRNA+ in+ response+ to+
soluble+ factors,+ although+ macrophage+ upregulation+ of+ CXCL5+ mRNA+ is+ reduced,+ as+





































CXCL1,+2+AND+5+MRNA+Macrophage! gene! expression! of! CXCL1,! CXCL2! and! CXCL5! was! then!investigated!using!a!3D!spheroid!coSculture!system.!As!mentioned!previously!in!
section+ 3.3,! monocytes! were! added! to! A549! spheroids! for! 48! hours! in! the!spheroid! coSculture! model.! Monocytes! differentiate! into! macrophages! as! they!infiltrate!into!tissue!in#vivo#[23],!or!by!adherence!to!plastic!culture!plates!in#vitro#for#5S7! days! in!media! [321,! 322],! often! supplemented!with! GMSCSF! or!MSCSF.!Therefore,!it!is!likely!that!monocytes!will!begin!to!differentiate!as!they!infiltrate!tumour! spheroids! and! respond! to!A549Sderived! factors! in! the!media,! but!may!require! longer! than! 48! hours! culture! to! become! fully! differentiated!macrophages.!These!cells!will!be! referred! to!here!as! ‘myeloid!cells’,!but! ideally!would!be!isolated!and!analysed!for!such!characteristics!as!increased!cytoplasmic!to! nuclear! ratio,! and! increased! numbers! of! mitochondria! and! lysosomes,!indicative!of!macrophage!differentiation![323].!
Figure+ 3.5+ Myeloid+ cells+ isolated+ from+ docetaxelXtreated+ A549+ spheroids+ show+



























3.5).! The! chemokine! CXCL5! was! upregulated! by! approximately! 4Sfold.!Upregulation! of! these! CXC! cytokines! by! macrophages! confirms! earlier!microarray!and!RTSPCR!findings!from!cells!in!monolayer!systems,!shown!in!Fig+
3.3+and!3.4.!
3.4.4+MYELOID+CELLS+FROM+DOCETAXELXTREATED+TUMOUR+SPHEROIDS+UPREGULATE+
THEIR+RELEASE+OF+CXCL1++In!order!to!investigate!whether!changes!in!CXC!chemokine!expression!at!mRNA! level! could! also! be! seen! at! the! protein! level,! an! enzymeSlinked!immunosorbent! assay! (ELISA)! was! used.! Ideally,! all! three! chemokines! would!have!been!investigated,!but!because!of!budget!restrictions!an!ELISA!for!one!gene!was! chosen.! Of! the! three! chemokines,! the! most! is! known! about! CXCL1! (also!called!GROSα,!homolog!of!KC!in!mice!and!CINCS1!in!rats).!It!was!determined!to!be!a!more! potent! chemoattractant! of! human! neutrophils! than! CXCL2! and! CXCL5,!using!neutrophils!isolated!from!neonates!and!adults![327].!The!chemoattraction!of!neutrophils/granulocytic!cells!by!CXCL1!has!also!been!established!in!a!murine!breast! cancer! model! [126],! whereby! recruited! CD11b+Gr1+! cells! supported!tumour! growth! and!metastasis,! particularly! in! chemotherapyStreated! tumours.!Therefore,! CXCL1!was! selected! for! investigation!by!ELISA.!The! levels! of!CXCL1!protein! in! the! supernatants! of! nonSinfiltrated! spheroids,! and! myeloid! cellSinfiltrated! spheroids! exposed! to! either!DMSO!or! docetaxel,!were! assessed! (Fig+
3.6).! The! production! of! CXCL1! protein! by! tumour! spheroids! incubated! with!DMSO!or! docetaxel! for! 48! hours!was! significantly! (p! <! 0.05)! lower! than!when!spheroids! were! infiltrated! by! myeloid! cells.! Docetaxel! treatment! of! tumour!spheroids!in!the!absence!of!myeloid!cells!did!not!increase!CXCL1!production!by!tumour!cells.!Therefore,!it!is!likely!that!the!increase!in!CXCL1!seen!for!docetaxel!treatment!of!myeloid!cellSinfiltrated!tumour!spheroids!is!due!to!CXCL1!secretion!by!myeloid! cells.!However,! the!possibility! that! the!presence!of!myeloid! cells! in!spheroids!may!have!stimulated!the!tumour!cells!to!upregulate!CXCL1!cannot!be!excluded.!
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3.5+DISCUSSION++Monocytes! and! macrophages! are! constantly! recruited! to! tumours! by!tumour!and!stromal!cellSsecreted!factors![127,!140,!162,!299S303],!and!in!some!instances! recruitment! of!macrophages! increases! following! chemotherapy! [162,!212,! 290].! Recruited! monocytes! subsequently! differentiate! into! TAMs! as! they!cross! the! tumour! vasculature! where! they! then! respond! to! local! stimuli! and!signals,! including!those!induced!by!exposure!to!chemotherapeutic!agents.!Upon!such!treatments,!pronounced!changes!occur! in! tumour!metabolic!activity![328]!and!also! in!gene!expression!of!breast!cancer!tumours!(measured!3!weeks!after!treatment! with! doxorubicin! or! docetaxel! chemotherapy)! [329].!Chemotherapeutic! agents! can! also!directly! or! indirectly! alter! stromal! cell! gene!expression!and!polarisation,!as!summarised!in!Fig+1.5.!!
Figure+ 3.6+ Effect+ of+ myeloid+ cell+ infiltration+ and+ docetaxel+ treatment+ on+ CXCL1+




















In!summary,!the!data!in!this!chapter!show!that!treatment!with!docetaxel!for! 96! hours! in# vitro# is! sufficient! to! induce! approximately! 70%! apoptosis! and!50%!necrosis! in!A549!nonSsmall!cell! lung!cancer!cells.!CoSculture!of!docetaxelStreated! A549! cells! with! MDMs! resulted! in! an! upregulation! of! neutrophil!chemokines!CXCL1,!CXCL2!and!CXCL5!at!the!mRNA!level!in!macrophages,!which!was!not!observed! in! response! to!DMSOStreated! (viable)! tumour!cells.!All! three!chemokines!were!also!upregulated!in!myeloid!cells!isolated!from!A549!spheroids!treated!with!docetaxel,!in!comparison!with!DMSOStreated!controls.!Furthermore,!this! expression! was! confirmed! at! protein! level! at! least! for! CXCL1,! which! was!higher! in! conditioned!media! from!myeloid! cellSinfiltrated! spheroids! than!A549!spheroids! treated! with! DMSO! or! docetaxel,! and! was! increased! (p! =! 0.0143)!further! still! when! myeloid! cellSinfiltrated! spheroids! were! also! treated! with!docetaxel.!Timepoints! from! 24! to! 96! hours! were! selected! based! upon! previously!reported! findings! [330].! Prolonged! exposure! (72h,! 96h)! of! A549! human! lung!adenocarcinoma!cells!to!docetaxel!is!required!to!elicit!cell!death!in!A549!human!lung!carcinoma!cells!by!apoptosis!and!necrosis.!This!slow!effect!of!docetaxel!on!inducing! cell! death! is! supported!by! a!previous! report!using!paclitaxel! [330]! (a!taxane! chemotherapeutic! from! which! docetaxel! was! derived).! Paclitaxel!induction! of! tumour! cell! death! was! durationSdependent,! rather! than!concentrationSdependent,!as!was!shown!by!the!treatment!of!5!different!tumour!cell! lines! (including! A549! lung! carcinoma! cells)! with! paclitaxel! in# vitro! at!different!concentrations!and! for!different!durations.!This!slow! induction!of!cell!death! is! most! likely! to! be! a! product! of! the! replicationShalting! mechanism! of!taxaneSinduced!cell!death,!which!inhibits!microtubule!dynamics!by!binding!to!βStubulin! subunits.! An! increased! dose! may! not! disrupt! microtubule! dynamics!further,!but!prolonging!the!cell!cycleSinhibitory!effects!may!cause!higher!levels!of!necrotic!and!apoptotic!cell!death.!The! percentage! of! apoptotic! and! necrotic! cells! varies! in! in! the! tumours!with! tumour! type! and! the! chemotherapeutic! agent! used.! Such! variability! in!tumour! responsiveness! to! these! agents! is! important! clinically,! as! it! is! as! a!predictor!of!both!progressionSfree!and!overall!survival!in!many!forms!of!cancer!
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[218,! 331,! 332].! Ideally,! treatment! with! chemotherapy! would! induce!apoptosis/necrosis! in!100%!of!tumour!cells,! followed!by!a!controlled!clearance!of! cell! debris! by! phagocytes.! However,! viable! residual! masses! often! remain,!partly!due!to!intrinsic!chemoSresistive!mechanisms!of!tumour!cells!and!partly!to!extrinsic! factors! like! the!chemoprotective!effects!of!stromal!cells/factors! [162].!Several! clinical! studies! have! investigated! cell! death! in! the! tumour! following!chemotherapy.! Partially! or! completely! excised! residual! tumour! masses! from!patients! with! disseminated! nonSseminomatous! germScell! tumours! and! postSchemotherapy!surgery!were!analysed!for!the!percentage!of!necrotic!cells![331].!Analysis!of!these!samples!showed!that!half!of!the!patients!had!<10%!viable!cells!in!residual!masses!from!tumours.!However,!other!studies!have!found!that!levels!of! necrosis! following! chemotherapy! vary! greatly;! primary! tumours! surgically!resected! from! patients! with! hepatoblastoma! and! treated! with! neoSadjuvant!chemotherapy! had! levels! of! necrosis! ranging! from! 5–99%,! where! 10! of! 32!patients! had! >90%! tumour! necrosis,! and! the! median! was! 70%! [218].! Similar!studies! have! investigated! the! percentage! of! apoptotic! tumour! cells! following!chemotherapy.!For!example,!TUNEL!staining!of!cancer!patient!biopsies!revealed!that! the! percentage! of! apoptotic! cells! within! a! tumour! at! 24h! was! between!0.06%!and!12%,!reaching!37%!by!48h![332].!Taken! together,! these! studies! show! that! chemotherapyStreated! tumours!can! vary! greatly! in! their! postStherapy! viability,! and! so! for! the! purposes! the!experiments! reported! here,! a! concentration! was! selected! which! induced! the!highest!levels!of!apoptosis!and!necrosis.!A!treatment!of!10µM!docetaxel!for!96h!was! selected,! resulting! in! approximately! 60–70%!apoptosis! and!50%!necrosis.!!Notably,! apoptosis! was! measured! using! Annexin! V,! which! binds! to! exposed!phosphatidylserine! on! cell! surfaces.! As! such,! Annexin! V! also! binds! cells!undergoing! secondary! necrosis! as! well! as! apoptosis.! In! secondary! necrosis,!otherwise!known!as! type!2!necrosis,!a!cell!undergoing!apoptosis!activates!selfShydrolytic!enzymes,!but!also!swells!and!potentially!releases!its!contents,!rather!than! being! engulfed! by! phagocytes.! The! value! for! the! percentage! of! cells!undergoing!apoptosis!(as!measured!by!Annexin!V)!will!also! include!these!cells,!leading! to!an!overSrepresentation!of! the!number!of!cells!undergoing!apoptosis.!
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Additionally,!these!cells!will!also!be!counted!as!necrotic!cells!based!on!propidium!iodide!(PI)!viability!dye!staining.!Time!permitting,!other!methods!for!analysing!apoptosis!would!also!have!been!used!to!confirm!the!above!findings!with!Annexin!V.!Such!apoptotic!stains!as!cleaved! caspase!3!or!TUNEL!staining! could!have!been!used.! !One!advantage!of!the!caspase!3!marker!would!have!been!that!it!is!activated!early!in!the!process!of!apoptosis![333],!and!is!a!key!executor!of!apoptosis!in!somatic!cells.!Additionally,!the!half!maximal! inhibitory! concentration! (IC50)!of!docetaxel!on!A549! tumour!cell! growth! should! also! have! been! calculated,! thus! allowing! for! a! better!understanding!of!the!effectiveness!of!this!drug!on!these!cells!in!culture.!In!monolayer!coScultures,!the!dead!and!dying!A549!cells!(or!factors!they!release)! stimulate! human!macrophages! to! upregulate! transcription! of! the! CXC!chemokines!CXCL1,!CXCL2!and!CXCL5.!Furthermore,!myeloid!cells!isolated!from!docetaxelStreated! A549! spheroids! showed! a! similar! upregulation! of!mRNA! for!these! CXC! molecules! compared! to! those! from! DMSOStreated! spheroids.! These!data! were! supported! by! the! finding! that! CXCL1Srelease! by! myeloid! cellSinfiltrated! spheroids! was! increased! following! their! exposure! to! docetaxel.!Changes!in!gene!expression!between!macrophages!exposed!to!docetaxelStreated!tumour! cells! for! 5! hours,! and! unconditioned! macrophages! cultured! in! IMDM,!were! analysed! for! differentially! expressed! genes! (DEGs),! i.e.! those! genes! that!showed! a! statistically! significant! increase! or! decrease! in! gene! array! analysis.!Given! the! importance!of!macrophage! cytokine!production! in! inflammation!and!cancer![106,!266,!334],!differentially!expressed!cytokines!were!focussed!on.!The!results! from!the!gene!array,!as!well!as! later!confirmation!by!RTSPCR,!showed!a!clear! upregulation! of! cytokines! CXCL1,! CXCL2! and! CXCL5! in! docetaxelStreated!macrophages.! These! ELR+!CXC! chemokines! are! expressed! by!macrophages! and!are!mainly!involved!in!recruitment!and!activation!of!neutrophils![93,!335,!336].!All!three!chemokines!are!ligands!of!CXCR2,!a!receptor!expressed!by!neutrophils!and! endothelial! cells! in! tumours! [337S339],! and! elevated! CXCL1! and! CXCL2!levels!have!been!correlated!with!increased!numbers!of!CD11b+Gr1+!granulocytic!cells! in! murine! metastatic! lung! (LM2)! tumours! [126].! Furthermore,! CXCL1!directly!enhances!tumour!growth!and!transformation![340],!as!well!as!acting!on!
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endothelial! cells! to! promote! angiogenesis! [233,! 341].! CXCL1! expression! by!human! monocyteSderived! macrophages! has! also! been! shown! previously,! in!response!to!exposure!to!human!immunodeficiency!virus!type!1!(HIVS1)! in#vitro![342],!and!production!of!CXCL1!and!CXCL2!by!tissue!macrophages!is!crucial!for!neutrophil!recruitment!into!inflamed!tissue![93].!Therefore,!the!upregulation!of!such! ELR+! CXC! chemokines! by! macrophages! during/after! chemotherapy! may!have! a! significant! role! in! neutrophil! recruitment! and! aspects! of! tumour!promotion.! Importantly,! CXC! chemokines! –! including! CXCL1,! CXCL2! –!are! also!expressed! highly! by! tumour! cells! [126],! including! A549! lung! carcinoma! cells![185].!Although!gene!expression!analysis!clearly!demonstrates!that!macrophages!upregulate! CXCL1,! CXCL2! and! CXCL5,! similar! analysis! of! A549! tumour! cell!expression! should! also! have! been! done! to! assess! the! importance! of! tumourSderived!CXC!chemokines!in!the!preS!and!postSchemotherapy!environment.!Conversely,! the!microarray! used! here! showed! that! expression! of! CCL2,!CCL7! and! CCL8! were! downregulated! significantly! by! macrophages! following!their!exposure!to!docetaxelStreated!A549!cells.!These!chemokines!are!ligands!of!the!CCR2! receptor,! and! individually! can!bind!additional! receptors!CCR1,!CCR3,!CCR4,!CCR5,! decoy! and!viral! receptors! [30].! CCR2! is!most!highly! expressed!on!monocytes/macrophages,!and! it!plays!a!central!role! in!monocytes/macrophage!chemotaxis! [13,!30].!The!observed!downregulation!of!CCL2,!CCL7!and!CCL8!by!macrophages!suggests!that!they!might!be!less!likely!to!recruit!other!monocytes!into! tumours! following!docetaxel! treatment.!These! results! are! in! opposition! to!previous! findings! that! undefined! stromal! cells! express! more! CCL2! following!chemotherapy![212].!!These!stromal!cells!may!not!have!been!macrophages!(later!findings!in!Chapter+4!suggest!they!may!have!been!neutrophils),!and!a!different!type!of! chemotherapy! (doxorubicin)!was!used.! It! is! also!possible! that!different!forms! of! cytotoxic! agent! elicit! different! forms! of! tumour! cell! death,! and! this!triggers!different!patterns!of!gene!expression!in!macrophages.!!Some!agents!may!also!have!direct!effects!on!tumour!cells.!!Ideally,! the! microarray! analysis! would! have! included! more! treatment!groups,! and! the! expression! of!macrophages! coScultured!with! docetaxelStreated!tumour!cells!could!have!been!compared!with:!
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• Macrophages!coScultured!with!the!drug!vehicle!DMSO!to!see!whether!this!alone!induced!changes!in!expression.!
• Macrophages!coScultured!with!DMSOStreated!A549!cells,!so!that!the!gene!expression!profile!of!macrophages!responding!to!viable!A549!cells!could!be! compared! with! that! of! macrophages! exposed! to! doxetaxelStreated!A549!cells.!
• Macrophages! coScultured! with! docetaxelStreated,! nonSmalignant!epithelial! cells,! to! study! whether! the! crossStalk! is! specifically! between!macrophages!and!malignant!lung!adenocarcinoma!cells.!Despite! not! being! included! in! the! microarray,! the! first! two! of! these!experimental!groups!were!included!as!controls!in!later!RTSPCR!experiments,!and!are!discussed!below.!These!data,!however,!lack!a!nonSmalignant!cell!control!that!has!been!used!by!previous!macrophage!and!tumour!cell!coSculture!experiments![343].! This! control! group! would! help! identify! whether! the! upregulation! of!CXCL1,! CXCL2! and!CXCL5! is! specifically! in! response! to! docetaxelStreated!A549!cells,! or! whether! docetaxelStreated,! nonSmalignant! lung! epithelial! cells! also!induce!this!response! in!macrophages.! It!would!also!have!been!beneficial! to!use!additional!malignant!cell!lines!in!order!to!confirm!these!findings.!To! determine! the! extent! to! which! upregulation! of! CXCL1,! CXCL2! and!CXCL5! is!mediated!by!direct!physical! contact,! a! transwell! coSculture!assay!was!used,! and!macrophage!gene!expression!analysed!by!RTSPCR.!This!also!ensured!purity!of!macrophage!mRNA,!since!the!two!cell!types!were!separated!in!culture!by! a! 0.3µm! pore! size! nylon! mesh.! Any! genetic! material! (mRNA/DNA)! in! the!docetaxelSinduced!A549! cell! debris! that!might! have! been! able! to! pass! through!the!membrane!during!coSculture!would!most!likely!have!been!discarded!with!the!removal!of!media!from!macrophages!after!coSculture,!such!that!any!tumour!cell!contamination! would! be! negligible.! The! results! showed! a! similar! (but! slightly!reduced)! induction! in! cytokines! CXCL1! and! CXCL2,! and! a! lower! induction! of!CXCL5! than! in! directly! coScultured!macrophages,! indicating! cellStoScell! contact!may!play!a!part!in!CXCL5!upregulation!by!macrophages!in!response!to!docetaxelStreated! tumour! cells.! Recently,! the! physical! interaction! between! macrophages!and!tumour!cells!has!been!shown!to!occur!between!MDASMBS231!human!breast!
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cancer! cells! and!murine!macrophages,! both! in#vitro! and! in#vivo# [344].! Physical!interaction! between! these! two! cell! types!was! shown! to! encourage! tumour! cell!intravasation,! an! important! step! in! the! metastatic! cascade,! although! the!molecules! responsible! for! their! interaction! were! not! known.! Another! study,!however,!identified!an!interaction!between!macrophages!and!breast!cancer!cells!via! vascular! cell! adhesion! moleculeS1! (VCAMS1)! and! α4! integrins,! which!supported!tumour!cell!survival!by!protecting!them!from!proSapoptotic!cytokines![345].! VCAMS1! expressed! on! the! surface! of! tumour! cells! interacted! with!macrophages! via! the! leukocyte!α4! integrins,! as! demonstrated!by! the!use!of! an!antiSα4! integrinSblocking! antibody.! This! highlights! a! possible! mechanism!through!which!macrophage!and!tumour!cell!interactions!may!occur!in!the!direct!coScultures! used! here! in! Figs+ 3.3+ and! 3.5,! which! could! be! investigated! in! a!similar! experiment! using! an! antiSα4! integrinSblocking! antibody.! Physical!interaction! between! macrophages! and! A549! cells! in! this! way! may! instigate!intracellular! signalling! in! macrophages,! contributing! to! their! increased!expression!of!CXCL1,!CXCL2!and!CXCL5.!Importantly,! the!macrophage!response!was!demonstrated!to!be!specific!for!docetaxelStreated!A549!cells!(or!dead/dying!A549! tumour! cells),! as! exposure! of!macrophages! to! docetaxel! alone! or! the! coSculture!of!macrophages!with!live,!nonSdocetaxelStreated!A549!tumour!cells!failed!to!induce!CXC!cytokine!gene!expression.!A! criticism! of! the! experimental! technique! used! here! is! that! RTSPCR!samples! were! run! in! duplicate! (two! technical! replicates),! i.e.! two! identical!repeats!were! run! in! two!adjacent!wells!on!a!RTSPCR!plate! for!each!donor,! and!were! used! to! calculate! the! relative! expression! of! that! particular! gene! in! that!particular!sample.!Instead,!the!samples!should!have!been!run!in!triplicate,!so!that!three! values! were! obtained! per! sample/gene! combination;! this! would! help! to!control!for!pipetting!error!and!provide!more!accurate!results.!! The!spheroid!model!offers!several!advantages!over!more!conventional!2D!monolayer!or!Transwell!coScultures.!Spheroids!are!more!representative!of!a!3D!tumour! mass! (albeit! a! more! simple,! nonSvascularised! one)! and! generate!something!of!the!drug!and!oxygen!diffusion!gradients!known!to!exist!in!tumours![319,!320].!Oxygen!consumption!and!diffusion!gradients! lead! to!hypoxic! cores,!
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which! are! also! challenged! by! reduced! nutrient! availability.! This! can! lead! to!altered! gene! expression,! proliferation! rate! (slower! proliferation! reduces!effectiveness!of!chemotherapy)!and!cell!death.!Drug!diffusion!gradients!also!lead!to!differing!drug! concentrations! through! the! spheroid,! as! is! the! case! in!patient!tumours! [43].! In! spheroids,! myeloid! cells! were! also! found! to! express! higher!levels!of!CXCL1,!CXCL2!and!CXCL5!mRNA!following!exposure!to!docetaxel!than!in!DMSOStreated! spheroids.! If! this! occurs! in! human! tumours! after! docetaxel!treatment,!it!could!result!in!the!recruitment!of!increased!numbers!of!neutrophils!from! the! circulation! into! the! tumour! residue.! ! This! could! impact! on! tumour!progression! after! the! conclusion! of! chemotherapy! as! tumourSassociated!neutrophils! have! been! shown! to! promote! tumour! growth! [185],! angiogenesis![346]! and! metastasis! [347].! ! Of! course,! this! would! only! be! relevant! where!tumours!are!inaccessible!and!cannot!be!surgically!removed!–!as!is!the!case!with!some! forms! of! lung! tumour! [348].! Further! studies! are! now! warranted! to! see!whether! such! neutrophil! chemoattractants! are! upregulated! by!monocytes/macrophages!in!response!to!tumour!cells!treated!with!docetaxel,!or!indeed!other!chemotherapeutic!agents.!!Given! the! aforementioned! benefits! of! the! tumour! spheroid! model,! it!would! have! been! interesting! to! conduct! arrays! not! only! from!macrophages! in!monolayers! but! also! from! myeloid! cells! isolated! from! docetaxelS! and! DMSOStreated! spheroids.! The!DEGs! in! these!may! have! been! different! if!myeloid! cells!had! been! exposed! to! docetaxelStreated! A549! cells! in! such! a! 3D!microenvironment! as! a! tumour! spheroid.! Monocytes! and! macrophages! are!capable!of!forming!strong!attachments!to!other!cells,!including!tumour!cells!and!other!monocytes/macrophages;!thus!a!potential!criticism!of!the!spheroid!model!used! here! is! that! when! the! spheroids! were! washed! (to! remove! uninfiltrated!myeloid! cells)! it! is!possible! that!not!all! of! the! cells!were! successfully! removed.!Light!microscopy!confirmed!that!the!majority!of!uninfiltrated!myeloid!cells!were!removed!(80–95%),!but!confocal!microscopy!could!be!used!to!identify!whether!all! uninfiltrated! myeloid! cells! were! washed! off,! since! the! myeloid! cells! were!labelled!with! a! CellTracker! dye! and! could! be! distinguished! from!A549! cells! in!this!way.! Additionally,! an! investigation! of! A549! cell! death! (similar! to!Fig+ 3.1)!
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should!have!been!done!using!docetaxelStreated!spheroids!to!observe!the!number!of! apoptotic! and! necrotic! cells! at! various! timeSpoints,! particularly! since! drug!diffusion!gradients!are!affected!by!the!3D!shape!and!cell!replication!is!reduced!in!hypoxic!core!regions!(making!chemotherapy!less!effective).!In! this! experiment! (and! when! conditioned! media! were! generated! and!used! in! Chapter+ 4),! monocytes! and! docetaxel! were! added! simultaneously! to!A549! spheroids.! This! could! be! seen! as! modelling! a! subset! of! monocytes! that!infiltrate! tumours! at! the! time! the! patient! is! being! treated!with! chemotherapy.!These! would! differentiate! into! TAMs! as! tumour! cells! are! responding! to!docetaxel.!However,!as!mentioned! in!section+ 2.2.4.2,! further!studies!could!use!an! adapted! version! of! such! in#vitro! spheroid! assays! to! also! investigate:! (i)! the!response! of! existing! TAMs! in! tumours! to! docetaxel! treatment,! or! (ii)! the!response!of!newly!infiltrating!monocytes!to!tumour!cells!recently!exposed!to!the!cytotoxic! agent.! This! could! be! done! by! simply! adding! monocytes! to! A549!spheroids! first! before! the! latter! were! exposed! to! docetaxel,! or! by! adding! the!docetaxel! to! spheroids! first! before! the! monocytes! were! allowed! to! infiltrate!them.! It! is! possible! that! monocytes/macrophages! in! these! two! scenarios! may!have!responded!differently!to!monocytes!infiltrating!spheroids!while!both!were!exposed!to!docetaxel!(Fig+3.5).!Therefore,!ideally!all!three!scenarios!would!have!been!applied!in!the!spheroid!model,!as!suggested!in!section+2.2.4.2.!It!is!possible!that!docetaxel! treatment! increased!monocyte! infiltration! into!docetaxelStreated!spheroids,! as! compared! with! DMSO,! and! that! the! increased! presence! of!infiltrated!myeloid!cells!in!spheroids!had!an!effect!on!myeloid!cell!expression!in!
Fig+3.5!and!conditioned!media!used!in!Chapter+4.!However,!this!is!unlikely!since!a!FACS!experiment!suggested!that! there!were!similar!numbers!of!myeloid!cells!present!in!tumour!spheroids!treated!with!docetaxel!and!DMSO!(Table+3.1).!The! supernatants! conditioned! by! the! various! tumour! spheroid! groups!shown!in!Fig+3.4+were!used!in!a!CXCL1!ELISA,!to!check!whether!upregulation!of!CXCL1!occurs!at!the!protein!level.!Since!spheroids!were!grown!in!96Swell!plates!in! small! volumes! of! media,! protein! concentrations! were! relatively! high.!Conditioned!media!from!tumour!spheroids!alone!contained!CXCL1!protein!at!a!!
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!concentration! of! approximately! 1µg/mL.! Tumour! cells! have! been! shown!previously! to! upregulate! immunodetectable! CXCL1! upon! exposure! to! some!forms! of! chemotherapeutic! agent,! such! as! combined! doxorubicin! and!cyclophosphamide! (DOX/CTX)! chemotherapy! in! mammary! MMTVSPyMT!tumours! [126].! However,! Fig+ 3.5! shows! that! tumour! spheroids! did! not!upregulate!CXCL1!in!response!to!docetaxel! in!the!absence!of!myeloid!cells.!The!reason! for! this! difference! could! be! because! the! mechanism! of! CXCL1!upregulation! by! tumours! cells! reported! for! DOX/CTX!was! via! endothelial! cellSderived! TNFα! [126],! whereas! the! spheroid!model! used! here! does! not! include!endothelial! cells.! Another! reason! could! be! the! differences! in! chemotherapy.!Their!mechanism!of!action!is!very!different,!since!docetaxel!inhibits!microtubule!dynamics,!whereas!doxorubicin!intercalates!into!DNA!and!disrupts!transcription!and!cyclophosphamide!crosslinks!DNA!strands!irreversibly.!!Importantly,!several!cell!types!are!known!to!be!capable!of!expressing!CXC!chemokines!in!human!tumours;!aside!from!monocytes/macrophages,!CXCL1!can!also!be!expressed!by!mast!cells![349],!tumour!cells![126,!232],!neutrophils![350],!
Sample! No.+infiltrated+monocytes!DMSOStreated!spheroids! 965,806!DocetaxelStreated!spheroids! 963,490!
Table+ 3.1+ Monocyte+ infiltration+ into+ A549+ spheroid+ treated+ with+ docetaxel+ or+ DMSO.+Analysis! of! the! number! of! CellTracker! labelled! monocytes! that! had! infiltrated! into! A549!spheroids! either! treated! with! docetaxel! or! its! vehicle! DMSO,! showed! that! docetaxel/DMSO!treatment! may! have! little! effect! on! monocyte! infiltration! (0.24%! increase! in! monocyte!infiltration! in!DMSOStreated!spheroids).!However,! these!data!are! from!one!experiment!and!so!further!confirmation! is!necessary!before!any! conclusions! can!be!made.!This! could!potentially!involve!an!experiment!where!both!monocytes!and! neutrophils! are!added! to! A549!spheroids,!and! treated!with! docetaxel! or!DMSO,! as! suggested! in! section+ 4.5.! Data! show! the! number! of!viable,!labelled!monocytes!that!had!infiltrated!into!a!total!of!120!spheroids!for!each!sample,!as!analysed!by!FACS.!!
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eosinophils! [351]! and! endothelial! cells! [350].! The!presence! of!myeloid! cells! in!tumour!spheroids! led! to!an! increase! in!CXCL1!protein!release! into!conditioned!media,!and!this!was!upregulated!further!in!the!presence!of!docetaxel.!Infiltration!into! a! 3D! tumour! mass! could! increase! CXCL1! expression! by! macrophages.!Previous! RTSPCR! analysis! showed! that! CXCL1!was! upregulated! approximately!85Sfold! in! Transwell! coScultures,! but! approximately! 150Sfold! in! direct! coScultures,! demonstrating! that! cellStoScell! contact! enhances! the! upregulation! of!CXCL1! by! macrophages.! Myeloid! cells! infiltrated! into! A549! spheroids! also!physically! interact!with! tumour! cells.! The! fact! that! CXC! chemokines!were! still!upregulated! by! 4S! to! 7Sfold! in! myeloid! cells! from! docetaxelStreated! spheroids!after! longer! coSculture! time! (48!hours! as! opposed! to! 5! hours! coScultures! used!previously)! suggests! that! this! might! be! a! sustained! response! of!monocytes/macrophages! in! docetaxelStreated! lung! tumours.! It! would! be!interesting! to!observe! later! timeSpoints,! such!as!72!hours!and!96!hours,! to! see!whether! myeloid! cells! were! still! viable! and! expressing! higher! levels! of! CXC!chemokines!in!docetaxelStreated!A549!spheroids.!!!Given! that!monocytes/macrophages!were! seen! to! increase! their!CXCL1,!CXCL2!and!CXCL5!mRNA!levels!substantially!in!both!a!Transwell!system!and!in!spheroids! –! and! that! tumour! spheroids! alone! do! not! produce! as!much! CXCL1!protein! as!when!myeloid! cells! are! also!present! –! it! follows! that!CXCL1!protein!present! in! the! conditioned! media! from! myeloid! cellSinfiltrated! spheroids! is!predominantly! released! by! myeloid! cells.! However,! it! is! possible! that! tumour!cells!become!a!major! source!of!CXCL1!only!after! coSculture!with!myeloid! cells,!and!so!as!an!additional!experiment,!myeloid!cells! from!the!spheroid!coSculture!model! could! be! isolated! and! conditioned! media! generated! from!myeloid! cells!alone!(no!tumour!cells)!for!ELISA!analysis!of!CXC!chemokines.!Likewise,!tumour!cells! could! also! be! collected! and! used! to! generate! conditioned!media,! and! the!relative!contributions!of!both!tumour!cells!and!myeloid!cells!could!be!assessed.!Interestingly,!signalling!via!TollSlike!receptors!like!TLR2,!TLR3!and!TLR4!has!been!shown!to!control!macrophage!expression!of!CXCL1!and!CXCL2!mRNA![92].! For! example,! TLR4! signalling! can! increase! CXC! expression! via! MyD88Sdependent! or! TRIFSdependent! signalling! pathways! and! increase! neutrophil!
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recruitment! [92].! Since! TLR4! is! known! to! bind! damageSassociated! molecular!patterns,! or! DAMPS,! which! derive! from! stressed! or! injured! tissues,!monocyte/macrophage! TLR4! signalling! could! be! involved! in! the! upregulation!seen! here! for! CXCLs! 1,! 2! and/or! 5! after! docetaxel! treatment.! Further! studies!could! explore! this! by! investigating! the! ability! of! macrophages! to! upregulate!these! CXC! chemokines! in! response! to! docetaxelStreated! tumour! cells! in! the!presence!of!such!TLR4!antagonists!as!presented!by!Eritoran![352].! If! inhibition!of!TLR4!blocked!macrophage!CXC!chemokine!induction,!this!would!suggest!that!DAMPs!and/or!other!TLR4!ligands!released!by!tumour!cells!after!chemotherapy!could! bind! TLR4! and! are! responsible! for! macrophage! chemokine! expression.!Should! this! be! the! case,! it! would! add! further! evidence! for! the! importance! of!macrophage!TLR4!signalling!in!the!chemotherapyStreated!tumour!environment.!As! discussed! previously! (see! section+ 1.5),! neutrophils! are! usually! the! first!responders!to!the!inflammatory!signals!that!can!be!released!by!endothelial!cells!or!resident!tissue!macrophages!at!the!inflammatory!site.!The!data!in!this!chapter!suggest!that!TAMs!resident!in!the!tumour,!or!monocytes!infiltrating!the!tumour,!may! respond! to! docetaxelSinduced! changes! in!A549! cells,! in! part! by! recruiting!neutrophils.! This! is! in! accordance! with! the! understanding! that! resident!macrophages!directly!control!the!synthesis!of!neutrophilSattracting!chemokines!in!response!to!bacterial! infection,!which!are!crucial! for!the!earliest!recruitment!step!in!initiating!an!innate!immune!response!to!microbial!challenge![92].!Had! time! permitted,! it! would! have! been! interesting! to! look! into! other!highly!expressed!DEGs!from!the!same!arrays.!For!example,!the!alpha!and!gamma!chains! of! fibrinogen! were! within! the! top! 20! upregulated! genes! following!chemotherapy,!shown!in!Supplementary+Table+1,!increasing!approximately!25Sfold! in! comparison! with! macrophages! from! nonSchemotherapyStreated!spheroids.!Fibrinogen!is!classically!known!for!its! importance!in!the!coagulation!cascade,! responsible! for! regulating!blood!clotting!at! sites!of! injury.!However,! it!has!more!recently!been!suggested!also!to!play!a!role!in!metastasis!via!the!coating!and! protection! of! tumour! cells! in! the! circulation! [353],! and! inhibition! of!coagulation!has!been!shown!to!limit!metastasis.!It!is!thought!that!this!‘cloaking’!of!metastasising!tumour!cells!may!protect!them!from!the!effects!of!NK!cells!and!
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other! cytotoxic! cells,! and! it! would! be! interesting! to! see! if! this! is! another!chemotherapySenhanced! and! macrophageSdependent! process.! Additionally!upregulated! in! the! top! 20! genes! was! SERPINE2,! a! potent! serine! protease!inhibitor! and! regulator!of! blood! coagulation,! indicating! that! a! controlled! set! of!coagulation!genes!is!being!modulated!here!in!macrophages.!Given!more!time,!it!would!be!interesting!to!identify!the!mechanism!behind!coagulationSrelated!gene!expression!specifically!after!chemotherapy,!since!tumour!cells![354]!and!stromal!cells,! including! macrophages! [355],! are! already! known! to! play! a! role! in!coagulationSassisted! metastasis.! The! connections! between! metastasis! and!coagulation! are! being! increasingly! recognised! and! may! prove! to! become! an!important!area!of!study![356].!In! conclusion,! the! findings! from! this! chapter! show! that!monocytes! and!macrophages! exposed! to! docetaxelStreated! A549! human! lung! tumour! cells!increase! the! expression! of! CXCL1,! CXCL2! and!CXCL5! at! the! transcription! level,!both! in! monolayer! (macrophage)! and! spheroidSbased! (monocyte)! coSculture!systems.! Ideally,! key! experiments! would! have! been! confirmed! using! a! second!human!nonSsmall!cell! lung!cancer!cell! line,!such!as!CaluS3!or!H157!cell! lines,! to!identify!whether! the!upregulation!of!CXC!chemokines!by!macrophages! is! just!a!response! to! docetaxelStreated! A549! cells,! or! whether! it! is! a! more! general!phenomenon.!The!findings!in!Figs+3.3,+3.4+and!3.6!showed!that!this!is!not!just!a!response! to! DMSOStreated! (viable)! A549! cells,! but! instead! is! induced! by! the!presence!of! docetaxel.! Conditioned!media! from! tumour! spheroids! and!myeloid!cells! contains! CXCL1! protein,! which! was! increased! in! conditioned! media!collected!from!spheroids!exposed!to!docetaxel,!rather!than!its!vehicle!DMSO.!The!fact! that! the! concentration!of!CXCL1! is!much! lower! in! conditioned!media! from!tumour! spheroids! alone,! together! with! the! transcription! expression! results,!suggests! that!myeloid! cells!may!be! the!dominant! source!of!CXC! chemokines! in!this! context.! Therefore,! in! patients! with! nonSsmall! cell! lung! cancer,! treatment!with! docetaxel! may! lead! to! the! expression! of! CXC! chemokines! by! TAMs! or!monocytes!infiltrating!into!the!tumour.!This!could!then!lead!to!the!recruitment!of!neutrophils! and! impact! on! tumour! responses! to! subsequent! rounds! of!chemotherapy! and/or! tumour! regrowth! after! the! cessation! of! chemotherapy.!
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4.1+INTRODUCTION+Neutrophils! are! generally! believed! to! be! the! first! innate! effectors! to! infiltrate!sites! from! the! circulation! during! initial! stages! of! infection! and! inflammation.!However,! there! is!now!evidence! that! show! resident!macrophages! at! such! sites!play! an! important! role! in! mediating! this! [93].! The! chemokines,! CXCL1! and!CXCL2,! control! the! initial! stages! of! neutrophil! recruitment! during! acute!inflammation!–!first!secreted!by!mast!cells!in!close!proximity!to!vasculature,!then!shifting!towards!macrophage!production!as!they!infiltrate!further!into!the!tissue![92,!93].!Both!of!these!chemokines!signal!through!the!CXCR2!receptor,!which!is!expressed! highly! on! neutrophils! [16,! 126,! 357].! Other! producer! cells! include!epithelial!cells![358]!and!neutrophils!themselves![294].!As!mentioned!previously!(see! section+ 1.2.1),! other! chemokines,! including! CXCL8! (ILS8)! [18],! TNFα,!leukotriene!B4!(LTB4)!and!complement!5a!(C5a)![19]!have!also!been!shown!to!recruit!neutrophils!during!inflammation,!and!CXCL8!signals!through!both!CXCR2!and! CXCR1! receptors! [243].! Although! CXCR1! and! CXCR2! are! both! very! highly!expressed!on!neutrophils,!they!are!also!present!on!monocytes/macrophages!and!endothelial!cells![222],!and!one!or!both!of!the!receptors!are!present!on!cytokineSactivated! dendritic! cells! [223],! basophils,! T! lymphocytes,! NK! cells! [224],! mast!cells![225],!and!on!some!nonSimmune!cells![226].!Interestingly,! high! levels! of! circulating! neutrophils! are! associated! with!poor!prognosis!in!several!types!of!human!cancer,!including!metastatic!melanoma![359],! bronchoalveolar! carcinoma! [360]! and! renal! carcinoma! [361],! suggesting!that!neutrophils!do!not!always!exhibit!antiStumour!functions!to!kill!tumour!cells.!Murine!neutrophils!have!been!shown!to!be!capable!of!expressing!the!polarized!activation!states,!N1!and!N2,!in!tumours![146],!as!summarised!in!Fig+4.1.!
! 97!
N1! tumourSassociated!neutrophils! (TANs)!are!cytotoxic! for! tumour!cells!and! can! also! promote! tumour! rejection! by! activating! CD8+! cytotoxic! T! cells,!under! the! stimulation! of! IFNSβ! in! the! tumour! [362].! Alternatively,! N2! TANs,!promote! tumour! cell! invasion! and! metastasis,! stimulated! by! such! tumourSderived!cytokines!as!TGFSβ![146,!295].!!!Neutrophils! are! a! known! source! of! TNFα! in! tissues,! including! tumours![146].! Other! TNFαSexpressing! cells! in! the! tumour! include! macrophages,!lymphocytes![266],!tumour!cells![272,!363],!mast!cells![93]!and!endothelial!cells![126,! 364].! As! mentioned! previously! (see! section+ 1.10),! TNFα! is! a! key! proSinflammatory! cytokine! that! signals! through! two! distinct! receptors,! TNFRI! and!TNFRII.!Signalling!via!these!receptors,!this!multifunctional!molecule!can!mediate!the! expression! of! cytokines,! growth! factors,! proteases,! genes! involved! in! cell!cycle! and! immune! cell! receptors! [365,! 366].! The!most! important! physiological!functions! of! TNFα! relate! to! its! regulation! of! such! processes! as! inflammation,!
Figure+ 4.1+ N1+ and+N2+polarisation+ of+ tumourXassociated+ neutrophils+ (TANs)+ in+mice.+TGFSβ! and! IFNSβ! in! the! tumour! environment! can! stimulate! N1! and! N2! phenotypes! in!neutrophils.! N1! neutrophils! are! associated! with! tumour! cell! cytotoxicity,! the! rejection! of!tumours!and!immune!memory,!and!with!upregulation!of!FAS,!TNFα,!CCL3!and!ICAMS1!mRNA.!Conversely,! N2! neutrophils! can! promote! several! aspects! of! tumour! progression,! including!tumour!growth,!angiogenesis,! invasion,!metastasis!and!immunosuppression,!and!upregulate!expression! of! CXCR4,! arginase,! CCL2,! CCL5,! VEGF,! MMP9,! cSmyc! and! STAT3!mRNA.! Image!adapted!from![289].!
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apoptosis,! and! angiogenesis:! TNFα! can! facilitate! neutrophil! chemoattraction![367];! adhesion! of! leukocytes! to! endothelial! cells! in! regions! of! inflammation![368]! (see! section+ 1.6.2);! regulate! coagulation! during! inflammation! [369];!facilitate! the! production! of! reactive! oxygen! species! by! immune! cells! and!endothelial! cells! [279];! regulate! cell! death! by! apoptosis! (including! virally!infected!host!cells)![370];!stimulate!angiogenesis![371,!372].!Furthermore,!TNFα!plays!a!complex!role! in! tumour!onset.! It!contributes!towards!DNA!damage!by!inducing!oxidative!stress!and!nucleotide!damage![278].!It! also! promotes! tumour! growth! and! supports! a! metastatic! tumour! cell!phenotype.! ! For! example,! when! Chinese! hamster! ovary! cells! were! transfected!with! the! human! TNFα! gene! and! implanted! into! nude! mice,! they! showed! an!increased! ability! to! invade! peritoneal! surfaces! and! metastasise,! compared! to!cells!transfected!with!a!control!vector![373].!This!could!be!blocked!by!inhibition!of!TNFα!with!a!neutralising!antibody,!showing!the!importance!of!TNFα!in!these!processes.! Similarly,! TNFα! also! induces! epithelialSmesenchymal! transition!(EMT),! an! indicator!of! an! invasive!phenotype,! in! colon!cancer! spheroids! [280].!Activated!macrophages!are!known!to!express!TNFα!in!tumours,!which!accelerate!TGFSβSinduced!EMT!in!tumour!cells!!(see!section+1.10).!!
4.2+AIMS+! The! in# vitro! results! discussed! in! Chapter+ 3! suggest! that!monocytes/macrophages! upregulate! ELR+! CXC! chemokines! CXCL1,! CXCL2! and!CXCL5! when! they! come! into! contact! with! docetaxelStreated! tumour! cells.! The!aim!of!the!work!in!this!chapter!was!to!investigate!what!effects!this!might!have!on!neutrophil!chemotaxis!and!gene!expression.!!
4.3+METHODS+In!summary,! in! this!chapter!an! in#vitro! cell!migration!assay!was!used! to!investigate! whether! media! conditioned! by! myeloid! cellSinfiltrated! A549!spheroids,!following!exposure!to!docetaxel!or!its!vehicle!DMSO,!was!chemotactic!towards!freshlySisolated!human!neutrophils.!This!assay!was!then!used!to!study!whether!this!was!dependent!upon!CXCR2!ligands!by!inhibiting!neutrophil!CXCR2!
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signalling.! To! examine! gene! expression! by! neutrophils! (i.e.! their! N1/N2!polarization!state),!they!were!exposed!to!medium!conditioned!by!A549!spheroid!and!myeloid! cells,! in! the! presence/absence! of! docetaxel,! and! expression! of!N1!and!N2!genes![295]!analysed!by!RTSPCR.!Finally,!the!ability!of!factors!secreted!by!neutrophils! after! their! exposure! to! docetaxelStreated! tumour! cells! to! stimulate!tumour! invasiveness! was! investigated! using! an! in# vitro# invasion! assay.!Monocytes! and! neutrophils! were! freshlySisolated! from! human! Buffy! coats! or!freshlySsampled!human!peripheral!blood,!respectively!(see!sections+2.2.1.3+and!
2.2.1.5),! and! subsequently! cultured! in! IMDM! supplemented! with! 10%! human!serum!and!2mM!LSGlutamine.!To!make!A549!(human!lung!adenocarcinoma)!spheroids,!100µL!of!a!1.5%!agarose! solution! (in!DMEM!without! serum!or!LSGlutamine)!was! added! to! each!well!of!a!flatSbottomed!96Swell!plate!using!a!multichannel!pipette.!After!allowing!agarose!solution!to!set!at!room!temperature,!1.5!x!104!A549!cells!were!added!to!each!well!in!IMDM!(with!10%!human!serum!and!2mM!LSGlutamine)!in!a!volume!of!200µL.!The!cells!were! then!kept!at!37oC!and!monitored! for! the! formation!of!spheroids! and! a! necrotic! core.! Half! of! the!medium!was! removed! and! replaced!with!fresh!medium!every!2S3!days.!Tumour!spheroids!were!expanded!in!culture!for!8S12!days,!at!which!point!they!had!developed!a!necrotic!core!that!was!visible!when!using!a!10x!bright!field!microscope.!One!x!105!freshlySisolated!peripheral!blood! monocytes! labelled! with! CellTracker! Green! (according! to! the!manufacturer’s! instructions! and! detailed! in! brief! in! section+ 2.2.10.1)+ were!added!to!each!spheroid.!At!the!same!time,!some!groups!received!docetaxel!at!a!final!concentration!of!10µM!in!each!well!or!an!equivalent!volume!of! its!vehicle!DMSO.!Monocytes!were!allowed!to!infiltrate!and!differentiate!for!48!hours,!after!which!spheroids!and!media!were!collected!using!a!P1000!pipette!with!a!cut!tip!and! placed! in! 15mL! centrifuge! tube.! Throughout! the! process! tubes!were! kept!cool! on! ice.! Once! spheroids! had! settled! to! the! bottom! of! the! tube,! all! of! the!conditioned!media!was! removed!and! collected! in! a!new!15mL!centrifuge! tube.!Any!remaining!cells!were!removed!by!centrifugation!at!500!x!g! for!10!minutes!and!filtration!through!a!0.22µm!pore!size!syringe!filter.!
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Neutrophil! migration! towards! media! conditioned! by! myeloid! cellSinfiltrated!A549!spheroids,!in!the!presence!of!docetaxel!or!its!DMSO!control,!was!assessed! using! a!migration! assay! (as! described! in! section+ 2.2.9.1).! One! x! 105!fresh! neutrophils! in! 500µL! IMDM! without! human! serum! were! placed! in! the!upper!chamber!of!a!24Swell!Transwell!plate,!with!a!pore!size!of!3µm.!At!the!same!time!400µL!of!conditioned!media!generated!from!myeloid!cellSinfiltrated!tumour!spheroids!treated!with!docetaxel!or!DMSO,!were!diluted!1!in!5!and!added!to!the!lower! chamber.! All! conditioned!media! had! been! previously! filtered! through! a!0.22µm! pore! size! syringe! filter! to! ensure! no! cells! were! present! in! the! media!before!use!in!the!assay.!The!Transwell!plates!were!then!incubated!at!37oC!for!3!hours! to! allow! neutrophil! migration! across! the! filters.! ! The! number! of! viable!(trypan!blue!negative)!neutrophils!that!had!migrated!into!the!media!in!the!lower!chamber!was!then!counted!using!CSChip!disposable!hemocytometers!(Neubauer!Improved).!! The!above!experiment!was!then!repeated!with!neutrophils!that!had!been!preSincubated! for! 30! minutes! at! 37oC! with! either! a! CXCR2Sblocking! antibody!(used! at! a! concentration! of! 1.5! µg/mL)! or! an! IgG! isotypeSmatched! control!antibody! at! the! same! concentration.!Neutrophils!were! then!washed! to! remove!excess,! unSbound! antibodies.! Finally,! the! experiment!was! repeated! again! using!an!antibody!to!neutralise!soluble!TNFα!in!the!conditioned!media.!An!antiShuman!TNFα! antibody,! or! IgG! isotypeSmatched! control,! were! added! to! conditioned!media!at!a!concentration!of!1µg/mL!for!30!minutes!at!37oC!immediately!before!use!in!assays.!For!a!list!of!antibodies,!see!section+2.1.3.!!! To! study! the! response! of! neutrophils! to! media! conditioned! by! tumour!spheroids,! freshlySisolated! neutrophils! were! cultured! for! 16! hours! in!conditioned!media!and!then!collected!for!RNA!isolation.!Neutrophil!viability!was!found!to!be!between!86S97%!by!trypan!blue!staining!following!16Shour!culture!in!IMDM!(with!human!serum!and!LSGlutamine)!(Table+4.1).!!!Neutrophil! total!messenger!RNA!was! isolated!using!an!RNeasy!Mini!Kit,!followed!by!reverse!transcription!to!cDNA!using!TaqMan!Reverse!Transcription!Reagents!and!SYBR!greenSbased!realStime!(RT)SPCR!(see!section+ 2.2.5).!Genes!
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were! selected! based! on! their! reported! expression! by! neutrophils! of! N1/N2!polarisation![146,!294,!295]!(Fig+4.1),!to!identify!whether!neutrophils!in!these!in#
vitro!studies!were!N1!or!N2!polarised.!The!following!primers!were!used!for!RTSPCR:!
Primer+ + Sequence+! ! Forward! ! ! ! Reverse!CCL2! ! 5’SCAGCCAGATGCAATCAATGCCS3’! ! 5’STGGAATCCTGAACCCACTTCTS3’!CCL3! ! 5’SAGTTCTCTGCATCACTTGCTGS3’! ! 5’SCGGCTTCGCTTGGTTAGGAAS3’!CXCR4! ! 5’SACTACACCGAGGAAATGGGCTS3’! ! 5’SCCCACAATGCCAGTTAAGAAGAS3’!FAS! ! 5’STCTGGTTCTTACGTCTGTTGCS3’! ! 5’SCTGTGCAGTCCCTAGCTTTCCS3’!HGF! ! 5’SGCTATCGGGGTAAAGACCTACAS3’! ! 5’SCGTAGCGTACCTCTGGATTGCS3’!ICAMS1! ! 5’SATGCCCAGACATCTGTGTCCS3’! ! 5’SGGGGTCTCTATGCCCAACAAS3’!MMP9! ! 5’STGTACCGCTATGGTTACACTCGS3’! ! 5’SGGCAGGGACAGTTGCTTCTS3’!STAT3! ! 5’SCAGCAGCTTGACACACGGTAS3’! ! 5’SAAACACCAAAGTGGCATGTGAS3’!TNFα! ! 5'SGGAGAAGGGTGACCGACTCAS3'! ! 5'SCTGCCCAGACTCGGCAAS3'!TGFSβ!! ! 5’SGGCCAGATCCTGTCCAAGCS3’! ! 5’SGTGGGTTTCCACCATTAGCACS3’!VEGF! ! 5’SAGGGCAGAATCATCACGAAGTS3’! ! 5’SAGGGTCTCGATTGGATGGCAS3’!
+Conditioned!media!were! collected! from! cultures! of!A549! spheroids! and!myeloid!cells,!as!well!as!neutrophils,!according!to!Fig+4.2.!Only!the!media!(and!soluble!factors)!were!collected!S!contaminating!cells!or!debris!were!removed!by!filtering!them!through!a!0.22µm!pore!size!syringe!filter.!For!the!in#vitro!invasion!assay! (see! section+ 2.2.9.2),!Matrigel!was! diluted! 1:4!with! phosphate! buffered!saline! (PBS),! and! 100µL! pipetted! into! the! insert! of! an! 8µm! pore! size,! 24Swell!Transwell! plate.! After! leaving! for! 2! hours! at! 37oC! to! allow! the! Matrigel! to!polymerise!and!form!a!gel,!PBS!was!removed!and!the!plate!was!air!dried!for!30!minutes.!Conditioned!media!were! filtered!to!remove!any!cells/debris!and!were!diluted! 1:4.! Subsequently,! 400µL! was! pipetted! into! the! lower! chamber! of! the!
Table+4.1+Percentage+viability+of+neutrophils+ following+16+hour+culture+ in+conditioned+
media.+Neutrophils!were!freshly!isolated!from!healthy!donors!before!culture! in!IMDM!for!16!hours.!Neutrophil!viability,!as!measured!by!trypan!blue!staining,!was!between!86S97%.!!
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Figure+ 4.2+ Collection+ of+ conditioned+ media+ from+ A549+ spheroids,+ monocytes+ and+
neutrophils.+ The! conditioned! media! were! collected! from! A549! spheroids! following! the!addition!of!monocytes!for!48!hours!to!allow!their!infiltration.!Docetaxel,!or!its!vehicle!DMSO!were!also!added!simultaneously.!In!later!experiments!this!conditioned!media!from!monocyteSinfiltrated! A549! spheroids! were! then! used! for! 16Shour! culture! with! neutrophils,! before!collecting!the!conditioned!media!again,!this!time!with!added!neutrophilSderived!factors.!For!some! experiments,! neutrophils! were! preSincubated! with! an! antiSCXCR2! antibody! to! block!CXCR2!signalling!prior!to,!and!during,!the!16Shour!culture.!
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CHEMOTACTIC+FOR+NEUTROPHILS+! As! shown! in! Chapter+ 3,! monocytes/macrophages! increase! their!expression! of! neutrophil! chemokines! CXCL1,! CXCL2! and! CXCL5! at!mRNA! level!upon!culture!with!docetaxelStreated!A549!cells.+This!suggests!that!macrophages!may! help! to! recruit! neutrophils! into! lung! tumours! following! treatment! with!docetaxel.! In! this!chapter,!monocytes!were!added! to! tumour!spheroids!and!coScultured! for! 48! hours! to! allow! monocyte! infiltration! and! differentiation! into!monocyteSderived! macrophages.! At! the! same! time,! docetaxel! was! added! to!chemotherapy! groups! at! a! concentration! of! 10µM.! Conditioned! media! from!myeloid!cellSinfiltrated!and!nonSinfiltrated! tumour!spheroids,!after!exposure! to!docetaxel! or! DMSO,! were! assessed! for! their! ability! to! cause! the! migration! of!human!neutrophils!(Fig+4.4).!
Figure+4.4+Release+of+neutrophil+chemoattractants+by+A549+spheroids+in!vitro:+effect+of+
exposure+to+docetaxel+(or+its+vehicle+DMSO)+in+the+presence+or+absence+of+infiltrating+





































! CoSculture! of! spheroids! with!myeloid! cells! led! to! slight,! nonSsignificant!increase!in!neutrophil!migration.!However,!the!highest!neutrophil!migration!was!observed! with! the! conditioned! media! from! myeloid! cellSinfiltrated! tumour!spheroids! exposed! to! docetaxel,! showing! approximately! 6Sfold! induction! of!neutrophil! chemotaxis! above! unconditioned! media,! and! an! increase! above!spheroids! coSincubated!with!myeloid! cells! and! DMSO.! It! should! be! noted! that!such! increases! in! neutrophil! migration! could! also! simply! be! due! to! increased!neutrophil! mobility,! rather! than! their! migration! along! a! chemoattractant!gradient!emanating!from!the!conditioned!media.!The!possibility,!therefore,!exists!that!neutrophils!may!simply!be!induced!to!be!more!mobile,!and!so!more!of!them!would!cross!the!membrane!into!the!lower!Transwell!chamber.!!! To!test!whether!the!above!movement!of!neutrophils!was!dependent!upon!CXCR2! ligands! (such! as! CXCL1,! CXCL2! and! CXCL5)! an! antiSCXCR2! blocking!antibody! was! used.! Untreated! neutrophils,! or! neutrophils! treated! with! antiSCXCR2! antibody! or! isotype! control,! were! used! in! a! migration! assay! using!conditioned! media! from! myeloid! cellSinfiltrated,! docetaxelStreated! spheroids.!The! results! shown! in! Fig+ 4.5! suggest! that! although! the! migrationSpromoting!factors!released!by!macrophages!in!docetaxelStreated!spheroids!appear!to!work!mainly!via!CXCR2,!this!was!not!the!only!signalling!pathway!involved.!!There!was!still! a!doubling!of!neutrophil!migration! in! the!presence!of! the!CXCR2!antibody.!!
Figure+4.5+Neutrophil+migration+induced+by+docetaxelXtreated,+myeloid+cellXinfiltrated+
spheroids+ in! vitro+ is+ markedly+ reduced+ by+ addition+ of+ a+ specific+ CXCR2Xneutralising+






















































































































































4.4.3+FUNCTIONAL+ASSAYS+4.4.3.1!INVASION!ASSAY!Previously,!TNFα!has!been!implicated!in!the!process!of!tumour!invasion.!As! mentioned! in! section+ 1.10.1,! macrophageSderived! TNFα! was! shown! to!enhance! epithelialStoSmesenchymal! cell! transition! (EMT)! in! colon! cancer!spheroids! [280],! which! is! associated! with! a! ! more! invasive! phenotype.!Additionally,! intraperitoneal! injection!of!mice!with!TNFα!enhanced!the!number!of! lung! metastases! when! the! mice! were! subsequently! injected! with! murine!fibrosarcoma! cells! [285]! (Table+ 4.2).! Although! a! marked! trend! towards#increased#TNFα! gene! expression! by! neutrophils! exposed! to! docetaxelStreated,!myeloid! cellSinfiltrated! A549! spheroids! (compared! to! those! exposed! to! DMSO!alone),! this! failed! to! reach! significance!due! to! the!high! variability!within! these!groups! (Fig+ 4.6).! ! As! TNFα! is! known! to! stimulate! the! invasiveness! of! tumour!cells! in# vitro! [375],! it! was! decided! to! investigate! the! potential! of! media!conditioned!by!such!neutrophils! in!an! in#vitro! assay!of!A549! invasiveness.!Had!time!permitted,! it!would!also!have!been!good!to!use!a!number!of!other!tumour!cell!lines!in!such!invasion!assays.!!Conditioned!media!from!these!cells!were!added!to!an!in#vitro!tumour!cell!invasion! assay! in! which! A549! cells! invade! through! a! layer! of! Matrigel! in! a!Transwell! system! (Fig+ 4.7).! Conditioned! media! from! myeloid! cellSinfiltrated!A549! spheroids! induced! tumour! cell! invasion! approximately! 2Sfold! above! the!control,! which! has! fresh! unconditioned! media! (IMDM)! in! the! lower! well.!However,! when! factors! released! by! neutrophils! are! included,! to! model! the!recruitment! of! neutrophils! to! docetaxelStreated! tumours,! proSinvasive! factors!dominate!and!induce!a!significant!(p!=!0.0198)!increase!in!tumour!cell!invasion.!!Since! CXC! chemokines! not! only! chemoattract! neutrophils! but! also!modulate!and!active!them![235,!376],!it!is!possible!that!CXCL1,!CXCL2!and!CXCL5!released!by!macrophages! in!a!docetaxelStreated! tumour!environment!may!also!be! responsible! for! neutrophil! promotion! of! invasion.! As! shown! in!Fig+ 4.8,! the!exposure! of! neutrophils! to! a! neutralising! antiSCXCR2! antibody! showed! that!blocking!CXCR2!signalling!markedly!reduced!their!ability!to!promote!tumour!cell!
! 108!
invasion!in!response!to!spheroidSconditioned!medium!tumour!cell!invasion.!This!suggests!that!either!CXCR2!ligands!released!by!myeloid!cells!in!docetaxelStreated!spheroids! trigger! this! in! neutrophils,! or! that! CXCR2! ligands! are! required! for!neutrophil! survival,! and! blocking! these! leads! to! neutrophil! death.! Therefore,!lower! amounts! of! proSinvasive! factors! are! present! in! the! conditioned! media.!Such!CXCR2!ligands!could!include!CXCL1,!CXCL2!and!CXCL5!released!by!myeloid!cells! as! suggested!by!Chapter+ 3,! but! could! also!be!A549! cellS,!myeloid! cellS! or!neutrophilSderived!CXCR2!ligands!CXCL1,!2,!3,!5,!6,!7!and/or!8![30].!
4.4.4+NEUTROPHILS+ENHANCE+TUMOUR+INVASION+THROUGH+EXPRESSION+OF+TNFΑ++! Given! that! TNFα! mRNA! was! upregulated! by! neutrophils! following!exposure! to! conditioned!media! from!myeloid! cellSinfiltrated! spheroids! treated!with! either! docetaxel! or! DMSO! (Fig! 4.6),! and! that! this! cytokine! is! known! to!stimulate! the! invasiveness! of! tumour! cells! [280],! ! a! neutralising! antibody! to!TNFα!was!used!to!see!if!the!increased!invasive!activity!reported!in!Fig+4.7!was!! !







































predominantly!driven!by!neutrophilSderived!TNFα! (Fig+ 4.9).! In! the! absence!of!
Figure+4.9+TNFα+released+by+neutrophils+(after+their+exposure+to+medium+conditioned+
by+ docetaxel–treated+ A549+ spheroids+ containing+ monocytes)+ stimulates+ tumour+ cell+










































Figure+ 4.8+ The+proXinvasive+ effects+ of+ spheroid/neutrophilXconditioned+medium+was+
ablated+ by+ a+ CXCR2Xneutralising+antibody.+Neutrophil!CXCR2!signalling!was! inhibited!by!addition!of!an!antiSCXCR2!antibody!to!the!spheroidSconditioned!media!before!it!was!added!to!neutrophils.!This!reduced!tumour!invasion,!in!comparison!with!an!isotype!control.!The!mean!±! SEM! from! 5! identical! experiments! or! 12! identical! experiments! (A549! spheroids! +!monocytes! +! Docetaxel! +! Neutrophils)! are! shown.! Data! are! expressed! as! fold! change! in!tumour!cell!invasion!w.r.t.!fresh,!unconditioned!medium,!MannSWhitney!U!test,!*!p!<!0.05.!
Dependency of Neutrophil-Induced  




















































predominantly!driven!by!neutrophilSderived!TNFα!(Fig.+ 4.9).! In! the!absence!of!TNFα,!neutrophil!induction!of!tumour!cell!invasion!was!significantly!(p!=!0.0286)!reduced,!suggesting!that!TNFα!was!a!crucial!factor!in!this!induction.!! Since! monocytes/macrophages! and! tumour! cells! are! also! known! to!release! this! factor,! the! effect! of! neutralising! TNFα! in! conditioned! media! from!docetaxelStreated!tumour!spheroids!and!myeloid!cells!(no!neutrophils)!was!also!investigated,! as! shown! in! Fig+ 4.10.! Tumour! invasion! was! marginally! reduced!when! TNFα! was! neutralised,! suggesting! that! tumour! cells! and! macrophages!contribute! to! the! overall! TNFα! production,! but! to! a! much! lesser! extent! than!when!neutrophils!are!present.!
+4.4.5+MYELOID+CELLS+ALSO+UPREGULATE+CXC+CHEMOKINES+IN+A549+SPHEROIDS+
EXPOSED+TO+ANOTHER+CHEMOTHERAPEUTIC+AGENT,+CYCLOPHOSPHAMIDE.+! In!order!to!understand!whether!the!experiments!described!in!Chapter+3!and!Chapter+ 4! is! specific! to! docetaxel,! or!may! also! occur!with! other! forms! of!chemotherapeutic! agent,! the! key! experiments! described! in! this! chapter! and!
Chapter+ 3! were! repeated! using! cyclophosphamide.! Unlike! docetaxel! that! kills!
Figure+ 4.10+ Neutralising+ TNFα+ in+ conditioned+ media+ from+ spheroids+ reduces+ tumour+
invasion+ in!vitro.!As!shown!in!Fig+4.9,!neutralising!TNFα!in!conditioned!media! from!myeloid!cellSinfiltrated!A549!spheroids! treated!with!docetaxel,!with!added!neutrophilSderived!factors,!significantly!reduces!A549!cell!invasion,!in!comparison!with!an!isotype!antibody!control.!In!the!absence! of! neutrophilSderived! factors,! tumour! cell! invasion! is! reduced,! and! although!neutralising! TNFα! significantly! reduces! tumour! invasion! in! comparison! with! an! isotype!antibody!control,!this!change!is!much!less.!This!suggests!that!there!is!more!TNFα!released!when!neutrophils! are! present,! and! that! TNFα! enhances! A549! cell! invasion.! Pooled! data! from! 4!identical! experiments! are! shown.!Data! are! expressed! as! fold! change! in! tumour! cell! invasion!w.r.t.!fresh,!unconditioned!medium,!*!p!<!0.05!w.r.t.!A549!cells!treated!with!DMSO.!
32"


































































cells! by! stabilising!microtubules,! cyclophosphamide! is! an! alkylating! agent! that!induces! cell! death! by! causing! irregular! base! pairing! and! generating! crosslinks!between!the!strands!of!DNA.!This!leads!to!disrupted!cell!division!and,!ultimately,!to!cell!death![377].!However,!in!order!for!this!to!occur,!cyclophosphamide!must!first! be! converted! into! the! active! component! 4Shydroxy! cyclophosphamide,! by!P450! enzymes! in! the! liver.! The! name! ‘cyclophosphamide’!will! be! used! here! to!describe! the! active! compound! 4Shydroxy! cyclophosphamide,! as! well! as! to!describe!the!unprocessed!proSdrug!used!in!the!in#vivo!experiments!in!Chapter+5.!! As!before!with!docetaxel,!A549!cells!were!exposed!to!cyclophosphamide!(100µM)! or! DMSO! for! 24h+ (as! determined! previously! by! members! of! this!research! group,! see! Fig+ 4.3).! Then! the! cyclophosphamideStreated! cells! and!supernatants!from!this!were!coScultured!with!macrophages!for!5h!in!a!Transwell!assay! (see!sections+ 2.2.9.2+ and!4.3).!Macrophage!expression!of!CXCL1,!CXCL2!and!CXCL5!is!shown!in!Fig+4.11.!As!can!be!seen,!CXCL1!and!CXCL2!were!slightly,!!but! not! significantly,! upregulated! compared! to! vehicleStreated! macrophages,!whereas! CXCL5! was! markedly! upregulated.! Exposure! to! cyclophosphamide!alone!did!not!induce!macrophage!expression!of!CXC!chemokines.+
Figure+ 4.11+ Macrophage+ levels+ of+ CXL1,+ CXCL2,+ CXCL5+ mRNA+ in+ response+ to+






































































MYELOID+CELLS,+ALSO+UPREGULATED+TNFΑ+EXPRESSION+BY+NEUTROPHILS.++! As! before,! conditioned! media! were! collected! from! tumour! spheroids!infiltrated! with! myeloid! cells,! but! in! the! presence! of! cyclophosphamide! or! its!vehicle! DMSO.! Neutrophils! were! incubated! for! 16! hours! in! this! conditioned!media! and! then! the! media! collected! again! and! added! to! tumour! cell! invasion!assays.! Neutrophil! viability! following! 16! hour! incubation! was! 86–97%! as!measured!by!trypan!blue!staining!(see!Section+4.5).!!There!was!a!significant!(p!!=!0.0143)! increase! in! invasion! in! the! cyclophosphamideStreated! group! in!comparison!with!its!vehicle!(Fig+4.12).!!! Interestingly,! conditioned! media! from! vehicleStreated,! myeloid! cellSinfiltrated!spheroids!alone!induced!tumour!invasion!approximately!2Sfold!above!the! nonSspheroidSconditioned! media,! whereas! the! corresponding!cyclophosphamideStreated!group!induced!invasion!almost!6Sfold.!Neutralisation!of! TNFα! in! conditioned!media! from! the! latter! group! significantly! (p! =! 0.0286)!inhibited! tumour! invasiveness! to! less! than! half! of! the! corresponding! isotype!control! group.! Therefore,! as! seen! with! docetaxel,! myeloid! cells! in!cyclophosphamideStreated!A549!spheroids!appear!to!stimulate!TNFα!release!by!neutrophils,!which!promote!the!invasiveness!of!A549!cells!in#vitro.!!
Figure+ 4.12+ Neutrophils+ exposed+ to+ media+ from+ cyclophosphamideXtreated,+ myeloid+





































































4.5+DISCUSSION+Initially,! it! was! discovered! that! myeloid! cells! upregulate! three!chemokines! for! neutrophils,! CXCL1,! CXCL2! and! CXCL5,! in! docetaxelStreated!tumour! spheroids.! Therefore,! it! follows! that! conditioned!media! from! these! coScultures!would! be! chemoattractive! for! neutrophils! in# vitro.! In! summary! of! the!results!from!this!chapter,!neutrophil!migration!assays!showed!that!not!only!did!neutrophils! increase! their! migration! in! conditioned! media! from! myeloid! cellSinfiltrated,!docetaxelStreated!tumour!spheroids,!but!also!that!this!was!mediated,!in! part,! by! CXCR2! signalling.! Although! no! distinct! polarisation! of! neutrophils!towards! an! N1! or! N2! phenotype! occurred! in! these! experiments,! they!upregulated! their!expression!of!proSinflammatory!chemokines!TNFα,!CCL3!and!CCL2,! in! comparison! with! neutrophils! exposed! to! medium! containing! DMSO.!NeutrophilSderived!TNFα!was!shown!to!stimulate!the!invasiveness!of!A549!cells!
in# vitro.! Essentially! similar! results! were! obtained! using! cyclophosphamide! in!these!assays.!Macrophages!were!shown!to!upregulate!mainly!CXCL5,!rather!than!CXCL1! and! 2,! in! response! to! cyclophosphamideStreated! A549! tumours! cells.!TNFα! released! by! neutrophils! following! their! exposure! to! factors! released! by!cyclophosphamideStreated,! myeloid! cellSinfiltrated! spheroids! stimulated! A549!cell!invasion!in#vitro.!Neutrophil! migration! induced! by! conditioned! media! from! tumour!spheroids! increased! less! than! 2Sfold! above! the! unconditioned! medium,!suggesting! that! tumour! spheroids! alone! do! not! secrete! significant! amounts! of!neutrophil!chemokines.!Moreover,!the!addition!of!docetaxel!to!tumour!spheroids!did!not!increase!the!release!of!chemoattractants,!showing!that!tumour!cells!are!not!responsible!for!a!significant!release!of!CXC!chemokines!or!other!neutrophilSchemotactic!molecules,! irrespective!of!chemotherapy!treatment.!This! is!notable!because!LM2!murine!mammary! tumour!cells!have!previously!been!reported! to!express! CXCL1! and! CXCL2! following! treatment! with! doxorubicin! and!cyclophosphamide! chemotherapy! [126],! contrary! to! the! results! shown! here.!This,! however,! may! be! explained! by! the! fact! that! CXCL1S! and! CXCL2Soverexpressing!tumour!cells!were!selected!in!this!earlier!study,!stimulated!by!a!transcriptional! hyperactivation! of! the! 4q21! chromosome! region! occurring! in!
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some! breast! cancers! [292].! This! would! not! be! present! in! the! A549! lung!carcinoma! cells! used! here.! Furthermore,! the! increase! in! CXC! chemokine!expression! reported! in! these! mammary! tumours! after! doxorubicin! and!cyclophosphamide! was! in! part! mediated! by! endothelial! cellSderived! TNFα!release.!!Endothelial!cells!were!not!present!in!the!spheroid!studies!described!in!this!or!the!previous!chapter.!!Neutrophil! migration! towards! conditioned! media! from! myeloid! cellSinfiltrated!tumour!spheroids!was!approximately!3!times!that!of!fresh!IMDM,!but!almost!doubled!upon!docetaxel! treatment!of!myeloid! cellSinfiltrated! spheroids.!This!shows!that!under!basal!conditions,!such!spheroids!release!a!certain!level!of!neutrophilSchemoattracting! factors,! which! may! maintain! a! steady! influx! of!neutrophils! into! untreated! tumours.! The! stress! and! damage! induced! by!chemotherapy! may! then! activate! signalling! pathways! that! lead! to! the!recruitment! of!much!higher! numbers! of! neutrophils.! The! release! of! neutrophil!chemokines! appears! to! be! dependent! upon! the! presence! of! both!myeloid! cells!and! docetaxel! in! this! spheroid! model.! However,! it! is! worth! noting! that!neutrophils! may! have! migrated! through! the! filter! in! between! the! upper! and!lower!chambers!of! the!Transwell!plate!but!remained!attached!to! the! filter,!and!thus!may!have!been!removed!along!with!the!Transwell!insert.!If!so,!the!number!of!infiltrated!neutrophils!would!be!underSrepresented,!although!it!may!not!have!an!effect!on!the!relative!migration!of!neutrophils!between!docetaxelS!and!DMSOStreated! groups.! The! migration! assay! used! here! is! a! simplistic! one! as! it! only!assesses! the!movement! of! neutrophils! through! pores! in! a!membrane! towards!conditioned!media,!which!could!simply!reflect!an!increase!in!neutrophil!motility!rather!than!a!directional!chemoattraction.!This!is!a!massive!oversimplification!of!the! processes! involved! in! neutrophil! recruitment! into! tumours!which! involves!release!from!the!bone!marrow,!extravasation!across!the!tumour!vasculature!and!infiltration!through!the!tumour!mass.!Therefore,!it!is!very!important!to!observe!whether! neutrophils! are! recruited! into! chemotherapyStreated! tumours! in# vivo.##This!is!investigated!in!Chapter+5.!The!data! in! this! chapter! also! show! that!CXCR2!on!neutrophils!mediates!the!effects!of!myeloid!cells!from!docetaxelStreated!spheroids!on!their!migratory!
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activity.! These! results! are! analogous! to! earlier! findings! that! neutrophil!infiltration!into!tumours!is!largely!dependent!upon!CXCR2![126,!185].!However,!it! is!worth!noting!that!CXCR2!also!binds!chemokines!CXCL3,!CXCL6,!CXCL7!and!CXCL8,! and! so! CXCR2! inhibition! will! also! block! signalling! by! these! molecules![30],! all! of!which! have! neutrophil! chemotactic! properties! [378S380].! The! gene!array! (Fig+ 3.2),! however,! did! not! identify! any! of! these! chemokines! to! be!upregulated!by!macrophages!conditioned!with!tumour!cells!or!docetaxelStreated!tumour!cells.!Had!time!permitted,!an!experiment!to!determine!the!dominant!CXC!chemokine!could!have!been!done.!Using! individual! inhibitors!of!human!CXCL1,!CXCL2!and!CXCL5!to!neutralise!protein!in!the!conditioned!media,!the!chemokine!most!responsible!for!neutrophil!migration!would!have!been!identified.!The!gene!array! identified! CXCL5! as! being! most! highly! upregulated! CXC! chemokine! by!myeloid!cells! in! the!docetaxelStreated!tumour!environment!(Fig+ 3.2);!however,!subsequent! realStime! PCR! analysis! suggested! that! myeloid! cell! expression!followed! the! pattern! CXCL1! >! CXCL2! >! CXCL5! (Figs+ 3.4,+ 3.5+ and+ 3.6).!Additionally,! the! CXCR2Sdependency! of! neutrophil! migration! towards!conditioned!media!generated!by!nonSdocetaxelStreated!spheroids!was!not!tested,!since!neutrophil!migration!and!infiltration!into!A549!tumours!has!already!been!shown! to!be! largely!dependent!upon!CXCR2!signalling!both! in#vitro! and! in#vivo![185].+ As!mentioned!previously!in!section+4.1!and!shown!in!Fig+4.1,!two!distinct!activation! states! have! been! identified! for! TANs,! stimulated! by! transforming!growth! factorSβ! (TGFSβ)! and! interferonSβ! (IFNSβ)! [146].! N1! neutrophils! are!described! as! expressing! increased! TNFα,! CCL3,! FAS! and! ICAMS1! mRNA;! in!contrast,! N2! neutrophils! express! higher! CCL2,! CCL5,! CXCR4,! MMP9,! VEGF,!arginase,! cSmyc,! and! STAT3! [295].!Hepatocyte! growth! factor! (HGF)! expression!has! also!been! reported!as! a!marker!of!protumour/N2Slike!phenotype,! since! its!release!by!neutrophils!has!been!shown!to!promote!enhanced!invasion!by!human!cholangiocellular! carcinoma! and! hepatocellular! carcinoma! cells! in# vitro# [381].!FreshlySisolated,! human! blood! neutrophils! were! cultured! for! 16! hours! in!conditioned! media! from! myeloid! cellSinfiltrated! tumour! spheroids,! and! their!gene!expression!was!analysed!by!RTSPCR!for!N1!and!N2!genes.!They!were!found!
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to! express! a!mixture!of!N1! and!N2!genes! S! both! in! the!presence!or! absence!of!docetaxel.!However,!neutrophils! isolated! from!untreated!mouse!or!human! lung!tumours! may! have! responded! differently! to! medium! conditioned! by! myeloid!cellSinfiltrated,!docetaxelStreated!A549!spheroids.!The!mRNA!for!CCL3!and!CCL2!were! upregulated! by! neutrophils! exposed! to! such! conditioned! medium.!Similarly,! STAT3! and! TGFSβ!were! also! induced,! although! their! expression!was!much! lower! than! either! CCL3! or! CCL2.! This! spheroidSconditioned! media! had!little! effect! on! FAS,! ICAMS1,! VEGF,! MMP9,! CXCR4,! and! HGF! mRNA! levels! in!human! neutrophils.! Although! the! difference! in! TNFα! expression! was! not!significant! between! the! two! groups,! a! trend! towards! a! large! increase! was!observed.!!The!results!in!Fig+4.6!show!that!VEGF!and!MMPS9!were!not!significantly!affected! at! the!mRNA! level! by! spheroidSconditioned!medium,! although! STAT3!was!upregulated!marginally,!which!is!a!signalling!factor!known!to!regulate!VEGF!and! MMPS9.! It! appears! that! docetaxel! does! not! have! a! great! effect! on! this!particular!pathway!at!this!timeSpoint.!It!would!have!been!interesting!to!observe!neutrophil! expression! of! STAT3! –! and! the! regulated! proSangiogenic! and! proSinvasive! genes!MMP9! and!VEGF! –! at! earlier! timeSpoints,! since! the! data! shown!here!represent!a!late!timeSpoint!(16h).!Previously!it!has!been!reported!that!early!and! sustained! STAT3! activation! in! dendritic! cells,! induced! by! ILS6! and! ILS10!respectively,! led! to! opposing! regulation! of! a! panel! of! inflammatory! and! antiSinflammatory!genes![382].!Therefore,!investigating!expression!at!an!earlier!timeSpoint!(e.g.!4h)!may!have!uncovered!an!early! induction!of!STAT3! in!neutrophils!that! drives! a! different! STAT3Sdependent! response.! It! would! also! have! been!interesting!to! investigate! the!expression!of!S100A8!and!S100A9!by!neutrophils!had! time! permitted.! Both! have! been! shown! to! promote! the! survival! and!metastasis! of! tumour! cells! in! the! mouse! PyMT! implant! model! –! and! to! be!stimulated! by! CXCL1! in! CD11b+Gr1+! cells! (most! likely! neutrophils)! [126].!Importantly,!S100A8!and!S100A9!were!expressed!at!higher!levels!by!neutrophils!after!doxorubicin!and!cyclophosphamide!chemotherapy,!and!they!may!also!have!been! induced! in! neutrophils! exposed! to! medium! conditioned! by! docetaxelStreated,!myeloid!cellSinfiltrated!tumour!spheroids.!!
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Both! CCL2! and! CCL3! are! potent! leukocyte! chemoattractants,! mainly!reported!to!attract!monocytes/macrophages,!but!also!known!to!affect!dendritic!cells!and!neutrophil!migration![127,!301,!383].!As!such,!the!fact!that!neutrophil!expression! of! CCL2! and! CCL3! increases! by! 35S! and! 25Sfold! respectively!(following! 16Shour! culture! in! conditioned! media! from! myeloid! cellSinfiltrated!spheroids),! and! over! 100Sfold! for! both! CCL2! and! CCL3! (in! the! presence! of!myeloid!cellSinfiltrated!spheroids!after!their!exposure!to!docetaxel),!shows!that!neutrophils! are! highly! likely! to! recruit! monocytes,! macrophages! and! other!lymphocytes! to! the! tumour.! This! is! in! line!with! their! known! ability! to! recruit!monocytes/macrophages! to! sites! of! inflammation! (see! section+ 1.5).+ These!results! are! also! in! accordance!with! previous! reports! of! CCL2! being! one! of! the!most!prevalent!cytokines!in!the!tumour!environment![384],!and!the!most!highly!upregulated! chemokine! in! murine! mammary! tumour! lysates! following!doxorubicin! treatment! [212].! TumourS! and! stromalSderived! CCL2! has! been!shown! to! contribute! towards!M2Spolarisation,! tumour! progression,!metastasis!and! chemotherapeutic! efficacy! via! the! recruitment! of! monocytes! and!macrophages! [127,! 301,! 302,! 384],! including! a! chemotherapySspecific!recruitment! of!myeloid! cells!which! leads! to! decreased! chemotherapeutic! drug!response! [212],! as! discussed! in! section! 1.11.1.! NeutrophilSderived! CCL2!induction!was!not!confirmed!at!protein! level,!and!CCL2!expression!(specifically!after!chemotherapy)!was!not!explored!further.!Although! there! was! a! marked! trend! towards# increased# TNFα! gene!expression!by!neutrophils!exposed!to!docetaxelStreated,!myeloid!cellSinfiltrated!A549!spheroids!(compared!to!those!exposed!to!DMSO!alone),!this!failed!to!reach!significance!due! to! the!high!variance!within! these! groups.! !Human!neutrophils!were! isolated! from! blood! samples! taken! from! healthy! volunteers,! and! such!primary! cells! are! particularly! susceptible! to! the! natural! variations! that! occur!between! human! donors.! This! experiment! might! have! benefited! from! the!inclusion! of! more! donors/repeat! experiments! and! also! a! neutrophils! plus!docetaxel!control!group.!However,!the!finding!that!neutrophils!in!chemotherapyStreated,!murine! tumours! upregulate! their! expression! of! immunoreactive!TNFα!support!the!in#vitro!data!presented!here!(see!Chapter+5).!
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Rather! than! investigating! neutrophil! migration! and! activation/gene!expression!separately,!as!detailed!above!in!Figs+4.3+and!4.5,!this!could!have!been!done!jointly!using!the!spheroid!model.!FreshlySisolated!monocytes,!labelled!with!CellTracker! dye,! could! have! been! added! to! A549! spheroids! and! treated! with!docetaxel!or!DMSO!(see!section+3.5! for!a!discussion!on!exactly!when!docetaxel!should! be! added,! to! model! TAM! response! or! tumourSinfiltrating! monocyte!response).! Then,! freshlySisolated! neutrophils! could! have! been! labelled! with! a!different!CellTracker!dye!and!also!added!to!tumour!spheroids.!After!washing!off!unSinfiltrated!cells,!CellTracker!labelled!monocytes!and!neutrophils!could!be!reSisolated!by! fluorescenceSactivated!cell! sorting,!as!well!as!unlabelled!A549!cells,!for! the! analysis! of! gene! expression! by! RTSPCR! of! these! 3! cell! types.! The!percentage! of! cells! that! are! neutrophils! could! be! compared! between! samples!treated! with! docetaxel,! and! those! treated! with! DMSO,! as! an! indication! of!recruitment!of!neutrophils!into!tumours.!Technically,!this!experiment!would!not!be!much!more!difficult! than! the! experiment!used! to! isolate!myeloid! cells! from!A549! spheroids.! It! could! be! used! to! confirm/identify! the! expression! of! CXC!chemokines!by!myeloid!cells!(as!well!as!tumour!cells!and!neutrophils),!and!the!expression!of!TNFα,!CCL2!and!CCL3!by!neutrophils!(as!well!as!tumour!cells!and!myeloid! cells).! The! differences! between! the! gene! expression! of! neutrophils!cultured! in!docetaxelSgenerated!spheroid!media!and!DMSOSgenerated!spheroid!media! shown! in!Fig+ 4.6! highlight! the! effects! that! docetaxel!may! have! on! TAN!gene! expression! in! patients! with! nonSsmall! cell! lung! cancer.! However,! this!experiment! lacks! a! neutrophil! plus! docetaxel! control,! which! would! identify!whether! neutrophils! upregulate! any! of! these! genes! in! response! to! the!chemotherapy! itself.! It! also! lacks! myeloid! cell! plus! neutrophil! controls,! to!identify!whether!the!coSculture!and!crossStalk!of!these!two!cells!(in!the!presence!of! docetaxel! or! DMSO)! leads! to! neutrophil! gene! expression,! in! the! absence! of!A549!spheroids.+The!experimental!setup!used!to!investigate!neutrophil!gene!expression!was!then!used! to! study! the! possible! biological! significance! of! such! neutrophil! secreted!factors! in! tumours.! Rather! than! collecting! neutrophils! for! expression! analysis,!the!conditioned!media!was!collected!–!including!neutrophil!secretory!products!–!!
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Tumour! invasiveness,!however,!was!found!to!be!most!highly! induced!by!conditioned! media! collected! from! myeloid! cellSinfiltrated! spheroids! and!neutrophils,! following! treatment! with! docetaxel.! Tumour! invasion! increased!significantly!(p!=!0.0198)!with!the!addition!of!neutrophilSderived!factors!to!3.5S
and! used! in! two! in#vitro# functional! assays.! The! invasiveness! of! tumour! cells! is!known!to!be!induced!by!TNFα!(see!Table+4.2)!directly![280,!373]!and!indirectly!by! stimulating! proSinvasive! functions! of! CD11b+Ly6G+! cells! [126]! or!macrophages! [375,! 385].! The! ability! of! factors! in! the! conditioned! media,!including!TNFα,!to!enhance!invasiveness!of!tumour!cells!was!assayed!using!an!in#
vitro! invasion! assay.! The! A549! human! lung! carcinoma! cells! were! used! in! an!invasion! assay! to! assess! their! ability! to! actively! degrade! extracellular! matrix!!(Matrigel)!and!migrate!towards!conditioned!media!from!myeloid!cellSinfiltrated!tumour! spheroids,! treated! with! docetaxel! or! DMSO,! and! cultured! with!neutrophils.!Neither!conditioned!media! from!neutrophils!and!docetaxelStreated!spheroids,! nor! from! monocytes! and! neutrophils! (freshlySisolated! monocytes!cultured!with!neutrophils!for!16!hours),!induced!tumour!invasion!greater!than!2Sfold!above!unconditioned!medium!alone.!These!controls! show! that!neutrophils!do! not! simply! release! proSinvasive! factors! in! response! to! docetaxel,! and! that!these! factors! are! not! released! just! because! of! monocyte! and! neutrophil! coSculture!in!the!absence!of!tumour!cells!or!their!secretory!factors.!!Conditioned!media! from!myeloid! cellSinfiltrated! spheroids! treated! with!docetaxel! induced! tumour! invasion! 2.4Sfold! above! the! control! (myeloid! cellSinfiltrated! spheroids! exposed! to!DMSO),! showing! that! even! conditioned!media!collected! in! the! absence! of! neutrophils! contains! proSinvasive! factors! that!encourage! tumour! invasiveness.! This!may! represent! a! production! of! TNFα! by!monocytes/macrophages!or!by!tumour!cells! themselves![272,!288,!363],!or!the!production! of! other! proSinvasive! factors! by! macrophages! induced! by! tumour!cells,!such!as!MMPs!1!and!9!and!COX2![386],!especially!since!macrophages!have!been! shown! to! accumulate! at! the! invasive! front! of! mammary! tumours! and!promote! invasion! [387].! It! is! worth! noting,! however,! that! no! major! proSinflammatory! cytokines! were! identified! as! being! upregulated! by! tumourSconditioned!macrophages!in!the!gene!array!shown!in!Fig+3.2.!
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fold!above!the!fresh,!unconditioned!media!control!group,!adding!to!the!effect!of!tumour! spheroids! and! myeloid! cells.! Notably,! the! effects! of! any! neutrophilSderived! factors! on! tumour! invasion! could! not! be! mediated! indirectly! via! the!stimulation!of!myeloid!cells!or!tumour!cells,!as!reported!elsewhere![301],!since!conditioned!media! was! collected! in! a! linear! manner,! where! only! the! secreted!factors!of! tumour!cells!and!myeloid!cells!were! incubated!with!neutrophils! (see!experimental!design!diagram!in!Fig+4.7).!The!in#vitro!data!presented!in!this!and!





Genetic!damage!to!tumour!cells! Chronic!exposure!of!murine!haematopoietic!stem!cells!(with!the!Fanconi!anaemia!mutation)!to!TNFα=induced!ROS=dependent!genetic!instability.! [388]!! High!doses!of!TNFα=induced!ROS=dependent!DNA!damage!in!human!p53–/–!colon!carcinoma!cells.! [278]!! TNFα=stimulated!ectopic!production!of!activation=induced!cytidine!deaminase!(AID),!an!important!RNA/DNA!editing!enzyme!that!can!lead!to!mutations!in!p53!and!c=myc,!in!human!colorectal!cancer!cell!lines.!
[389]!
Tumour!growth! Human!colon!cancer!cells!release!TNFα,!which!induced!murine!macrophages!to!upregulate!CSF=1,!VEGF!and!MMP2!in#vitro!and!support!tumour!growth.! [363]!EMT! Epithelial=to=mesenchymal!transition!of!human!colon!cancer!spheroids!is!stimulated!by!macrophage=derived!TNFα.! [280]!Tumour!invasion!and!metastasis! TNFα=dependent!MMP!induction!in!macrophages!is!capable!of!stimulating!the!invasion!of!human!breast!tumour!cell!lines!in#
vitro.#
[375]!




in! the! previous! chapter! suggest! that! neutrophils! in! docetaxelStreated! tumours!may!contribute!towards!the!production!of!proSinvasive! factors.!Thus!treatment!of!lung!cancer!patients!with!docetaxel!therapy!could!potentially!cause!a!release!of!CXC!chemokines!by!TAMs!and!the!recruitment!of!neutrophils!and!their!release!of!proSinvasive! factors.!This!might!be! a!mechanism!by!which! tumours! support!invasion! following! chemotherapy.!Enhanced! invasion! is! an! indicator! that!more!tumour!cells! are!being! induced! to!disassemble! their! connections!with!adjacent!cells! (although! these! may! not! have! had! time! to! form! in! this! invasion! assay),!degrade!extracellular!matrix,!and! increase! their!motility.!Such!motile!cells!may!invade!other!tissues!or!migrate!into!blood!vessels,!where!it!is!possible!they!will!be! transported! to! distant! sites! and! form! metastases.! Although! the! process! of!tumour!cells!metastasising!to!other!sites!requires!many!steps,!including!avoiding!immune!destruction!and!the!establishment!of!a!preSmetastatic!niche![391,!392],!an! increase! in! tumour! cell! invasiveness!would! still! increase! the! likelihood!of! a!successful! metastatic! event.! Therefore,! it! is! important! to! understand!mechanisms! through!which!chemotherapy!may!enhance!metastasis! [126,!162],!so!that!novel!therapies!can!be!used!to!target!such!mechanisms.!!An! additional! group,! however,! is! needed! to! identify! whether! the!induction! of! proSinvasive! factors! by! neutrophils! is! unique! to! the! docetaxelStreated!tumour!environment,!or!whether!this!occurs!in!the!absence!of!docetaxel!also.!Therefore,!a!similar!invasion!assay!should!be!done!using!conditioned!media!collected! from!myeloid! cellSinfiltrated! spheroids! (in! the! absence! of! docetaxel),!and!again!after!culture!with!neutrophils!for!16!hours.!Notably,!since!neutrophils!are!reported!to!survive!for!only!hours!in!culture!in#vitro#[99],!this!might!suggest!that! the!majority!of!neutrophils! in! the!cultures!used!here!may!have!died!by!16!hours,!and!that!it!might!be!the!cellular!content!of!dead!neutrophils!which!affects!tumour! invasion.! However,! the! growth! factors! GSCSF! and! GMSCSF! have! been!shown! to! prolong! the! survival! of! TANs! in! patients! with! lung! adenocarcinoma![393].!Furthermore,!using!the!same!human!lung!adenocarcinoma!cell!line!(A549!cells)!as!used!in!Chapters+3!and!4,!GSCSF!and!GMSCSF!were!shown!to!originate!in!A549!cells!in#vitro#and!promote!neutrophil!survival;!this!inhibition!of!neutrophil!death! was! only! observed! following! exposure! of! A549! cells! to! cellSfree!
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supernatants! from! peripheral! blood! mononuclear! cells! (PBMCs)! or! alveolar!macrophages.!!These! findings!are!highly!significant! for! this! thesis!since!the!neutrophils!in!this!experiment!were!cultured!for!16!hours!in!conditioned!media!from!human!myeloid! cells! and! A549! spheroids,! and! their! viability! was! between! 86–97%,!suggesting! that! myeloid! cellSstimulated! A549! cells! may! promote! neutrophil!survival!in!this!in#vitro!coSculture!system!as!well.!Measuring!the!concentration!of!GSCSF! and! GMSCSF! by! ELISA! in! conditioned! media! from! A549! spheroids,! and!comparing! with! myeloid! cellSinfiltrated! A549! spheroids,! could! be! used! to!investigate!this.!It!would!also!be!interesting!to!observe!any!effects!the!addition!of!docetaxel!chemotherapy!has!on!this!mechanism,!and!whether!it!is!important!for!TAN!viability!in!a!chemotherapyStreated!tumour.!!Furthermore,! the! conditioned! media! used! in! this! assay! have! been!incubated!with!tumour!spheroids!and!myeloid!cells!for!48!hours,!and!then!with!neutrophils!for!16!hours,!and!so!the!level!of!nutrients!remaining!may!be!low!in!the!conditioned!media!by!the!time!they!are!used!in!invasion!assays.!It!is!possible!that!docetaxel! treatment!of!spheroids!slowed!their!proliferation!during!the!48Shour!coSculture!with!myeloid!cells,!such!that!they!used!up!a!lesser!amount!of!the!nutrients! in! the!media.!Subsequently,!when!used! in! invasion!assays,!docetaxelSgenerated!conditioned!media!may!have!had!a!higher!concentration!of!nutrients!than!the!DMSOSgenerated!conditioned!media!control,!thereby!affecting!A549!cell!invasion.! The! docetaxel! still! remaining! in! conditioned!media! (not! taken! up! by!A549!cells,!myeloid!cells!and!neutrophils)!could!similarly!have!an!effect!on!the!invasiveness!of!A549!cells!in!the!invasion!assay;!however,!it!might!be!expected!to!reduce!tumour!cell!invasion!rather!than!to!enhance!it.!The!reduction! in! tumour!cell! invasion!observed!when!neutrophil!CXCR2!signalling! is! blocked,! as! shown! in!Fig+ 4.8,! demonstrates! a! dependency! on! this!receptor!for!the!promotion!of!tumour!cell!invasiveness!by!neutrophils.!Blocking!CXCR2! signalling! on! neutrophils! significantly! (p! =! 0.0159)! reduced! tumour!invasion! to! less! than! 2Sfold! above! controls,! indicating! that! not! only! do! CXCL1,!CXCL2!and!CXCL5!chemoattract!neutrophils,!they!–!or!other!such!CXCR2!ligands!
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as!CXCL3,!CXCL6,!CXCL7!and!CXCL8!–!also!stimulate!neutrophils!to!release!proSinvasive!molecules.!As!before,! it! is!possible! that!one,!or!a!combination!of! these!CXC!chemokines,!is!accountable!for!this!response,!and!so!further!studies!are!now!needed! to! dissect! this! –! possibly! by! depleting! CXCL1,! CXCL2! and! CXCL5!individually! from! the! conditioned! media! using! neutralising! antibodies.! In! this!way,! it!would! be! possible! to! identify! the! key! factor(s)! responsible! for! causing!neutrophil!proSinvasive!response.!!!!!! As! mentioned! previously,! both! TNFα! and! CCL2! were! upregulated! by!neutrophils!after!exposure!to!spheroidSconditioned!medium.!!Interestingly,!both!factors!have!been!shown!to!regulate!tumour!invasion!and!so!could!contribute!to!the!neutrophil!stimulation!of!tumour!invasiveness!reported!here;!however,!due!to! time!and!budget!constraints,!only!TNFα!was!explored!here! in! this! thesis.!To!investigate! the! importance! of! TNFα! in! this! mechanism,! a! TNFαSneutralising!antibody!was! used! to! deplete! conditioned!media! of! this! cytokine.! Neutralising!TNFα! in! the! media! led! to! a! significant! reduction,! approximately! halving! the!number!of! successfully! invading! tumour! cells,! thereby!demonstrating!a! central!role! for! TNFα! in! stimulating! A549! human! lung! carcinoma! cell! invasiveness.!Notably,! in! the! absence! of! docetaxel,! conditioned! media! from! myeloid! cellSinfiltrated! tumour! spheroids! (treated! with! DMSO)! and! neutrophils! did! not!induce! tumour! invasion! as! highly;! the! stimulation! of! an! invasive! tumour! cell!phenotype! is!primarily! induced!by! factors!secreted! in! the!docetaxelSchallenged!tumour! environment.! Enhanced! neutrophil! activation! and! recruitment! to! the!docetaxelStreated! tumour,! orchestrated! by! resident! TAMSderived! CXCL!chemokines,!may! lead! to! the! release! of! TNFα! and!more! invasive! tumour! cells.!Since! monocytes/macrophages! are! a! major! source! of! TNFα,! including! in! the!tumour!environment,!and!that!tumour!cells!themselves!can!release!TNFα![288],!the! relative! contribution! of! these! cells! types! and! neutrophils! needed! to! be!investigated.!As!shown!in!Fig+4.9,!not!only!was!tumour!invasion!reduced!in!the!absence!of!neutrophilSderived!factors,!but!the!dependence!upon!TNFα!was!much!less,!proving!that!neutrophils!are!required!for!the!maximum!production!of!TNFα!and! TNFαSdependent! tumour! cell! invasion.! The! induction! of! invasiveness! by!tumour! cells! and!myeloid! cells! is! dependent! on! other! factors! as!well! as!TNFα,!
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which!could!include!MMPs!1,!9!and!COX2![386].!One!criticism,!however,! is!that!the! neutralising! efficiency! of! antiSTNFα! and! antiSCXCR2! antibodies! were! not!investigated! in! the!context!of! this!assay.!This!could!have!been!done!using!dose!response!experiments!(observe!the!reduction!in!gene!expression!with!increasing!concentrations! of! antibody),! or!with! a! Ca2+!mobilisation! assay! to! demonstrate!blocking!of!TNFα!in!media!or!the!CXCR2!receptor.!Conditioned!media! from! tumour! cells! treated!with! docetaxel+ induced! a!less! than! 1.5Sfold! increase! in! tumour! cell! invasiveness.! This! suggests! tumour!cells!are!not!directly!enhancing!the!invasiveness!of!other!tumour!cells,!whereby!docetaxelSchallenged!tumour!cells!signal!the!invasion!and!escape!of!local!tumour!cells.!With!more! time,! further! experiments! to! gain!more! understanding! of! this!mechanism!would! include! infiltrating!monocytes! and! neutrophils! into! tumour!spheroids! simultaneously,! followed! by! the! addition! of! docetaxel.! This! would!allow! crosstalk! and!physical! interaction! between! all! 3! cell! types.! The! different!cell!types!could!be!isolated!using!fluorescenceSactivated!cell!sorting!(FACS),+and!individually!analysed!for!gene!expression!by!RTSPCR,!and!by!ELISA!or!cytometric!bead! array! from! cell! supernatants.! This! mixed! coSculture! would! be! more!representative!of!the!true!in#vivo!conditions.!Instead,!the!conditioned!media!here!were!collected!following!coScultures!of!tumour!spheroids!and!myeloid!cells,!and!then!these!conditioned!media!were!used!for!neutrophil!16Shour!culture!to!collect!neutrophilSderived!factors.!This!more!linear!approach!followed!a!progression!of!unfolding! events,! and! provided! information! as! to! which! cell! produced! each!factor,!also!allowing!easier!manipulation!of!cells!with!blocking!antibodies.!! As!shown!in!Fig+4.11!and!Fig+4.12,!the!docetaxelSresponsive!upregulation!of! CXC! chemokines! by!monocytes/macrophages,! and! the! promotion! of! tumour!invasion!were!not!unique!to!docetaxel!–!similar!results!were!obtained!using!4Shydroxy!cyclophosphamide!(the!active,!metabolised!form!of!cyclophosphamide).!However,! whereas! CXCL1! was! highly! induced! in! monocytes/macrophages! by!docetaxel! (Fig+ 3.4),! when! cyclophosphamide! was! used! the! most! highly!upregulated! chemokine! analysed! was! CXCL5.! CXCL1! and! CXCL2! mRNA! were!expressed! at! much! lower! levels! than! with! docetaxel.! Nonetheless,!cyclophosphamide!still!induced!an!upregulation!of!CXCL5,!which!is!important!for!
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neutrophil!activation!and!recruitment![238].!Future!experiments!should!include!investigating! expression! of! all! three! CXCL! chemokines! at! the! protein! level! in!media!conditioned!by!docetaxel!versus!cyclophosphamideStreated,!myeloid!cellSinfiltrated!and!nonSinfiltrated!tumour!spheroids.!!As!with!docetaxel,!the!tumour!invasion!assay!showed!an!almost!identical!ability! of! cyclophosphamide! to! induce! the! proSinvasive! function! of! neutrophils!via! their! secreted! TNFα.! The! tumour! invasion! induced! by! conditioned! media!from! myeloid! cellSinfiltrated! A549! spheroids! treated! with! docetaxel! was!significantly!increased!(p!=!0.0143)!by!the!addition!of!neutrophilSderived!factors.!However,!conditioned!media!from!just!neutrophils!plus!cyclophosphamide!alone!was! not! investigated,! and! so! this! should! be! included! to! observe!whether! it! is!simply! that! cyclophosphamide! induces! the! secretion!of! proSinvasive! factors!by!neutrophils.! It! would! have! been! interesting! to! observe! how! general! this!mechanism! of! inducing! tumour! invasiveness! is,! using! a! panel! of!chemotherapeutics,!and!different!tumour!cell!lines#in#vitro.!It!is!possible!that!this!TNFαSdependent! invasion! of! tumour! cells! is! unique! to! A549! cells,! and! so! it! is!important! to! use! other! cell! lines! in# vitro,! which! could! include! MCFS7! human!breast! cancer! cells! and! HTS29! human! colorectal! carcinoma! cells.! ! However,!intratumoural!TNFα!is!explored!in!four!different!tumour!models!later! in#vivo! in!
Chapter+5.!Additionally,! neutrophils! were! found! to! upregulate! TGFSβ! mRNA!(approximately! 15Sfold)! upon! exposure! to! medium! conditioned! by! docetaxelStreated,! macrophageSinfiltrated! spheroids.! Since! this! growth! factor! has! been!shown! to! polarise! tumourSassociated! neutrophils! towards! a! proStumour!phenotype![146],!as!well!as!inducing!epithelialSmesenchymal!transition!(EMT)!in!colon! carcinoma! in! concert! with! TNFα! [280],! its! expression! by! neutrophils! in!docetaxelStreated! tumours! may! drive! neutrophils! towards! an! N2! phenotype!(although! this!was!not! seen! in! the!16h!coScultures!used!here,!which! induced!a!mixed!N1/N2!phenotype)!and!tumour!cells! towards! invasion!and!metastasis.!A!similar! confirmation! of! TGFSβ! expression! at! the! protein! level! by! ELISA! or!cytometric! bead! array! is! now! warranted,! before! pursuing! neutrophilSderived!
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TGFSβ!as!a!potentially!important!modulator!of!neutrophil!phenotype!and!tumour!metastasis.!! Despite!the!advantages!of!using!a!spheroidSbased!model!over!traditional!monolayer! coScultures! (including! the! presence! of! drug! diffusion! gradients! and!hypoxic! cores! as! in! tumours),! this! model! still! lacks! many! features! of! human!tumours.!The!biggest!drawback!is!the!simplification!in!terms!of!cell!types,!since!tumours!are!comprised!of!tumour!cells!and!a!multitude!of!stromal!cells!including!monocytes/macrophages,! neutrophils,! endothelial! cells,! fibroblasts,!lymphocytes,! and!mast! cells,! of! which! only! two! are! represented! in! the!model!used!here.!Therefore,!intricate!crosstalk!between!the!array!of!cell!types,!as!well!as!subsets!within!cell!types,!is!not!present.!Additionally,!extracellular!matrix!and!tissue!structure!are!not!fully!formed,!in!part!because!the!spheroids!form!over!a!short!period!of!time!and!often!remain!below!1mm3!in!volume![319].!Endothelial!cells!and!vasculature!do!not!exist!in!this!model,!and!so!the!many!tumourSdriven!processes! that! modulate! their! supply! of! oxygen! and! nutrients,! vital! to! their!progression,!are!not!present.!Therefore,!it!is!very!important!to!test!and!validate!such! in# vitro# spheroidSbased! findings! using! in# vivo! models,! as! is! done! here! in!
Chapter+5.!In! summary,! the! data! in! this! chapter! suggest! that! myeloid! cells! in!chemotherapyStreated! tumour! spheroids! produce! CXCL! chemokines! that! are!chemotactic!towards!neutrophils.!These!factors!(and!potentially!others)!released!by! macrophageSinfiltrated,! docetaxelStreated! spheroids! failed! to! polarise!neutrophils!towards!an!N1!or!N2!phenotype.!However,!the!upregulation!of!TNFα,!CCL2!and!CCL3!may!be! important! for! the!regrowth!and! invasion/metastasis!of!tumours! after! such! forms! of! chemotherapy.!Moreover,! this! effect!was! not! just!limited! to! docetaxel,! as! cyclophosphamide! also! triggers! a! similar! interplay!between! macrophages! and! neutrophils.! It! remains! to! be! seen! whether! this!constitutes!a!general!response!to!chemotherapy!treatment.!Attempts!have!been!made!to!explore!this!further!in!the!in#vivo#studies!described!in!Chapter+5.!If!this!also! occurs! in! patients! with! lung! cancer! after! treatment! with! docetaxel! or!cyclophosphamide! (or! other! forms! of! chemotherapy),! it! might! be! a! method!
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5.1+INTRODUCTION+! The! involvement! of! innate! immune! cells! in! tumour! responses! to!chemotherapy! has! been! shown! in! a! number! of! recent! studies! [126,! 162,! 212,!290,!291],!as!summarised!in!Fig+1.5.!The!findings!in!Chapters+3+and!4+describe!a!possible! collaboration! between! chemotherapyStreated! A549! lung! tumour! cells!and! human! myeloid! cells! to! increase! neutrophil! chemotaxis! in# vitro.! This!collaboration! also! stimulated! neutrophils! to! release! factors! that! enhance! the!invasiveness!of!A549!cells!in#vitro!via!a!mechanism!involving!the!cytokine!TNFα!and! neutrophil! CXCR2! signalling.! This!mechanism!was! triggered! by!A549! cells!exposed!to!different!chemotherapeutic!agents!docetaxel!and!cyclophosphamide!(Fig+4.11+and!Fig+4.12).!Therefore,!in!this!chapter!the!response!of!myeloid!cells!was!investigated!in#vivo#using!various!mouse!tumour!models.!! A!very!common!side!effect!and!limiting!factor!of!chemotherapy!treatment!is! neutropenia,! the! presence! of! abnormally! low! numbers! of! neutrophils! in! the!blood!(less!than!2!x!106!neutrophils!per!millilitre),!which!is!not!only!caused!by!the! suppression! of! neutrophil! production! by! chemotherapy,! but! also! its! direct!cytotoxic! effects! [394].! A! patient’s! chemotherapy! treatment! regimen! will! be!stopped! or! changed! to! a! reduced!dose! if! a! patient! becomes!neutropenic,! since!this!condition!is!associated!with!increased!chance!of!potentially!lifeSthreatening!infections,!such!as!Streptococcal! infections![395].!Many!forms!of!chemotherapy!are!known! to! cause! this!decrease! in! the!number!of! circulating!neutrophils! (i.e.!neutropenia),! and! so! it! is! feasible! that! chemotherapy! may! also! reduce! the!number! of! neutrophils! infiltrating! into! tumours,! causing! a! decrease! in! the!numbers!of!TANs.!!However,!the!in#vitro!studies!described!in!Chapters+3!and!4!suggest!that!docetaxel! chemotherapy! is! likely! to! cause! an! increase! in! expression! of! CXC!
! 129!
chemokines!by!TAMs,!and!thus!neutrophil!recruitment.!If!this!were!found!to!be!true! in# vivo,! such! neutrophil! recruitment! might! overcome! the! general!neutropenic! state! of! the! patient,! and! lead! to! a! local! increase! in! TANs.!Additionally,! other! such! factors! as! GSCSF! and! GMSCSF! have! been! shown! to!prolong! the! survival! of! TANs! in! patients! with! lung! adenocarcinoma! [393],! as!mentioned!previously!in!section+4.5.+If!present!in!tumours!after!chemotherapy,!such! factors! might! promote! TAN! survival! despite! chemotherapySinduced!neutropenia.! Interestingly,! TANs! accumulate! in! orthotopic! mouse! mammary!tumour! (PyMT)! transplants! following! combined! treatment! with!cyclophosphamide!and!doxorubicin![126].!!The! markers! CD11b! and! Ly6G! are! commonly! used! to! identify! murine!TANs! [146,! 396,! 397].! The! CD11b! integrin! –! a! differentiation! marker! of! the!myelomonocytic! lineage!–! is! transcriptionally!upregulated! in!precursor!cells!as!they!mature,! but!decreases! again! as!monocytes!differentiate! into!macrophages![398].! CD11b! is! the! integrin! alpha! M! chain,! which! forms! a! dimer! with! the!integrin! beta! 2! subunit! (CD18)! to! form! macrophageS1! antigen! (MacS1),! an!important!adhesion!receptor!and!regulator!of!inflammation.!Ly6G!is!a!small!GPISlinked!protein!that,!together!with!Ly6C,!forms!the!complex!known!as!the!myeloid!differentiation! antigen,! or! Gr1,! in! mice.! Flow! cytometry! analysis! using! a!monoclonal! antibody! to! Ly6G! (1A8)! has! shown! that! Ly6G! is! predominantly!expressed! in! murine! bone! marrow,! and! to! a! much! lesser! extent! in! other!lymphoid!tissues!that!contained!activated!T!and!B!lymphocytes![399].!The!Ly6G!antibody! predominantly! bound! to! the! surface! of! mouse! neutrophils,! whereas!Ly6C! is! present! on! bone! marrow! cells,! subsets! of! monocytes/macrophages,!neutrophils,! endothelial! cells,! plasma! cells! and! subsets! of! T! cells! [84,! 400].!Antibodies! to! the! entire! Gr1! complex! are! also! used! to! identify! neutrophils.!!However,!as!mentioned!previously!(see!Table+1.1),!Gr1!is!not!just!expressed!by!murine! neutrophils! and! granulocytic! MDSCs,! but! also! by! inflammatory!(CX3CR1loCCR2+Gr1+)! monocytes! [22].! Similarly,! both! antiSGr1! [401,! 402]! and!antiSLy6G![403S405]!antibodies!have!been!used! to!deplete!neutrophils! in!mice,!but!the!antiSLy6G!antibody!is!favoured!due!to!the!preservation!of!nonSneutrophil!Gr1+! cells,! which! are! depleted! by! the! antiSGr1! antibody! [405].! The! antiSLy6G!
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monoclonal! antibody! 1A8! specifically! depletes! blood! neutrophils! and! does! not!affect! Gr1+! blood! monocytes.! Additionally,! murine! neutrophils! can! also! be!identified!by! the!marker!Ly6B.2!(7/4),!but!again,! this!marker! is!also!expressed!on!some!bone!marrow!progenitors!and!monocytes!as!well.!Ly6G!has,!therefore,!been!proposed!to!be!a!more!specific!marker!for!neutrophils.!In! Acharyya! et! al.! (2012)! [126],! cell! populations! from! LM2! mouse!mammary! tumours!were! analysed! by! flow! cytometry! using! antibodies! for! the!markers!Ly6G!and!Gr1,!as!well!as!F4/80,!CD31!and!CD11b!antibodies.!!Cells!were!separated! into! the! following!populations:! CD11b+Gr1+!cells,! CD11b+Ly6G+! cells,!CD11b+Ly6C+! cells! (predominantly! monocytes),! F4/80+! cells! (macrophages),!CD31+!cells!(endothelial!cells),!and!unsorted!cells!(predominantly!tumour!cells).!Sorted! cells! were! used! to! investigate! the! expression! of! Cxcr2! gene! by! each!population,! as! shown! in! Fig+ 5.1+ (taken! from! [126]).! The! results! showed! that!CD11b+Gr1+!cells,!and!specifically!the!CD11b+Ly6G+!neutrophil!population!(since!Gr1+! cells! also! include! such! nonSneutrophil! cells! as! granulocytic! MDSC! and!inflammatory! monocytes),! had! the! highest! Cxcr2#mRNA! levels.! The! other! cell!populations!had!only!low!levels!of!this!gene.!As! mentioned! in! previous! chapters,! the! chemokines! CXCL1,! CXCL2,!
#
CXCL1/2 expression in lung metastatic cell lines, the expression
of CXCR1, CXCR2, and DARC was negligibly low both at
the RNA and protein levels (Figure 2C and Figure S2F and Mu¨ller
et al., 2001). Based on these results, we postulated that CXCL1/2
mediates tumor cell survival via paracrine mechanisms.
CXCR2 receptor is expressed by several stromal cell types
such as endothelial and myeloid cells (Murdoch et al., 2008).
Using a combination of immunostaining and FACS, we did
a comprehensive analysis of major cell types in the tumor micro-
environment whose abundance changed upon CXCL1/2 knock-
down in the LM2 xenograft and PyMT-F transplant models. A
significant reduction in CD11b+Gr1+ myeloid cells was observed
inCXCL1/2 knockdown tumors in both models (Figures S2G and
S2H). Myeloid-derived suppressor cells (MDSC) represent a
heterogeneous group including precursors for neutrophils and
monocytes that express both CD11b and Gr1 (Gabrilovich and
Nagaraj, 2009). Gr1+ in mice includes cells that express the
macrophage marker Ly6C and cells that express the neutrophil
marker Ly6G (Ostrand-Rosenberg and Sinha, 2009). Detailed
characterization of the myeloid cells showed a decrease in the
CD11b+Ly6G+ granulocytic MDSC population in CXCL1/2
knockdown tumors compared to controls (Figures 2D and S2I).
No appreciable decrease was observed in the CD11b+Ly6C+,
F4/80+ macrophages, SMA+ myofibroblast, Ter119+ erythroid
cells, or endothelial cells in the CXCL1/2 depleted tumors
(Figures S2J–S2P, Table S1, and data not shown). In line with
our hypothesis, CD11b+Gr1+ cells and specifically the CD11b+
Ly6G+ subpopulation expressed CXCR2 (Figures 2E and S2Q).
Within the recruited CD11b+Ly6G+ population in the PyMT
immunocompetent transplant tumors, 6%, 12%, and 25% of
the cells expressed CD80, F4/80, and Sca1, respectively,
and a minority expressed CD86, CD117, IL4Ra, VEGFR1, and
CD34 (Table S2). Sca1, amarker of the hematopoietic stem cells,
was expressed in CD11b+Ly6G+ populations, indicating poten-
tial progenitor-like phenotype of the tumor granulocytic cells
recruited by CXCL1/2 (Table S2).
Interestingly, a reduction both inmonocytic CD11b+Ly6C+ and
granulocytic CD11b+Ly6G+ cells occurred in the lungs of mice
bearing CXCL1/2 depleted tumors with minimal changes in the
number of F4/80+ macrophages (Figures S2R–S2T). Compared
Figure 2. Carcinoma-Derived CXCL1/2 Supports Cancer Cell Survival and Recruit Granulocytic Myeloid Cells to Tumors
(A and B) Representative images and quantification of apoptosis in mammary tumors analyzed by cleaved caspase-3 staining. Mouse mammary glands were
injected with LM2 cells (A and B) or PyMT-F cells (B) expressing shRNA control or shCXCL1/2 and analyzed at endpoint (LM2, 6 weeks; PyMT-F, 9 weeks after
tumor implantation). Scale bar, 30 mm. Data are averages ± SEM; n = 4 mice per group. p values were calculated by Student’s t test.
(C) Expression of the indicated genes frommicroarray gene expression analysis in nontumor humanmammary epithelial cell lineMCF10A, parental MDA-MB-231
breast cancer cells and lung metastatic lines derived from MDA-MB-231 (Minn et al., 2005).
(D) Flow cytometric analysis of recruited myeloid cells in tumors formed by LM2 cells transduced with either control shRNA or shCXCL1/2 at 5 weeks after tumor
inoculation. A representative gating is shown. Numbers indicate either CD11b+Ly6G+ or CD11b+Ly6C+ cells in the quadrant expressed as percentages of total
CD45+ leukocytes from the same tumor. Results are representative of three independent experiments (n = 3).
(E) Expression of Cxcr2 receptor in sorted subpopulations of LM2 tumors determined by qRT-PCR. Error bars represent 95% confidence interval for qRT-PCR
analysis. Data are representative of two independent experiments.
See also Figure S2 and Tables S1 and S2.
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Figure+ 5.1+ The+ levels+ of+ CXCR2+mRNA+ are+ highest+ in+ granulocytic+ cell+ populations+ LM2+
murine+ breast+ tumours.+ Sorted! subpopulations! of! murine! metastatic! breast! (LM2)! tumours!were! used! to! analyse! messenger! RNA! expr ssion! of! the! Cxcr2! gene.! The! CD11b+Gr1+! and!CD11b+Ly6G+! granulocytic! populations! showed! highest! expression! of! the! receptor,! with!much!lower! expression! by! CD11b+Ly6C+! (predominantly! monocytes),! F4/80+! (macrophages),! CD31+!(endothelial!cells),!and!unsorted!cell!populations.!Image!adapted!from![126].!
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CXCL3,!CXCL5!and!CXCL8!all!signal!through!the!CXCR2!receptor!and!are!potent!neutrophil!chemotactic!and!activating!factors![30,!93,!228].!Several!reports!have!suggested! that! blockade! of! CXCR2! signalling!may! be! therapeutically! beneficial!where!excessive!neutrophil!infiltration!causes!progressive!damage;!this!has!been!suggested! in! such! inflammatory! disorders! as! colitis,! type! 1! diabetes,! cystic!fibrosis!and!reperfusion!injury![244,!258,!406,!407],!as!well!as!murine!lung,!skin!and! gastrointestinal! cancers! [126,! 337].! Several! CXCR2Sinhibiting! molecules!have! been!developed,! some!of!which! are! currently! in! clinical! trials! (see!Table+
1.3).!! The! CXCR2! inhibitor! SB! 265610! shows! specificity! towards! CXCR2! and!inhibits! CXCL8!binding! this! receptor!with! an! IC50! of! 10nM! in! humans.! In! a! rat!model,! SB!265610! antagonises!CXCL1! (CINCS1)Sinduced!neutrophil! chemotaxis!in! a! concentrationSdependent! manner! [260].! ! Furthermore,! in! two! orthotopic!xenograft! murine! breast! cancer! models! (MDA231SLM2! and! CN34SLM1),!combined!treatment!with!cyclophosphamide!and!doxorubicin!triggered!not!only!CXCL1! upregulation! by! tumour! cells! but! also! increased! stromal! expression! of!TNFα!(largely!described!as!being!by!endothelial!and!other,!unidentified!stromal!cells)!which!also!augments!CXCL1!expression!by!tumour!cells.!It!was!suggested!that!CXCL1/2Sinduced!S100A8/9!expression!by!recruited!CD11b+Gr1+!cells!leads!to!chemoresistance![126].!!Given! the! findings! reported! in!Chapters+ 3! and!4! –! that! A549! cells! and!certain!chemotherapeutic!agents!stimulate!myeloid!cells!to!upregulate!CXCLs!1,!2!and/or!5,!leading!to!increased!tumour!cell!invasiveness!via!neutrophilSderived!TNFα! –! further! in# vivo! studies! were! undertaken! to! investigate! the! effects! of!chemotherapy! on! neutrophil! recruitment! and! TNFα! expression! in! mouse!tumours,!and!the!possible!role!of!CXCL1!expression!by!TAMs!in!this.!
5.2+AIMS++! The! aim! of! the!work! in! this! chapter!was! to! test! the! relevance! of! the! in#
vitro!findings!discussed!in!Chapters+3+and!4!to!mouse!tumours,!using!a!variety!of! mouse! tumour! models! and! chemotherapeutic! agents.! This! includes!investigating!the!upregulation!of!CXCL1!expression!by!TAMs,!and!the!number!of!
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TNFαSexpressing! TANs! in! chemotherapyStreated! tumour.! The! hypothesis! that!blocking! CXC! chemokine! signalling! through! systemic! inhibition! of! CXCR2! will!reduce!neutrophil!infiltration!into!tumours,!as!well!as!their!production!of!TNFα,!was!tested! in#vivo.!Finally,! in!the!same!way!as!reported!previously! in!xenograft!MDA231SLM2! and! CN34SLM1! tumours! [126],! this! work! aimed! to! assess! the!effect! of! doxorubicin! and! cyclophosphamide! chemotherapy,! combined!with! SB!265610! treatment,! on! the! growth! of! primary! PyMT! transplants! and! their! lung!metastases.!
5.3+METHODS+! In! summary,!mice! bearing! subcutaneous! LLC! (syngeneic! lung)! tumours,!orthotopic!PyMT!(transgenic!murine!mammary)!tumour!transplants,!orthotopic!ASVSB!(transgenic!murine! liver)!tumours,!or!orthotopic!4T1!(syngeneic!murine!mammary)!tumours!were!used!for!immunofluorescence!analysis!of!TANs!using!a!Ly6G! antibody,! in! combination! with! a! CD11b! antibody! where! stated.! These!tumourSbearing!mice! were! treated! with! cyclophosphamide! (LLC),! doxorubicin!plus! cyclophosphamide! (PyMT),! etoposide! (ASVSB),! paclitaxel! (4T1)! or! the!appropriate! vehicles! for! these! agents.! The! numbers! of! Ly6G+! neutrophils,!Ly6G+TNFα+! neutrophils,! and! TAMs! expressing! CXCL1! were! then! assessed,! as!described! in! section+ 2.2.12.2.! In! the! PyMT! transplant! model,! the! effects! of!combining!chemotherapy!with!CXCR2!inhibition!(i.e.!treatment!with!SB!265610)!on!the!above!parameters!(and!tumour!levels!of!the!apoptosis!marker,!caspase!3)!were!examined.!Frozen!sections!of!chemotherapy!or!vehicleStreated!LLC,!4T1!and!ASVSB!mouse! tumours!were! generated! during! previous! studies! by! other! scientists! in!Professor!Lewis’s!group!in!Sheffield!(LLCs!and!ASVSB),!or!in!the!laboratory!of!a!collaborator! (the! 4T1! tumours! by! Dr.! Michele! De! Palma! at! the! Swiss! Federal!Institute!of!Technology!Lausanne!in!Lausanne)!(see!section+2.2.12.1).!While!the!
in#vivo! studies!using! the!PyMT! transplants!were! conducted!by! scientists! in! the!laboratory! of! Dr.! Joan! Massagué! (Memorial! Sloane! Kettering! Centre! in! New!York),! they!were!designed! jointly! by! the! Lewis! and!Massagué! labs! (with! input!from!this!PhD!project).!
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5.3.1+LEWIS+LUNG+CARCINOMA+(LLC1)+EXPERIMENTS+Mice! (FVB)!were! implanted!with!mouse! LLC1! lung! tumour! cells! by! Dr.!Hughes! in!Professor!Lewis’s! group! in! Sheffield.! LLC1! cells! (1! x!106! cells)!were!injected! subcutaneously! into! the! mouse! hind! flank.! !When! tumours! reached! a!volume! of! 100mm3! they! were! given! intraperitoneal! injections! of!cyclophosphamide!(150mg/kg)!every!48!hours!for!a!total!of!3!injections.!!These!mice!were!then!culled!48!hours!after!the!last!dose!of!cyclophosphamide!and!the!tumours!were!removed!and!snap!frozen!(as!described!in!section+2.2.12.1).!
5.3.2+ASVXB+ASVSB!mice!are!transgenic!mice!that!carry!the!Simian!vacuolating!virus!40!(SV40)!oncogene!under!the!control!of!the!liverSspecific!albumin!promoter![408].!These! mice! develop! spontaneous! hepatocellular! carcinoma! from! 12! weeks! of!age.! At! 16! weeks! of! age,! ASVSB! mice! were! given! either! vehicle! or! the!chemotherapeutic! agent! etoposide! (10! mg/kg),! in! a! sequence! of! daily!intraperitoneal!injections!for!5!days,!then!rested!for!2!days,!and!given!another!5!days! of! the! same! treatment.! !Mice!were! culled! 48! hours! after! the! last! dose! of!etoposide! or! vehicle,! tumours! removed! and! frozen! as! described! in! section+
2.2.12.1.!These!studies!were!conducted!by!Dr.!Munitta!Muthana!and!Dr.!Russell!Hughes!in!the!laboratory!of!Professor!Claire!Lewis.!
5.3.3+4T1!Frozen!sections!of!4T1!tumours!were!kindly!provided!by!Dr.!De!Palma!in!Switzerland.!One!million!cells!in!100µL!!of!PBS!were!injected!into!the!mammary!fat!pad!of!7Sweek!old!BALB/c!mice!and!then!given!3!intraperitoneal!injections!of!paclitaxel!(10mg/kg)!separated!by!5!days.!These!mice!were!then!culled!72!hours!after!their!last!injection!and!tumours!removed!and!frozen.!
5.3.4++PYMT+Mice!(FVB)!were!injected!with!the!FVB.MMTVSPyMT!cell!line,!1!x!105!cells!per! mouse! in! 50µL,! in! a! 1:1,! Matrigel:cell! suspension! (in! PBS)! mix.! When!tumours!reached!approximately!150mm3,!mice!were!randomised!into!treatment!groups.!Doxorubicin!was!given!at!2mg/kg!once!a!week,!and!cyclophosphamide!was! given! at! 45mg/kg! once! a! week.! For! mice! given! the! CXCR2! inhibitor,! SB!
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265610,!this!was!given!at!2mg/kg,!5!times!per!week.!For!vehicleStreated!control!mice! an! equivalent! volume! of! PBS! (chemotherapy! vehicle)! and! PEG400! (SB!265610!vehicle)!were!used.!Mice!were!culled!after!two!rounds!of!this!combined!chemotherapy!(15!days)!due!to!the! large!size!of!control! tumours.!At!this!point,!tumours! and! lung! tissues! were! removed! and! fixed! overnight! in! 4%!paraformaldehyde.!
5.3.5+IMMUNOFLUORESCENT+STAINING+OF+FROZEN+TISSUE+SECTIONS+! Frozen! tumours!were!cut!on!a! cryotome! into!10µmSthick!sections,! fixed!with! 4%! PFA! (except! PyMT! sections! which! were! already! fixed)! and!immunofluorescently! labelled! according! to! the! methods! described! in! section+
2.2.12.2,+ using! the! antibodies! from! suppliers! listed! in! section+ 2.1.3.! For! the!analysis!of!CXCL1!(GroSalpha),!TNFα,!Ly6G,!F4/80,!CD31,!CD11b!and!cleaved!(i.e.!active! form!of)! caspase!3,! the! following!antibody!concentrations!and!durations!were!used!(in!PBST!buffer,!see!section+2.1.6):!
Primary/conjugated+Antibodies+ Application+of+antibody+to+sections+Rat!m!antiSCD11b! 4µg/mL!for!2!hours!at!RT!Rat!m!antiSmouse!F4/80! 4µg/mL!for!16!hours!at!4oC!Rat!m!antiSmouse!Ly6G!(1A8)!FITC! 20µg/mL!for!2!hours!at!RT!Rat! m! antiSmouse! TNFα! (LEAF™!purified)! 20µg/mL!for!6!hours!at!RT!Rabbit!p!antiSactive!Caspase!3! 4µg/mL!for!2!hours!at!RT!Rabbit!p!antiSCD31! 2µg/mL!for!1!hour!at!RT!Rabbit!p!antiSGRO!alpha!(murine!CXCL1)! 4µg/mL!for!2!hours!at!RT!
Secondary+antibodies+ !Goat!m!antiSrat!AlexaFluor®!555! 10µg/mL!for!1!hour!at!RT!Goat!m!antiSrat!AlexaFluor®!633! 10µg/mL!for!1!hour!at!RT!Goat!m!antiSrabbit!APC! 10µg/mL!for!1!hour!at!RT!!
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! The! use! of! CD11b/Ly6G! (dual! immunofluorescent! staining)! and! Ly6G!(single!staining)!for!the!labelling!of!neutrophils!was!compared!(Table+5.1),!and!this!showed!that!less!than!6%!of!Ly6G+!cells!were!not!CD11b+!in!that!particular!tumour,! suggesting! that! Ly6G! can! be! used! alone! to! label! TANs.! A! Ly6G! single!stain!was!used!to!label!neutrophils!in!PyMT,!LLC!and!4T1!tumours.!!
!Slides!were!washed!thoroughly!for!15!minutes!in!PBST!after!exposure!to!each!of!the! primary! antibodies! listed! above.! Where! applicable,! secondary! antibodies!were! added,! and! the! slides!washed.! After! the! final! wash,! tissue! sections!were!counterstained!with!300nM!DAPI! for! 2!minutes,!washed! in!PBST,! and! covered!with!Prolong!Gold!AntiSfade! reagent! and! a! coverslip.! Confocal!microscopy!was!done! using! a! Zeiss! LSM! 510! confocal! microscope! and! LSM! 510! software! to!capture! between! 5! and! 8! images! of! randomly! selected! fieldsSofSview! (FOV)! at!x25!or!x40,!as!stated.!All! the!cells! in!each!FOV!were!counted!manually!and!the!images! were! counted! blind.! Isotype! antibody! controls! were! used! to! ensure!background! staining! was! low/absent! for! each! staining! experiment,! and! each!time!the!confocal!microscope!settings!were!changed.!! A!semiSquantitative!method!using!ZSstack!images!of!tumour!sections!was!also! applied! in! order! to! assess! changes! in! immunofluorescence! per! cell! (e.g.!TNFα! in! neutrophils)! in! the! different! treatment! groups.! The! levels! of!immunodetectable!protein!were!determined!by!taking!11!images!of!each!stained!tumour! section! at! different! focal! depths! in! each! sample.! This!was! done! at! 40x!
Table+5.1!Comparison+of+ immunofluorescent+ staining+of+TANs+using+CD11b+and+Ly6G+
antibodies,+or+Ly6G+antibody+alone.!Neutrophils!in!transgenic!ASVSB!murine!liver!tumours!were! labelled! using! CD11b! and! Ly6G! antibodies.! The! sum! of! CD11b+Ly6G+! (dual! positive)!cells! and! Ly6G+! cells! in!5! fieldSofSview! from! one!vehicleStreated!and!one! etoposideStreated!ASVSB! tumour!were! counted,!and!used! to! calculate! the!percentage!of!Ly6G+! cells! that!were!also!CD11b+.!Very!few!(<6%)!Ly6G+!cells!were!not!CD11b+.!!
Tumour No.(Ly6G+(cells No.(CD11b+Ly6G+(cells %(Ly6G+(cells(also(CD11b+
Vehicle 24 23 95.83%
Etoposide 35 33 94.29%
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magnification!in!4!randomly!selected!regions!of!each!tumour.!Images!were!then!analysed!in!ImageJ!software,!where!the!channelSofSinterest!was!isolated!and!the!ZSstack! images! displayed! as! individual! images! (rather! than! stacked).! A!macro!(see!section+ 2.2.12.3)!based!on!a!previously!reported!analysis! [148]!was! then!run! to! set! thresholds! and! transform! the! image! into! a! format! that! could! be!quantified.! To! get! a! semiSquantitative! measurement! of! signal! fluorescence!intensity! the! Measure! function! (ImageJ)! was! then! used.! A! total! value! was!calculated!for!each!ZSstack!by!summation!of!these!fluorescence!intensity!values,!which!was! done! for! 4! FOV/ZSstacks! in! each! tumour.! The! average! and! SEM! of!these!4!tumours/donors!is!shown.!








MAMMARY+TUMOUR+TRANSPLANTS++! Immunofluorescent! analysis! was! used! to! enumerate! the! number! of!CXCL1+! TAMs! and! ‘other’! (nonSTAM)! cells! in! PyMT! tumours! treated! with!doxorubicin! and! cyclophosphamide,! in! the! presence! or! absence! of! the! CXCR2!inhibitor,!SB!265610!!(Fig+5.2).!!The! inhibitor! SB! 265610! is! a! CXCR2Sspecific! antagonist.! It! has! been!shown! to! inhibit! CXCR2! and! prevent! neutrophil! accumulation! in! hyperoxiaSexposed! newborn! rats,! and! antagonises! rat! CXCL1! (CINCS1)Sinduced! calcium!mobilisation! in! rat! neutrophils! in# vitro! with! a! half! maximal! inhibitory!concentration!(IC50)!of!3.7nM![260].!The!affinity!of!SB!265610!was!investigated!by!observing!the!binding!of!radiolabelled!CXCL8!(ILS8)!to!Chinese!hamster!ovary!(CHO)! membranes! stably! expressing! CXCR1! or! CXCR2,! in! the! presence! or!!absence!of!SB!265610![409].!The!inhibitor!SB!265610!was!found!to!block!CXCL8!binding! CXCR2,! IC50! =! 39.1! ±! 11.0nM,! whereas! it! blocked! CXCL8! binding! to!CXCR1,! IC50! =! 7,400! ±! 2,400nM,! thus! demonstrating! considerable! specificity!towards!CXCR2.! Similarly,! SB!265610! inhibited! calcium!mobilisation! in!human!neutrophils!in!response!to!CXCL1!(which!binds!CXCR2,!not!CXCR1),!IC50!=!5.2!±!1.5nM,!whereas! it! inhibited! calcium!mobilisation! in! response! to! CXCL8! (which!binds! both! CXCR1! and! CXCR2),! IC50! 426! nM! [409].! However,! only! two!experimental!repeats!of!CXCL8!binding!were!done.!Increases! in! both! the! number! F4/80+CXCL1+! TAMs! in! tumours,! and! the!proportion!of!TAMs!expressing!CXCL1+following+treatment!with!doxorubicin!and!cyclophosphamide,!were!seen+ (Fig+5.2+B+and+ C).!Combining!this!chemotherapy!with! SB! 265610! failed! significantly! to! alter! either.! Interestingly,! however,! the!number! of! ‘other’! (i.e.! F4/80–)! cells! expressing! CXCL1! increased! in!chemotherapyStreated! tumours! (Fig+ 5.2+ D),! and! increased! further! in! the!chemotherapy! plus! SB! 265610Streated! tumours.! These! nonSTAM! cells! that!express!CXCL1!could!be!tumour!cells,!based!on!their!larger!nuclear!morphology.!!
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However,! time!permitting,! it!would!have!been! interesting! to!use!a!panel!of!cell!markers!to!identify!these!other!CXCL1Sproducer!cell!types.!!
5.4.2+CHEMOTHERAPY+INCREASES+TUMOUR+RECRUITMENT+OF+LY6G+TNFΑ++CELLS+IN+
FOUR+MURINE+TUMOUR+MODELS++! The!role!of!myeloid!cells!in!tumours!following!chemotherapy!varies!with!type! of! treatment! and! tumour! model,! as! has! been! recently! reviewed! [312].!Therefore,! 4! different! murine! tumour! models! were! used! to! investigate! the!!presence!of!Ly6G+TNFα+!cells!in!tumours!following!chemotherapy,!and!to!see!!
Figure+5.2+Effect+of+doxorubicin+and+cyclophosphamide+on+CXCL1+expression+by+F4/80++















































































!whether! TANs! respond! in! a! general! way! to! a! range! of! chemotherapeutics! in!these!different!models.!!Frozen! sections! of! tumours! from! four! murine! models! (given! different!
Figure+5.3+The+number+of+Ly6G+TNFα++cells,+and+the+proportion+of+Ly6G+cells+that+are+
TNFα+,+ increases+in+tumours+from+4+different+ tumour+models+given+different+types+of+
































































































































































































TRANSPLANTED+PYMT+MURINE+MAMMARY+TUMOUR+MODEL++! Overall! TNFα! protein! levels! in! Lewis! lung! carcinoma! (LLC)! tumours,!treated! with/without! cyclophosphamide! chemotherapy,! were! measured! by!confocal!microscopy.!!The!fluorescence!intensity!of!TNFα!staining!was!measured!in!ZSstacks! from!these! tumours! to!get!a! semiSquantitative!measurement,!based!on!a!previously!described!method![148].!Levels!of!TNFα! in!chemotherapyStreated! tumours!were! increased!above!sizeSmatched! controls,! as! shown! in! Fig+ 5.5+ B,! which! supports! the! findings! in!
Chapters+3+and+4.! !Additionally,!the!number!of!TNFα+!cells!(Fig+5.5+C)!showed!an! increasing! trend! between! control! and! chemotherapyStreated! tumours,!
Figure+5.5+TNFα+protein+levels+generally+ increase+in+LLCs+in+following+treatment+with+
cyclophosphamide+although+the+number+of+TNFα++cells+was+not+significantly+increased.+(A)! Representative! images! of! TNFα! staining! (green)! and! DAPI! (blue)! in! LLCs.! ! TumourSbearing!mice!were! treated!with! cyclophosphamide! chemotherapy! (150mg/kg),! and! (B)! the!level!of!TNFα!was!significantly!increased!in!tumours!excised!from!cyclophosphamideStreated!mice,!by!comparison!with!sizeSmatched!tumours!from!control!mice!injected!with!vehicle!only.!(C)!The!number!of!all!TNFαSexpressing!cells!did!not!significantly! increase,!but!a!clear!trend!towards!an!increase!was!observed.!Therefore,!significant!increase!in!TNFα!staining!(B)!must!be!due!to!an!increase!in!mean!fluorescence!per!cell.!(D)!TNFα!levels!were!determined!using!a!semiSquantitative! analysis! of! TNFα! immunofluorescent! staining! in! ZSstack! images! (see!
section+ 2.2.12.3).! Images! were! taken! at! x40! magnification.! The! mean! ±! SEM! from! 4!experiments!are!shown,!MannSWhitney!U!test,!*!p!<!0.05.!Scale!bar!=!20µm.!
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The" sum" of" TNFα" staining"
ﬂ u o r e s c e n c e" i n t e n s i t y"
measured" in" ZMstacks" at" 40x"
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Figure+ 5.6+ Overall+ TNFα+ levels+ in+ PyMT+ transplants+ significantly+ increase+ following+
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inhibition! of! CXCR2! receptor! using! SB! 265610.! This! suggests! that! signalling!through! CXCR2! (expressed! most! highly! on! granulocytic! cells,! at! least! in! LM2!murine! breast! tumours,! Fig.+ 5.1)! is! central! to! TNFα! upregulation! by!!chemotherapy.!The!CXCR2!inhibitorSalone!group!trended!towards!a!decrease!in!TNFα+!cells,!and!a!significant!(p!=!0.0286)!decrease!in!immunodetectable!TNFα!was! observed! in! tumours! from! SB! 265610Streated! mice,! in! comparison! with!control!tumours.!
+5.4.5+NEUTROPHILS+ARE+NOT+THE+ONLY+TNFΑXEXPRESSING+CELLS+IN+PYMT+AND+LLC+
TUMOURS+THAT+RESPOND+TO+CXCR2+INHIBITION+During! imaging!of! tumour!sections! it!was!noted! that!not!all!TNFα+! cells!were! Ly6G+! neutrophils.!Many! other! cell! types! are! known! to! express! TNFα! in!tumours,!including!macrophages![266],!endothelial!cells![126],!T!lymphocytes,!B!lymphocytes,! NK! cells! [410],! mast! cells,! and! tumour! cells! [288].! Given! that!endothelial! cell! production! of! TNFα! has! been! previously! implicated! in! tumour!growth,! metastasis! and! response! to! chemotherapy! [126],! and! the! general!importance! of! TAMs! as! major! TNFαSproducing! cells! [288],! tumours! were! coSstained!for!TNFα!and!either!the!endothelial!cell!marker!CD31,!or!the!pan!mouse!macrophage! marker! F4/80.! In! addition,! pericytes! are! capable! of! expressing!TNFα! [411],! and! so!TNFα+!perivascular! cells! (i.e.! possible!pericytes)!were! also!counted!in!these!tumour!sections!to!assess!their!relative!contribution.!Had!time!permitted,!it!would!have!been!good!to!use!a!pericyte!marker,!like!alphaSsmooth!muscle! actin! (αSMA)! or! NG2! proteoglycan,! to! identify! these! cells! in! frozen!sections.!Similarly,!tumour!cells!are!also!capable!of!expressing!TNFα![272,!412],!and! given! that! markers! for! macrophages,! neutrophils,! endothelial! cells! and!pericytes!were!used!to!stain!for!these!cells,!the!remaining!‘other’!TNFα+!cells!are!likely!to!be!predominantly!tumour!cells.!In!addition,!most!of!these!‘other’!TNFα+!cells!have!larger!nuclei,!also!suggesting!that!they!might!be!tumour!cells.!
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As! seen! in!Fig+ 5.7+ A,! the! largest! increases! in! TNFα+! cells!were! seen! in!Ly6G+TNFα+! population! and! the! ‘other’! population;! however,! significant!increases!(p!<!0.05)!were!also!observed!in!the!number!of!F4/80+TNFα+!cells!and!CD31+TNFα+!vessels.!The!CXCR2!inhibitor!SB!265610!alone!did!not!significantly!alter!the!number!of!TNFα+!cells!of!any!cell!population!in!comparison!with!control!
Figure+5.7+ Identification+of+some+of+the+TNFαXexpressing+cell+ types+in+PyMT+tumours:+










































tumours,!except!for!F4/80+TNFα+!cells,!which!showed!a!small!but!significant!(p!=!0.0286)!increase.!! Importantly,!combination!of!chemotherapy!and!CXCR2!inhibitor!had!very!little! effect! on! the! number! of! TNFα+! cells! of! all! cell! types! –! macrophages,!endothelial!vessels,!perivascular!cells,!and!‘other’!cells!–!except!for!neutrophils;!the! number! of! Ly6G+TNFα+! cells! reduced! with! the! application! of! the! CXCR2!inhibitor!(Fig+5.7+A).!Significantly,!LLCs!treated!with!cyclophosphamide!(Fig+5.8)!confirmed! the! findings! of! the! PyMT! model! (with! the! exception! of! the! CXCR2!inhibitorStreated! groups).! Increased! TNFα+! cells! following! chemotherapy!treatment!of!tumours!were!noted!in!this!model!as!well,!with!similar!increases!in!Ly6G+TNFα+!cells!and!‘other’!TNFα+!cells.!However,!the!number!of!CD31+TNFα+!vessels!did!not!change,!and!a!small!but!significant!(p!=!0.0176)!increase!in!TNFα+!perivascular!cells!was!observed.!
Figure+5.8+Identification+of+the+TNFα++cell+types+in+LLC+tumours.+To!confirm!the!results!in!



























FURTHER,+NONXSIGNIFICANT+TREND+! Tumour!measurements! were! taken! twice! weekly! during! treatment! and!used! to! calculate! tumour! volume! (provided! by! Dr.! Joan! Massagué;! Memorial!SloanSKettering!Cancer!Center,!USA).!The!final!tumour!volumes!measured!at!day!36! post! partum! are! shown! in! Fig+ 5.9.! Doxorubicin! and! cyclophosphamide!chemotherapy! treatment,! as!well! as! treatment!with! SB! 265610,!were! initiated!when! tumour! volume! reached! approximately! 150mm3! (see! section+ 5.3.4).! In!comparison! with! control! tumours,! chemotherapy! treatment! reduced! tumour!volume.! Chemotherapy! plus! SB! 25610! also! led! to! a! significant! (p! <! 0.05)!
Figure+ 5.9+ The+ size+ of+ PyMT+ tumour+ transplants+ was+ significantly+ reduced+ by+





























































decrease! in! tumour! volume,! as! compared! with! both! control! tumours! and! SB!265610Sonly! treated! tumours.! However,! despite! this! group! showing! lower!tumour!volumes!on!average,!the!difference!between!chemotherapyStreated!and!chemotherapy! plus! SB! 265610Streated! tumours,! was! not! significant.! Tumour!volumes!in!SB!265610Sonly!treated!mice!were!lower!than!control!mice,!but!the!difference!was!not!significant.!
5.4.7+TREATMENT+WITH+DOXORUBICIN/CYCLOPHOSPHAMIDE+AND+THE+CXCR2+
INHIBITOR,+SB+265610,+RESULTS+IN+AN+INCREASE+IN+TUMOUR+APOPTOSIS+IN+PYMT+
TUMOUR+TRANSPLANTS+! Tumours!were!analysed!by!immunofluorescence!microscopy!for!changes!in!the!number!of!apoptotic!cells!between!different!treatment!groups.!To!identify!apoptotic!cells,!an!antiSactive!caspase!3!antibody!was!used.!Caspase!3!is!cleaved!early! in! apoptosis! and! it! cleaves! other! apoptosisSrelated! caspases,! including!caspases! 6,! 7! and! 9! [413].! However,! it! is! worth! noting! that! caspase! 3! is! not!required!for!apoptosis!of!all!cells.!!There!was!a!trend!towards!increased!numbers!of!active!caspase!3+!cells!in!tumours! exposed! to! the! CXCR2! inhibitor! alone! in! comparison! with! control!tumours!(Fig+5.10).!Surprisingly,!a!significant!increase!in!the!number!of!caspase!3+! cells!was!not!observed!between!control! tumours!and!chemotherapy! treated!tumours,!suggesting!that!chemotherapy!did!not!induce!apoptotic!cell!death!(or!at!least!a!form!of!this!which!resulted!in!the!generation!of!active!caspase!3).!These!tumours! were! smaller! (Fig+ 5.9)! and! so! it! is! possible! that! doxorubicin! and!cyclophosphamide! chemotherapy! induce! necrotic,! rather! than! apoptotic,! cell!death.! A! comparison! of! chemotherapyStreated,! and! chemotherapy! plus! SB!265610Streated!tumours,!showed!a!significant!(p!=!0.0286)!increase!in!apoptotic!cells! (Fig+ 510),! suggesting! that! CXCR2! inhibition! may! prevent! antiSapoptotic!mechanisms!required!for!cell!survival!after!chemotherapy.!
5.4.8+ONXGOING+METASTASIS+STUDY+! The!lungs!from!all!of!the!PyMT!transplantSbearing!mice!mentioned!in!the!previous!section!were!collected,!fixed!in!formalin!and!embedded!in!paraffin!wax,!sectioned,! and! then! stained! for! the!PyMT!antigen! to! identify!metastatic! foci! in!
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this! tissue! (as! described! in! section+ 5.3.6! and! Supplementary+ Method+ 1).! In!summary,! tissue! sections! were! deparaffinised! with! xylene! and! histoclear! and!rehydrated!using!a!series!of!ethanol!washes.!The!sections!were!then!subjected!to!heatSinduced! epitope! retrieval! in! combination! with! citrateSbased! antigen!retrieval! solution.!Slides!were!blocked!with!2.5%!normal!goat! serum!and!a! rat!antiSPyMT! antibody!was! used! (dilution! 1:200)! overnight! in! 2.5%! normal! goat!serum.! ImmPRESS! reagent! (antiSrat,! mouse! adsorbed)! was! used! to! detect! the!primary! antiSPyMT! antibody,! and! the! peroxidase! substrate! DAB! (3,! 3’Sdiaminobenzidine)!was!used!to!detect!signal.!The!lung!tissue!sections!were!then!counterstained!using!haematoxylin,!dehydrated!and!mounted!with!Cytoseal!XYL!(RichardSAllen! Scientific).! This! work! was! done! by! Dan! Macalinao! in! Dr.! Joan!Massagué’s!group!(Memorial!SloanSKettering!Cancer!Center,!USA).!Although!the!
Figure+ 5.10+ Cleaved+ (active)+ caspase+ 3+ immunostaining+ shows+ that+ blocking+ CXCR2+
with+SB+265610+in+combination+with+chemotherapy+increases+apoptosis+in+the+tumour+







































































staining! for! lung!metastases!has!been!optimised!and!metastases! can!be!clearly!seen! in! paraffinSembedded! lung! sections! (Fig+ 5.11),! the! number! of!micrometastases!was! low!and! they!were!very!small,!and!so!were!not!were!not!suitable!for!analysing!the!effects!of!chemotherapy!and!SB!265610!on!metastasis.!The! low! numbers! of!metastatic! cells! is! likely! due! to! the! short! duration! of! the!treatment,! which! lasted! just! 15! days! before! the! mice! were! culled.! This!experiment!is!currently!being!repeated!with!longer!treatment!duration!to!allow!larger!metastases!to!form.!
5.5+DISCUSSION+! In!summary,!this!chapter!investigated!the!in#vitro! findings!from!Chapter+
3!and!Chapter+4+in!an+in#vivo!setting,!using!various!tumour!models!in!which!mice!were! administered! different! forms! of! chemotherapeutic! agent.!Immunofluorescent!analysis!of!F4/80!and!CXCL1!in!PyMT!tumours!showed!that!the! number! of! CXCL1+! macrophages! increased! after! chemotherapy.! However,!large!numbers!of!F4/80–!cells!were!also!CXCL1+,!suggesting!CXCL1!upregulation!
Figure+5.11+Immunohistochemical+identification+of+lung+micrometastases+in+mice+with+
orthotopic+ PyMT+ transplanted+ tumours.+ Five! µM! sections! lungs! from! PyMT! tumourSbearing!mice!were!immunostained!for!PyMT!antigen.!Small!metastatic!foci!were!detected!but!the!numbers!of!these!were!low.!This!experiment!is,!therefore,!currently!being!repeated!in!the!Massagué!lab,!using!a!longer!treatment!duration!(to!allow!the!metastases!to!grow!to!a!larger!size).!Scale!bar!=!100µm!+
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is! a!more! general! feature! of! tumour! response! to! chemotherapy,! and! increased!further!in!tumours!treated!with!combined!chemotherapy!and!CXCR2!inhibition.!Four! tumour! models! treated! with! different! chemotherapies! were! used! to!investigate! neutrophil! accumulation! and! TNFα! expression.! In! all! 4! models,!Ly6G+TNFα+! cells! were! significantly! (p! <! 0.05)! increased! following!chemotherapy! treatment.! A! semiSquantitative! analysis! of! overall! TNFα! protein!levels! in! LLC! and! PyMT! tumours! suggested! a! similar! chemotherapySspecific!upregulation,! and! importantly,! this! was! inhibited! in! PyMT! tumours! when!chemotherapy! was! given! with! CXCR2! blockade.! Not! all! TNFα+! cells! were!neutrophils,! and! immunofluorescent! analysis! of! different! cell! populations!showed! that! numbers! of! TNFα+! neutrophils! and! ‘other’! cells,! including!macrophages! and! presumably! tumour! cells,! increase! in! chemotherapyStreated!PyMT! and/or! LLC! tumours.! Smaller! increases! in! TNFα+! endothelial! cells! and!perivascular! cells! were! seen! in! PyMT! and! in! LLC! tumours,! respectively.!Nonetheless,! as! expected,! only! the! number! of! chemotherapySinduced! TNFα+!neutrophils!decreased!in!PyMT!tumours!upon!CXCR2!blockade.!Although!tumour!volume!trended!towards!a!decrease!in!combined!chemotherapy!and!SB!265610Streated!mice,!the!difference!between!this!group!and!chemotherapy!alone!was!not!significant.! Analysis! of! the! number! of! apoptotic! cells! did,! however,! show!increased! induction! of! apoptotic! cell! death!with! combined! therapy,! suggesting!that!SB!265610!treatment!can!improve!tumour!responsiveness!to!chemotherapy.!
# Macrophage! expression! of! CXCL1! is! known! to! be! important! for! the!recruitment!of!neutrophils!in!tissue!inflammation![93].!The!data!in!this!chapter!show! that! inhibition! of! CXCR2! did! not! significantly! reduce! the! effect! of!chemotherapy! on! CXCL1+! TAM! accumulation,! and! therefore,! this! and! possibly!CXCL1+! TAM! survival! may! not! be! dependent! on! CXCL/CXCR2! signalling.! It!remains! to! be! seen! what! the! factors! are! that! either! recruit! CXCL1+! TAMs! or!activate!CXCL1–!TAMs!to!express!CXCL1!(and!possibly!other!CXCLs).!With!further!experimentation,! it!might! be! possible! to! determine!whether! TAMs! accumulate!and! express! CXCL1! after! chemotherapy! via! activation! of! TLR4! signalling! [92],!induced! by! damageSassociated!molecular! patterns! (DAMPS;! e.g.! HMGB1,! HSPs,!ATP)!that!are!released!by!necrotic!cells.!Although!the!number!of!F4/80+CXCL1+!
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cells! markedly! increased! postSchemotherapy,! an! increase! was! also! seen! in!F4/80–CXCL1+! cells!which! could! have! been! tumour! cells! since! they!were! large!cells!with! large! nuclei.! To! investigate!whether! these! cells! are! tumour! cells,! an!antiScytokeratin! antibody! (binds! tumour! cells)! could! have! been! used! in!combination!with!CXCL1.!As!mentioned!previously,!several!different!cell!types!in!the!tumour!are!capable!of!secreting!CXCL1![93,!126,!232,!350].!Therefore!it!is!not!possible!to!guarantee!the!source!of!CXCL1!stain!in!these!images.!However,!only!cells!with!overlapping!F4/80!and!CXCL1!stain!were!counted! for!F4/80+CXCL1+!cell!counts.!Additionally,!it!is!worth!noting!that!the!control!PyMT!tumours!were!not!sizeSmatched!to!the!chemotherapy!treated!tumours,!and!that!tumour!volume!has! previously! been! shown! to! affect! TAM! phenotype! [414].! Therefore,! it! is!possible!that!the!larger!size!of!control!tumours!affected!the!expression!of!CXCL1!by!macrophages!or!other!cells.!This!applies! to!other! findings!below,!except! for!LLC! tumour!data!where! the! controls!were! sizeSmatched.! Interestingly,! these! in#
vivo! results! are! contrary! to! the! finding! that! tumour! cells! in! docetaxelStreated!tumour!spheroids!failed!to!upregulate!CXCL1!expression!(Fig+3.6).!!This!could!be!due! to! the! use! of! a! different! type! of! chemotherapy! (doxorubicin! and!cyclophosphamide! in!the!PyMT!study!and!docetaxel! in!the! in#vitro!studies),! the!type!of!tumour!cells!used!(PyMT!transgenic!murine!mammary!tumour!cells,!and!human! A549! lung! carcinoma! cells! in! in# vitro# studies),! or! because! the! in# vitro!spheroid! model! lacks! true! in# vivo! complexity! (such! as! the! presence! of!vasculature! or! lymphocytes,! which! may! be! needed! for! tumour! cells! to!express/upregulate! CXCL1).! Alternatively,! the! nonSF4/80–! cells! seen! to!upregulate! CXCL1! in! PyMT! tumours! after! doxorubicin! and! cyclophosphamide!treatment!may!not!have!been!tumour!cells,!but!rather!an!abundant!stromal!cell!type! like! fibroblasts! [415].!The! increase! in!F4/80–CXCL1+! cells! shows! that! this!chemotherapySinduced! CXCL1! expression! is! not! just! a! feature! of!macrophages!but! is! a!more! general! effect.! It! has! not! been! identified! here! whether! this! is! a!direct! or! indirect! effect! of! chemotherapy! (doxorubicin! and! cyclophosphamide)!on! these! cells/cell! types.! Previously,! LM2!murine!mammary! cancer! cells! have!been! shown! to! express! higher! levels! of! CXCL1! protein! in! response! to! TNFα! in#
vitro,!and!that!inhibition!of!the!NFSκB!pathway!blocked!this![126].!Therefore,!it!is!also! possible! that! PyMT! murine! mammary! cancer! cells! also! respond! to!
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doxorubicinS! and! cyclophosphamideSinduced! TNFα! (Fig+ 5.6)! via! an! NFSκBSdependent!mechanism!to!upregulate!CXCL1.!Although!combining!chemotherapy!with! SB! 265610! had! no! discernable! effect! on! CXCL1+!macrophages,! it! led! to! a!significant!increase!in!the!number!of!other!CXCL1+!cells,!possibly!because!CXCR2!inhibition! blocked! a! negative! feedback! mechanism! that! normally! limits! CXC!chemokine!production.!Cells!in!the!tumour,!potentially!tumour!cells,!may!have!a!negative!feedback!regulatory!loop!that!relies!on!CXCR2!signalling,!such!that!high!levels! CXC! chemokines! (including! CXCL1)! feedback! and! inhibit! tumour! cell!production!of!these!chemokines.!Blocking!this!negative!feedback!by!SB!265610!would! cause! the! cells! to! upregulate! CXCL1.! It! is! possible! therefore! that! using!combined!chemotherapy!and!SB!265610!in!the!clinic!may!lead!to!higher!levels!of!CXCL1!being!expressed!by!tumours,!and!possibly!released!into!the!bloodstream!to!recruit!tumourSpromoting!neutrophils.!CXCL1!signals!only!through!the!CXCR2!receptor!even!though!it!reportedly!binds! to! the! nonSsignalling! receptor,! Duffy,! and! two! viral! receptors! [30].!Therefore,!the!proStumour!effects!of!CXCL1,!such!as!the!promotion!of!melanoma!and!breast!tumour!growth![126,!340],!tumour!angiogenesis!in!colorectal!cancer![341],!and!metastasis!in!breast!cancer![126]!could!conceivably!be!blocked!by!the!systemic!inhibition!of!such!a!CXCR2!inhibitor!as!SB!265610!(if!it!is!safe!to!do!so!in!patients).!Nevertheless,! if! tumour/plasma!CXCL1!protein! levels!also! increase!in! cancer! patients! given! chemotherapy! and! SB!265610! therapy,! it!might!mean!that! a! high! concentration! of! SB!265610! needs! to! be! administered! for! effective!blockade! of! CXCR2! signalling,! and! this! could! be! associated! with! harmful! side!effects.!Chemotherapy! can! cause! neutropenia,! in! both! humans! and! mice! [394,!416].! Therefore,! a! neutropenic! state! associated! with! fewer! circulating!neutrophils! could! lead! to! lower! intratumoural! neutrophil! counts.! However,!immunofluorescent! staining! of! four! different! tumour! models! and! types! of!chemotherapy! suggested! the! opposite,! since! 3! out! of! 4! chemotherapeutic!regimes!in!different!tumour!models! induced!a!significant!(p!<!0.05)! increase!in!accumulation!of!Ly6G+!TANs!(Fig+5.4).!Recruitment!of!neutrophils/granulocytic!cells! into! the! tumour! by! CXC! chemokines! has! been! previously! described! [126,!
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185],! and! it! has! been! suggested! that! chemotherapy! encourages! this! process![126],! although! the! supporting! evidence! is! not! definitive.! As! mentioned!previously,!PyMT,!4T1!and!ASVSB!models!lacked!sizeSmatched!controls,!and!so!it!is!possible!that!neutrophil!infiltration!is!also!affected!by!tumour!size,!rather!than!(or! as! well! as)! chemotherapy! treatment.! Therefore,! despite! the! fact! that! the!results! from!these!nonSsizeSmatched!models!are!very!similar! to! those! from!the!LLC!model,!which!did!have!sizeSmatched!controls,!these!experiments!should!be!repeated! using! sizeSmatched! control! tumours! for! proper! comparison.! In!addition,!although!Ly6G!is!a!good!marker!for!murine!neutrophils![399]!and!more!than!94%!of!Ly6G!cells!also!stained!for!CD11b!(Table+5.1),!combined!use!of!antiSCD11b+! and! antiSLy6G! antibodies! would! have! allowed! the! counting! of! dual!stained! CD11b+Ly6G+! cells,! which! would! ensure! more! accurate! counting! of!neutrophils.!This!was!done!with!the!ASVSB!model!here,!shown!in!Fig+5.3.+!A!marked!upregulation!in!the!overall!levels!of!immunoreactive!TNFα!was!seen!in!both!LLCs!and!PyMT!transplants!after!chemotherapy,!confirming!earlier!reports!that!chemotherapy!increases!TNFα!expression!by!endothelial!cells,!bone!marrowSderived! cells! and! smooth! muscle! cells! in! murine! mammary! tumours![126].!Higher!TNFα!in!tumours!correlates!with!poor!prognosis!in!many!types!of!cancer! [268S271],! and! is! known! to! induce! epithelialSmesenchymal! transition!(EMT)! in! colon! cancer! spheroids! [280],! and! so! such! a! chemotherapySinduced!increase!in!TNFα!may!support!tumour!invasiveness.!This!is!further!supported!by!the! finding! that! LM2!mammary! tumour! cells! treated!with!TNFα! for! two!hours!showed!an!upregulation!of!CXCL1,!which!correlated!with!increased!S100A9+!cell!accumulation!in!tumours,!enhancing!tumour!survival!and!metastasis![126].!!Crucially,! a! dramatic! reduction!of!TNFα! staining!was!observed! in!PyMT!tumours!following!treatment!with!chemotherapy!and!SB!265610,!demonstrating!that! chemotherapySspecific! TNFα! upregulation! is! dependent! upon! CXCR2!signalling.!The!fact!that!granulocytes/neutrophils!are!the!main!Cxcr2Sexpressing!cell!in!LM2!tumours!(Fig+5.1),!are!known!to!be!recruited!and!activated!by!CXCR2!signalling![93],!and!are!capable!of!expressing!TNFα![146,!295],!suggests!that!SB!265610! may! block! neutrophil! recruitment! and! TNFαSexpression! in! these!tumours.! This! is,! however,! based! on! semiSquantitative! fluorescence! intensity!
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values!from!a!ZSstack!through!10µm!sections!of!tumour,!and!ideally!would!have!been!confirmed!by!western!blot!analysis!or!ELISA!of!tumour!homogenates!from!this!experiment.!However,! such! tumour! samples!were!not!available!as! the!LLC!and! PyMT! studies! had! already! been! completed! by! the! time! of! the!immunofluorescent!analyses!reported!in!this!thesis.!!Furthermore,!a!set!focal!distance!between!each!ZSstacked!image!was!not!used!when!generating!ZSstacks,!but!instead,!just!the!numbers!of!images!per!stack!were!kept!constant.!Ideally,!both!the!numbers!of!images!and!the!depth/distance!(in! the! ZSaxis)! between! images! would! be! kept! the! same.! It! is! possible! that!antibodies! bind! more! readily! to! epitopes! on! the! surface! of! the! (10µmSthick)!sections!and!are!less!efficient!at!binding!epitopes!deeper!into!the!tissue,!meaning!the!staining!is!not!uniform!across!the!section,!thus!making!it!important!to!keep!a!constant!depth!between!captured!images.!However,!the!high!number!of! images!taken!per!stack!(11! images)!across!the!10µmSthick!sections!meant! that!despite!not!using!a! set!ZSaxis!distance,! the!distance!between!ZSstacks!did!not!differ!by!much!and!is!unlikely!to!have!had!a!significant!effect!on!the!overall!results.!TNFα! can! be! expressed! on! cell! surfaces! as! a!membraneSbound! protein,!secreted! into! the! local! environment! as! a! soluble! factor,! or! bound! to! TNF!receptors,!TNFRI!and!TNFRII![288,!417].!Therefore,!as!with!CXCL1,!it!is!possible!that! staining! for! each! factor!may!not! represent! expression! by! a! given! cell,! but!could!represent!uptake!of!these!factors!by!the!cell.!The!TNF!receptor,!TNFRI,! is!constitutively!expressed!at! low! levels!on!almost!all!nucleated!human!cells,! and!TNFRII! is! expressed! on! myeloid! cells! including! macrophages,! as! well! as!peripheral!T!cells!and!alveolar! lymphocytes! [418S422].!These! receptors!can!be!enzymatically! cleaved! from! the! cell! surface! to! form! soluble! receptors! (sTNFRI!and!sTNFRII),!which!are!able!to!neutralise!TNFα!and!act!as!TNFα!antagonists,!or!to!stabilise!soluble!TNFα!by!binding!it!and!forming!a!more!stable!complex![423].!Therefore,! TNFα! signal! detected! by! immunofluorescence! could! be! due! to! the!detection! of! membraneSbound! TNFα,! soluble! TNFα,! TNFα! being! taken! up! by!TNFRI/TNFRIISexpressing!cells,!or!bound!by!soluble!forms!of!these!receptors!in!a! neutralising! or! stabilising! way,! and! may! have! very! different! effects! in! the!tumour!microenvironment.!However,!since!TNFα!was!detected!in!these!tumour!
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sections! using! an! antibody! that! also! neutralises! TNFα! (Rat! antiSmouse! TNFα!FITC;!Biolegend,!UK),!only!‘free’!TNFα!that!is!not!bound!to!TNF!receptors!would!be!stained!(since!they!bind!competitively).!With!more!time!and!access!to!freshlySexcised!tumours,!cell!populations!could!have!been!analysed!by!flow!cytometry!to!see!if!there!is!an!observable!increase!in!viable!CD11b+Ly6C–Ly6G+!cells!(TANs)!in!the! tumour.! FACS! could! then! have! been! used! to! separate! various! cell! types!(neutrophils,! macrophages,! endothelial! cells,! lymphocytes,! tumour! cells)! and!their!ability! to! release!TNFα!or!CXCL1!could!have!been!assessed! in! shortSterm!cultures!by!ELISA.!! Given!that!cells!other!than!neutrophils!are!known!to!express!TNFα!in!the!tumour! [126,! 266,! 288,! 410],! and! that! not! all! TNFα+! cells!were! Ly6G+,! further!characterisation!of!TNFα+!cells! in! the!PyMT!and!LLC!was!done.!Analysis!of! the!number! of! TNFαSexpressing! cells! of! key! tumour! populations! in! two! different!models!offers!novel!insight!into!the!expression!of!this!important!cytokine!in!the!vehicleStreated! and! chemotherapyStreated! tumour.! Additionally,! the! PyMT!model! was! used! to! observe! the! changes! in! TNFα+! cells! of! each! population!following!CXCR2! inhibition!with!SB!265610,! for! the!study!of!how!this! inhibitor!may!alter!CXCR2Sexpressing!cell!dynamics.! In!both!tumour!models,!neutrophils!and! the! ‘other’! cell! group! showed! upregulation! of! TNFα! expression! after!chemotherapy,!as!well!as!macrophages,!which!were!not!investigated!in!the!LLC!model!but!should!be!confirmed! in! future!studies.!A!smaller!but!significant!(p!=!0.0159)! induction! in! CD31+TNFα+! vessels! in! the! PyMT! model! was! observed,!which!confirmed!previous!observations!with!this!chemotherapy!regimen!and!in!a!breast!tumour!model![126],!but!this!might!not!be!a!general!feature!since!there!was!no!significant!difference!in!LLC!tumours.!The!‘other’!cell!population!is!likely!to! be! mostly! tumour! cells,! judging! by! larger! nuclear! morphology! and! by!elimination! of! neutrophils,! endothelial! cells! and! perivascular! cells.! Increasing!numbers!of!TNFα+!tumour!cells!would!align!with!prior!reports!that!tumour!cells!express! TNFα! [272,! 363]! and! show! that! they! respond! to! chemotherapy! to!upregulate! this! cytokine.! Given! the! opposing! roles! that! TNFα! can! have! in!different! concentrations! and! environments,! as! evidenced! by! proS! and! antiStumour! functions! in! cancer! [288],! the! increased! expression! of! TNFα! by!
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(unconfirmed)! tumour! cells! following! chemotherapySinduced! stress,! suggests!that! this! molecule! is! advantageous! for! their! survival.! Such! advantages! could!include! recruitment! of! proStumour! TAMs! to! the! tumour! [363],! increased!angiogenesis![424]!and!metastasis![280,!425].!!Interestingly,! PyMT! tumours! from! mice! treated! with! combined!chemotherapy! and! SB! 265610! clearly! demonstrated! that! only! the! Ly6G+! cell!population! responded! to!CXCR2! inhibition,! and!macrophages,! endothelial! cells,!perivascular!cells!and! ‘other’!cells!did!not.!These!results!explicitly!demonstrate!that,!at!least!in!the!PyMT!murine!breast!tumour!transplant!model,!SB!265610!at!this! concentration! (2mg/kg)! only! modulates! Ly6G+! cell! recruitment! and/or!production! of! TNFα.! The! Ly6G–! cell! populations! either! do! not! respond! to! the!inhibitor,! or! compensate! between! cell! recruitment! and! TNFα! expression,! such!that! the! number! of! TNFα+! cells! remains! unchanged.! Given! that! granulocytes!were!shown!to!be!the!main!Cxcr2Sexpressing!cells!in!the!LM2!metastatic!breast!cancer! model,! it! seems! likely! that! SB! 265610! is! showing! specificity! for!granulocytes/neutrophils! in! this! experiment.! Use! of! this! CXCR2! inhibitor! was!also! indirectly! associated! with! CD11b+Gr1+! cell! reduction! in! tumours! from!combined! chemotherapy! and! SB! 265610Streated! mice,! in! comparison! with!chemotherapyStreated!mice!without!the!inhibitor![126].!Furthermore,!the!results!in!Fig+5.4!show!that!CXCR2!inhibition!decreases!both!the!number!of!neutrophils,!as! well! as! the! percentage! of! neutrophils! that! are! TNFα+.! Therefore,! CXCR2!inhibition!is!not!just!blocking!the!recruitment!of!neutrophils!by!CXC!chemokines!secreted!by!macrophages!and!other!cells,!but!is!blocking!neutrophil!induction!of!TNFα,! potentially! also! induced!by! the! same!CXC! chemokines.! Previously! it! has!been!reported!that!CXCR2!ligands!are!able!to!induce!TNFα![426],!supporting!this!hypothesis;!however,!the!induction!of!TNFα!by!CXCL1!and!CXCL5!was!shown!to!be! via! macrophages,! and! could! be! inhibited! by! reparixin! (CXCR1! and! CXCR2!inhibitor),!whereas!macrophages!in!the!PyMT!tumour!model!did!not!respond!to!CXCR2! inhibition.! This! discrepancy! could! be! because! reparixin! inhibits! both!CXCR1!and!CXCR2,!which!are!both!expressed!on!macrophages!and!neutrophils![427],!whereas!SB!265610!is!far!more!specific!for!CXCR2![409].!
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The!fact! that!SB!265610!specifically!reduces!the!number!of!Ly6G+TNFα+!cells,! and!does!not!affect!other!populations,! suggests! that! inhibiting!neutrophil!contribution! to! TNFα! in! the! tumour! results! in! the! significant! decrease! seen! in!overall! TNFα! levels! in! the! PyMT! tumour! with! the! SB! 265610! inhibitor.! Since!TNFα+!neutrophils!are!outnumbered!by!TNFα+! ‘other’!cells!and!are!at!a!similar!level!to!TNFα+!macrophages,!this!implies!that!neutrophil!production!of!TNFα!is!greater!per!cell!than!these!other!populations.!The!‘other’!cell!population!will!also!include!such!nonStumour!CXCR2Sexpressing!cells!as!lymphocytes,!dendritic!cells,!mast! cells,! and!NK!cells,! so! it! is!possible! that! some!of! these! cells!may!produce!TNFα!and!be!responsive!to!SB!265610,!but!that!the!inhibitory!effects!are!masked!by!other!populations! in! this!group.!Crucially,!however,! the!suggested!use!of!SB!265610!in!combination!with!chemotherapy!aims!to!reduce!proStumour!effects!of!recruited!myeloid! cells,! specifically! neutrophils.! Although! combination! therapy!dramatically! decreases! the! number! of! TNFα+! neutrophils! in! comparison! with!chemotherapy! alone,! the! larger! TNFα+! ‘other’! and! considerable! TNFα+!macrophage!populations!appear!unchanged!by!combined!therapy,!which!elicits!the!question!of!whether!TNFα!from!these!populations!will!still!maintain!the!proStumour! and!proSmetastatic! effects! suggested! in!Chapter+ 4.! It! seems,! however,!that!inhibition!of!neutrophilSderived!TNFα!by!SB!265610!treatment!does!in!fact!suppress!overall!TNFα!levels,!therefore!suggesting!that!other!TNFα+!populations!cannot!maintain!the!high!level!of!TNFα!production!in!the!absence!of!neutrophils,!making! combined! SB! 265610! and! chemotherapy! very! relevant! to! the! clinical!setting.!!! The!data!on!changes!in!the!size!of!PyMT!transplants!after!chemotherapy!in! the! absence! or! presence! of! a! CXCR2! inhibitor! (provided! by! Dr.! Joan!Massagué’s! lab! for! the! general! interest! of! the! reader! and! to! accompany! the!immunofluorescent!staining!done!here)!showed!that!chemotherapy!significantly!(p!=!0.0041)!reduced!tumour!size,!compared!to!control!tumours.!Chemotherapy!is!well!known!to!reduce! the!size!and!growth!of! tumours,!and! to!correlate!with!better! prognosis! in! many! types! of! cancer! [428S431].! Similarly,! chemotherapy!given!with!SB!265610!also!reduced!tumour!volume!in!comparison!with!control!tumours,!and!SB!265610!onlyStreated!tumours.!However,!the!difference!between!
! 158!
the! volumes! of! combination! therapyStreated! tumours! and! standard!chemotherapyStreated!tumours! failed! to!reach!significance!(p!=!0.0898),!unlike!previous! reports!using! the!LM2!murine!mammary! tumour!model! [126].! In! the!current!PyMT!tumour!study,!one!tumour!was!smaller! in!size!than!the!others!in!the! chemotherapyStreated! group,! but! was! not! found! to! be! an! outlier! by!Chauvenet’s! criterion! test.! Since! there! is! a! clear! trend,! but! only! 6! mice! were!included! in! each! group,! the! Massagué! group! is! currently! repeating! this! PyMT!experiment!in!order!to!make!the!analysis!more!robust.!! As! mentioned,! combining! doxorubicin! and! cyclophosphamide!chemotherapy!with!SB!265610!has!also!been!shown!to!make!LM2!tumours!more!responsive! to! chemotherapy! [126].! To! see! whether! such! combined! therapy!might! increase! apoptosis! in! PyMT! transplants! (without! causing! changes! in!tumour!volume),! tumours!were!stained!with!an!antiSactive!caspase!3!antibody,!and! the! number! of! cleaved! caspase! 3+! cells! counted.! The! fact! that! SB! 265610!alone!showed!an! increasing! trend!(nonSsignificant)! in!comparison!with!control!tumours,! suggested! that! blocking! CXCR2! signalling! even! in! tumours! not!undergoing!chemotherapy!treatment!might!be!beneficial.!!It!will!be!interesting!to!see!if!this!achieves!significance!after!the!Massagué!lab!has!completed!the!repeat!experiment! by! the! end! of! December! 2013.! If! so,! this!would! be! in! line!with! an!earlier! report! in! which! AZ10397767! (Astrazeneca),! a! small! molecule! CXCR2!inhibitor,!reduced!neutrophil!infiltration!into!A549!lung!carcinoma!spheroids!in#
vitro#and!in#vivo,!slowing!tumour!growth!and!progression![185].!Remarkably,!in!the! PyMT! transplants! stained! in! the! current! study,! chemotherapy! treatment!failed! significantly! to! increase! tumour!apoptosis! compared! to! control! tumours.!Since! chemotherapyStreated! tumours! were! significantly! smaller,! it! is! possible!that! the! treatment! induced!cell!death!by!necrosis,!not! apoptosis,! or! that! it! just!slowed! tumour! replication! dramatically.! However,! the! main! mechanism! of!tumour!cell!killing! for!both!doxorubicin!and!cyclophosphamide!reported! in! the!literature! is! via! induction! of! apoptosis! [432,! 433],! and! so! higher! numbers! of!cleaved!caspase!3+!cells!would!be!expected!in!chemotherapyStreated!tumours!in!comparison!with! control! tumours.! These! data! suggest! that! this! chemotherapy!regimen!may!not!have!been!fully!effective!in!these!mice,!even!with!the!significant!
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reduction! in! tumour!volume.!Future!studies!could!confirm!these! findings!using!other! apoptosis! assays! such! as! TUNEL! or! annexinSV! staining! of! tumours! after!chemotherapy!treatment.!!Previously,! combining! these! chemotherapeutic! agents! with! this! CXCR2!inhibitor!reduced!the!formation!of!lung!metastases!in!mice![126].!However,!this!was!shown!using! the!highly!metastatic! cell! lines!MDA231SLM2!and!CN34SLM1,!selected! for! their! metastatic! potential,! grown! as! orthotopic! xenografts.! It!remains! to!be!seen!whether! this! combination! is!effective! in! the! less!metastatic!PyMT!transplant!model.!! !! !
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CHAPTER+6:+SUMMARY+AND+GENERAL+DISCUSSION+As! outlined! in! detail! in! Chapter+ 1,! macrophages! and! neutrophils! are!major!components!of!the!innate!immune!system.!They!have!a!common!lineage!in!their! early! stages! of! development! and! share! a! number! of! characteristics! as!mature!cells!(see!Table+1.2).!!However,!at!later!stages!of!maturation,!these!two!cell!types!acquire!a!number!of!distinct!features!which!enable!them!to!cooperate!in! early! immune! responses! to! infection! and! inflammation! [56].! In! addition! to!stimulating!other!cells!of! the! immune!system![69,!106],!neutrophils!can!recruit!and!activate!monocytes!(and!vice!versa)!in!acute!inflamed!sites!via!the!release!of!such!chemokines!as!CXCL1,!CXCL2,!and!TNFα,!as!well!as!HNP1,!HNP3![87,!93].!Inflammation! is! a! key! component! of! both! the! onset! and! progression! of! many!forms!of!malignant!tumour![139],!and!the!extent!of!tumour!infiltration!by!such!cells!is!an!important!determinant!of!disease!outcome,!as!they!have!the!potential!to! destroy! or! support! tumours! depending! upon! their! state! of! activation! [102,!146,!191,!295,!311].!Evidence!is!also!emerging!from!in#vitro!studies!that!tumour!exposure! to! cytotoxic! agents! can! also! lead! to! changes! in! the! tumour!microenvironment,!which!in!turn!lead!to!immune!cell!activation![291].!The! work! described! in! this! thesis! investigated! the! interplay! between!macrophages! and! neutrophils! in! chemotherapyStreated! tumours! –! first! in! a!variety! of! in# vitro! models! and! then! in! chemotherapyStreated! mouse! tumours.!Human!monocytes/macrophages!were! found! to! upregulate! CXCL1,! CXCL2! and!CXCL5! after! exposure! to! the! human! nonSsmall! cell! lung! cancer! cell! line,! A549,!treated! with! docetaxel! in# vitro.! These! findings! suggested! that! monocytes!infiltrating! into! tumours! (and! then! differentiating! into! TAMs),!may! upregulate!these! chemokines! in! nonSsmall! cell! lung! cancer! patients! receiving! docetaxel!chemotherapy,! as! summarised! in! Fig+ 6.1.! Had! time! permitted,! it! would! have!been! interesting! to! see! whether! TAMs! expressed! these! CXCL! chemokines! in!resected! human! nonSsmall! cell! lung! carcinomas! (NSCLCs)! following! their!treatment!with!docetaxel! (and!possibly!other!chemotherapeutic!agents).! ! !Dual!immunofluorescent! staining! for! TAMs! (using! an! antibody! for! the! pan!macrophage! marker,! CD68)! and! CXCL1,! CXCL2! or! CXCL5,! would! allow! the!number! of! CD68+CXCL+! cells! to! be! compared! in! docetaxelStreated! versus!
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untreated! NSCLCs.! Ideally,! these!would! be! ‘matched’! samples! (i.e.! ‘before’! and!‘after’! chemotherapy)! from!the!same!patients.!Furthermore,! conditioned!media!from! docetaxelStreated! myeloid! cells! and! tumour! spheroids! were! shown! to!induce!neutrophil!migration!in#vitro,!in!a!CXCR2Sdependent!manner.!Neutrophils!conditioned!in!this!way!expressed!high!levels!of!TNFα,!CCL2!and!CCL3,!of!which!CCL2!and!CCL3!were!upregulated!between!docetaxelStreated!and!DMSOStreated!groups.!Given!that!CCL2!and!CCL3!can!recruit!macrophages!and/or!neutrophils![145,! 434],!TANs! in!docetaxelStreated!NSCLC! tumours!may! contribute! towards!further!recruitment!of!macrophages!and!neutrophils,!resulting!in!higher!levels!of!TAMs! and! TANs.! Interestingly,! increased! numbers! of! TAMs! have! already! been!shown! in! chemotherapy! (doxorubicin)Streated! murine! tumours! as! a! result! of!upregulated!CCL2!expression!by!(unidentified)!stromal!cells![212].!!Neutrophil!expression!of!TNFα!was! investigated! further!since!TNFα!can!contribute!towards!genetic!instability!of!tumour!cells,!tumour!growth,!epithelialStoSmesenchymal! transition! and! invasiveness! of! tumour! cells,! metastasis! and!tumour! angiogenesis! (see! Table+ 4.2),! and! was! upregulated! over! 150Sfold! by!neutrophils! exposed! to! conditioned! media! from! docetaxelStreated! A549!spheroids! and! myeloid! cells! (in! comparison! with! neutrophils! cultured! in!spheroidSunconditioned!medium!containing!DMSO).!Notably,!however,!although!a!large!increasing!trend!was!seen!between!conditioned!media!from!myeloid!cellSinfiltrated!A549!spheroids!treated!with!either!docetaxel!or!DMSO,!this!difference!was! not! significant.! Nonetheless,! media! from! myeloid! cellSinfiltrated! A549!spheroids,!treated!with!docetaxel!and!conditioned!by!neutrophils,!induced!A549!cells! to! become! more! invasive! in# vitro,! via! a! mechanism! that! was! dependent!upon!TNFα!and!neutrophil!CXCR2Ssignalling!(Fig+6.1).!The!above!in#vitro!effects!were!not! confined! to!docetaxelStreated! tumour! cells! since! similar! results!were!obtained! using! a! second! chemotherapeutic! agent,! cyclophosphamide.! ! This!suggested! that! tumour! cells! exposed! to! a! number! of! such! commonly! used!therapeutic!agents!might!elicit!similar!effects!on!TAMs!and!TANs.!!
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So,!the!possible!recruitment!of!TANs!and!their!upregulation!of!TNFα!after!chemotherapy! were! then! investigated! in! four! different! mouse! tumour!models!(each! treated!with!a!different!chemotherapeutic!agent).! !These!studies!showed!an!increase!in!TNFα+!neutrophils!in!chemotherapy!versus!vehicleStreated!mouse!tumours.! Furthermore,! a! collaborative! study!with! the!Massagué! group! in!New!York,! showed! that! combining! chemotherapy! (doxorubicin! and!cyclophosphamide)! with! systemic! inhibition! of! CXCR2! (using! SB! 265610)!reduced!both!the!number!of!TNFα+!neutrophils!and!the!overall!levels!of!TNFα!in!PyMT!tumour!transplants.!!However,!the!possible!effect,!if!any,!of!this!combined!treatment!on!the!formation!of!lung!metastases!in!this!mouse!model!had!not!been!demonstrated! at! the! time! of! submission! of! this! thesis! (and! the! focus! of! an!ongoing!study!in!the!Massagué!laboratory).!
Figure+ 6.1+ TAMs+ in+ chemotherapyXtreated+ tumours+ may+ stimulate+ neutrophil+
recruitment+ and+ TNFα+ expression:+ possible+ role+ in+ the+ regulation+ of+

























If! combining! doxorubicin! and! cyclophosphamide! chemotherapy! and! the!CXCR2! inhibitor! does! significantly! reduce! metastasis! in! the! PyMT! transplant!tumour!model,!this!may!potentially!have!implications!for!the!treatment!of!breast!cancer!patients.!Doxorubicin!and!cyclophosphamide! (sometimes!known!as! ‘AC’!chemotherapy),!is!currently!used!to!treat!breast!cancer!patients![435],!so!it!could!perhaps! be! administered! with! SB! 265610! to! such! patients! as! a! neoadjuvant!therapy! to!block! the!accumulation!and!activation!of!TANs! in!both!primary!and!metastatic! tumours.! It! has! not! been! identified! yet! whether! this!mechanism! of!neutrophil!accumulation!and!TNFα!expression!occurs!in!lung!metastases!(or!any!other! form! of! metastasis)! following! chemotherapy,! and! so! combining!chemotherapy!with!CXCR2!inhibition!may!not!be!beneficial!as!adjuvant!therapy,!when!the!primary!tumour!has!been!resected.!However,!this!combined!treatment!may! be! beneficial! as! a! neoadjuvant! therapy,! and! may! improve! the! efficacy! of!chemotherapy! and! reduce! tumour! metastasis,! as! suggested! previously! in! two!metastatic! mammary! cancer! mouse! models! treated! with!doxorubicin/cyclophosphamide!plus!SB!265610![126].!!In! addition! to! such! small! molecular! weight! CXCR2! antagonists! as! SB!265610,! the! use! of! antiSCXCR2! antibodies! could! also! be! investigated! in! preSclinical! trials! using! this! PyMT! murine! mammary! cancer! model.! As! discussed!previously!(see!section+1.9),!CXCR2!is!expressed!most!highly!on!neutrophils,!but!can! also! be! expressed! by!monocytes/macrophages,! dendritic! cells,! endothelial!cells,!mast!cells,!lymphocytes,!as!well!as!such!nonSimmune!cells!as!neurons!and!glial! cells.! Therefore,! systemic! inhibition! of! CXCR2! is! likely! to! block! CXCR2Sinduced! signalling! in! these! cells! as!well,! leading! to! possible! side! effects.! Since!CXCR2! signalling,! like! TNFα! signalling,! is! important! for! inflammation! and!immune! responses,! it! is! possible! that!CXCR2! inhibitors!will! also! leave!patients!susceptible! to! bacterial! and! fungal! infection! [246],! as! is! sometimes! observed!with!systemic!TNFα!inhibition!(see!section+1.10.2).!The!fact!that!mice!deficient!in!CXCR2!have!defects!in!the!wound!healing!process![259]!suggests!that!systemic!CXCR2Sinhibition! of! patients!may! also! impede! their!wound! healing! responses.!However,!a!safety!and!efficacy!study!of!CXCR2! inhibitor!SCH527123!(ScheringSPlough)!used!to!treat!patients!with!severe!asthma!reported!that!SCH527123!was!
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safe,! and! was! not! associated! with! an! increase! in! adverse! events! except! for! a!small! but! significant! increase! in! minor! gastrointestinal! symptoms! [251].! A!similar!study!observed!the!safety!and!efficacy!of!the!CXCR2!inhibitor!SB!656933!(GlaxoSmithKline),! which! was! used! for! the! treatment! of! patients! with! cystic!fibrosis![258].!The!inhibitor!(given!at!doses!of!20mg!or!50mg)!was!generally!well!tolerated,! although! 5! of! 146! patients! were! withdrawn! from! the! trial! due! to!adverse!effects,!and!increases!in!the!systemic!inflammatory!markers!fibrinogen,!CSreactive! protein! (CRP)! and! CXCL8!were! found! in! the! blood.! SB! 656933!was!also!reported!to!be!safe!and!well!tolerated,!even!up!to!1100mg!given!as!a!single!dose!to!healthy!patients![257].! !Therefore,!initial!clinical!studies!of!the!safety!of!CXCR2! inhibitors! suggest! that! inhibiting! CXCR2! systemically! using! small!molecule!CXCR2!antagonists!(at!biologically!relevant!doses)!is!safe!in!humans.!!FollowSon! studies! are! now! warranted! to! investigate! the! effects! of!selectively! knocking! down! expression! of! TNFα! in! neutrophils! on!metastasis! in!various! murine! tumour! models.! This! could! be! done! by! inducing! tumour!formation! in!mice!previously! given! a! bone!marrow! transplant!where! the!bone!marrow! cells! had! been! treated! with! a! lentivirus! containing! a! short! hairpin!(sh)RNA! against! TNFα! (or! a! control! shRNA)! under! the! control! of! the! Ly6G!promoter.!Alternatively,!murine!neutrophils!could!be!isolated!from!the!tumours!of!TNFα–/–!mice!and!could!then!be! injected!into!the!tumours!of!wildStype!mice.!This!is!likely!to!increase!the!proportion!of!TNFα–/–!TANs!within!the!tumours,!and!the! growth! and!metastasis! of! these! tumours! could! be! compared!with! tumours!injected!with!an! identical!number!of!neutrophils! from! tumours!grown! in!wildStype!(i.e.!TNFαSexpressing)!mice.!Interestingly,! the! expression! of! TNFα!was! investigated! in! a!mouse! skin!wound!healing!model!by!in#situ#hybridisation!and!immunofluorescence!analysis![436],!and!was!shown!to!be!produced!by!a!layer!of!neutrophils!–!and!to!a!lesser!extent!by!macrophages!–!in!close!proximity!to!wound!clots.!NeutrophilSderived!TNFα!is!known!to!be!a!crucial!part!of!the!wound!healing!process![437].!So,!it!is!tempting!to!speculate!that!tumours,!which!have!been!described!as!‘wounds!that!do! not! heal’! [137],! take! advantage! of! such! preSexisting! ‘wound! healing’!mechanisms! as! the! upregulation! of! CXCL! chemokines! [58,! 229]! and! the!
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recruitment/activation!of!TNFαSexpressing!neutrophils!to!support!angiogenesis,!matrix!remodelling!and!tumour!growth.!The! findings! of! this! thesis! suggest! that! combining! chemotherapy! with!TNFα! inhibitors!might! also!be!beneficial! in! the! treatment!of! cancer!patients! at!risk! of! developing! metastasis! (i.e.! stage! 2! breast! cancer! patients,! where! the!cancer! may! have! spread! to! the! lymph! nodes,! but! has! not! metastasised! yet).!However,!as!discussed! in!sections+ 1.10.2!and!4.1,! systemic! inhibition!of!TNFα!can!be!associated!with!increased!susceptibility!to!infection.!Notably,!combined!chemotherapy!and!GSCSF!is!commonly!used!to!treat!a!variety!of!cancers![438S440]!in!order!to!counteract!the!neutropenic!side!effects!of!many!chemotherapeutic!drugs,!and!the!associated!increase!in!susceptibility!to!infection.! Granulocyte! colonySstimulating! factor! is! capable! of! mobilising!peripheral!blood!progenitor!cells,!helping! to!sustain!blood!neutrophil!numbers!in! chemotherapyStreated! patients,! which! is! important! for! protecting! the! body!against! infection.! The! use! of! chemotherapy! and! GSCSF! combined! therapy! has!been! associated! with! improved! progressionSfree! survival! in! patients! with!chronic!lymphocytic!leukaemia![438].!However,!such!therapy!is!not!beneficial!in!all! types! of! cancer! patients! given! chemotherapy,! which! includes! early! breast!cancers! [441]! and! inflammatory/locally! advanced! breast! cancers! [442].!Furthermore,! combined! chemotherapy! and! GSCSF! therapy! has! even! been!identified!as!a!poor!prognostic!factor!in!patients!with!head!and!neck!squamous!cell!carcinoma!when!given!as!adjuvant!therapy![443].!The! use! of! combined! chemotherapy! and! GSCSF! to! treat! patients! with!cancer!may!appear!contradictory!to!the!results!discussed!here.!Increased!blood!neutrophil! levels! stimulated! by! GSCSF,! and! the! increase! in! CXC! chemokine!expression! by! macrophages! and! other! cells! in! the! tumour! in! response! to!chemotherapy! (Chapter+ 5),! would! suggest! that! there! would! be! more!intratumoural! neutrophils! in! tumours! of! these! patients.! Neutrophils! can! be!polarised! in! the! tumour! by! such! factors! as! TGFSβ,! such! that! their! tumour!destructive! properties! are! suppressed,! and! their! tumour! promoting/N2!phenotype! activated! [295].! Furthermore,! the! results! in! this! thesis! suggest! that!
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these! neutrophils! may! respond! to! the! chemotherapyStreated! tumour!environment! by! upregulating! their! expression! of! TNFα,! potentially! stimulating!tumour! cell! invasiveness,! which! is! an! important! feature! in! the! process! of!metastasis![444].!A!possible!reason!why!combined!chemotherapy!and!GSCSF!can!improve!patient!prognosis! is! that!GSCSF!may!promote!the!polarisation!of!TANs!away! from! an! N2! phenotype! towards! N1,! restoring! their! tumour! destructive!capabilities!(although!TNFα!has!been!reported!to!be!expressed!by!N1Spolarised!neutrophils! [295],! but! can! support! tumour! progression! and! metastasis,! as!mentioned!above).!In!a!previous!study,!murine!colon!adenocarcinoma!(C26)!cells!were! unable! to! form! tumours! when! injected! into! syngeneic! mice! transduced!with! the! GSCSF! gene,! rather! than! an! unrelated! control! gene,! which! correlated!with! very! high! numbers! of! associated! neutrophilic! granulocytes! [445].!Interestingly,!GSCSF!has!been!shown!to!have!opposing!effects!on!the!expression!of! TNFα! by! whole! blood! (including! neutrophils)! in# vitro;! GSCSF! was! found! to!increase! TNFα! expression! as! measured! by! ELISA,! yet! preStreatment! of! whole!blood!with! GSCSF! reduced! LPSSinduced! TNFα! secretion! [446].! ! Therefore,! it! is!possible! that! combined! chemotherapy! and! GSCSF! treatment! may! condition!neutrophils! and! reduce! their! expression! of! TNFα! in! response! to! stimuli! in!chemotherapyStreated!tumours.!
6.1+CONCLUDING+REMARKS+! The! findings! in! this! thesis! identify! a! novel!macrophage/neutrophil! axis!contributing! to! the! upregulation! of! TNFα! in! tumours! after! chemotherapy.!Crucially,! TNFα! has! been! shown! to! be! upregulated! in! human! primary! breast!tumours! following! neoadjuvant! doxorubicin! and! cyclophosphamide!chemotherapy![126].!This!novel!macrophage/neutrophilSdependent!mechanism!was!found!to!involve!the!expression!of!CXC!chemokines!by!TAMs!and!CXCR2!on!neutrophils.!If!current!studies!combining!chemotherapy!with!a!CXCR2!antagonist!in! tumourSbearing! mice! show! a! reduction! in! the! formation! of! postStherapy!metastasis,!this!approach!could!be!used!in!patients!to!reduce!tumour!recurrence!and!increase!survival!after!chemotherapy.!!! !
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Upregulated)
" " " "1" ILMN_1672148" AKR1B10" 57016" 6.068605478" 1.49E603"
2" ILMN_2278335" AKR1B15" 441282" 5.950108178" 8.66E604"
3" ILMN_2412336" AKR1C2" 1646" 5.87972193" 9.13E604"
4" ILMN_1801442" KRT81" 3887" 5.562068532" 6.61E604"
5" ILMN_2060413" CD24" 100133941" 5.547963079" 9.48E604"
6" ILMN_1665865" IGFBP4" 3487" 5.287727338" 1.65E603"
7" ILMN_1720998" CA12" 771" 5.214947793" 6.99E604"
8" ILMN_2133205" GPX2" 2877" 5.114019255" 8.07E603"
9" ILMN_1746085" IGFBP3" 3486" 5.089582439" 1.05E602"
10" ILMN_3307841" AGR2" 10551" 4.9036228" 2.91E603"
11" ILMN_2371055" EFNA1" 1942" 4.883440678" 2.04E603"
12" ILMN_1687757" AKR1C4" 1109" 4.868529694" 4.00E604"
13" ILMN_1712082" GCNT3" 9245" 4.848964645" 2.37E604"
14" ILMN_2315044" FGG" 2266" 4.654760779" 3.58E602"
15" ILMN_1655595" SERPINE2" 5270" 4.578834173" 1.23E604"
16" ILMN_1656487" FGA" 2243" 4.561850639" 8.49E603"
17" ILMN_1713124" AKR1C3" 8644" 4.43627328" 1.37E604"
18" ILMN_1753143" RHPN2" 85415" 4.372056429" 2.73E603"
19" ILMN_1770338" TM4SF1" 4071" 4.32235871" 7.24E603"
20" ILMN_1773567" LAMA5" 3911" 4.286644055" 1.90E604"
21" ILMN_2382942" CA12" 771" 4.279721259" 8.98E604"
22" ILMN_2396875" IGFBP3" 3486" 4.176009552" 1.99E602"
23" ILMN_1771599" PLOD2" 5352" 4.126275561" 2.33E603"
24" ILMN_2108735" EEF1A2" 1917" 4.060044566" 6.99E604"
25" ILMN_1779017" FGA" 2243" 4.039377397" 1.05E602"
26" ILMN_1670379" ANTXR1" 84168" 4.038274026" 4.92E604"
27" ILMN_2387385" IGFBP1" 3484" 3.999221532" 8.51E604"
28" ILMN_2041222" FLJ40504" 284085" 3.91322459" 2.66E603"
29" ILMN_2381945" FGA" 2243" 3.869836384" 1.48E602"
30" ILMN_1754795" FAT1" 2195" 3.857175958" 2.37E604"
31" ILMN_1677511" PTGS2" 5743" 3.795429724" 2.07E603"
32" ILMN_2174127" DCBLD2" 131566" 3.771386897" 4.00E604"
33" ILMN_1721770" PAPPA" 5069" 3.767235047" 1.20E603"
34" ILMN_2063168" MALL" 7851" 3.742252784" 2.11E602"
35" ILMN_1694778" LOC646723" 646723" 3.719929515" 1.16E603"
36" ILMN_2315780" TACC2" 10579" 3.677210775" 5.79E603"
37" ILMN_1681983" RSPO3" 84870" 3.579048952" 8.66E604"
38" ILMN_1666893" TRIML2" 205860" 3.5471121" 3.14E604"
39" ILMN_1775830" TM4SF20" 79853" 3.536519575" 3.86E602"
40" ILMN_3251672" DSG2" 1829" 3.497382598" 1.03E603"
41" ILMN_1676278" ABCC2" 1244" 3.489174119" 4.00E604"
42" ILMN_2171384" CXCL5" 6374" 3.47538525" 1.36E603"
43" ILMN_2380237" C1QTNF1" 114897" 3.472773902" 2.34E603"
44" ILMN_3305152" XAGE1A" 653219" 3.453159194" 6.61E604"
45" ILMN_2054297" PTGS2" 5743" 3.437097065" 8.66E604"
46" ILMN_1691494" XAGE1B" 653220" 3.404017398" 4.00E604"
47" ILMN_1763196" WDR72" 256764" 3.344962239" 1.48E603"
48" ILMN_1753584" KRT8" 3856" 3.343347519" 1.92E603"
49" ILMN_1794863" CAMK2N1" 55450" 3.329647789" 1.21E602"
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50" ILMN_1729117" COL5A2" 1290" 3.323185412" 4.20E603"
51" ILMN_3247578" FAT1" 2195" 3.321059116" 9.77E604"
52" ILMN_2366192" FGL1" 2267" 3.308415833" 2.43E602"
53" ILMN_1735499" DCBLD2" 131566" 3.299315505" 7.78E604"
54" ILMN_2101832" LAPTM4B" 55353" 3.274211364" 1.89E603"
55" ILMN_2139761" LIMCH1" 22998" 3.259611805" 6.08E603"
56" ILMN_1656369" C8ORF4" 56892" 3.220160763" 1.56E603"
57" ILMN_2041190" F2RL1" 2150" 3.196566671" 4.43E603"
58" ILMN_1703593" BAIAP2L1" 55971" 3.186142725" 1.04E603"
59" ILMN_1752562" CXCL5" 6374" 3.178668538" 1.25E602"
60" ILMN_2269256" DNAJC12" 56521" 3.167815193" 1.56E603"
61" ILMN_1742534" COL4A5" 1287" 3.155887774" 1.98E603"
62" ILMN_1775829" PERP" 64065" 3.134424162" 1.47E603"
63" ILMN_1691410" BAMBI" 25805" 3.123938596" 8.75E604"
64" ILMN_2371053" EFNA1" 1942" 3.098001894" 4.38E602"
65" ILMN_2400407" CNTN1" 1272" 3.092681751" 2.76E602"
66" ILMN_2380163" PTPRF" 5792" 3.034912055" 1.10E603"
67" ILMN_2149226" CAV1" 857" 3.01886244" 8.51E604"
68" ILMN_1730487" CALD1" 800" 2.996332131" 2.71E603"
69" ILMN_2411236" NRCAM" 4897" 2.943901991" 1.98E603"
70" ILMN_1658499" SYT13" 57586" 2.907554143" 1.97E602"
71" ILMN_1779228" CDH2" 1000" 2.903035218" 1.22E603"
72" ILMN_1700031" PRAME" 23532" 2.89046379" 1.14E603"
73" ILMN_1765966" CHGB" 1114" 2.864989977" 2.03E602"
74" ILMN_1795342" MLPH" 79083" 2.851679823" 5.09E604"
75" ILMN_1722809" NRCAM" 4897" 2.838917657" 2.72E603"
76" ILMN_1709674" GFPT2" 9945" 2.822310424" 2.32E602"
77" ILMN_1680196" LAPTM4B" 55353" 2.819217643" 2.61E603"
78" ILMN_1680874" TUBB2B" 347733" 2.815008124" 7.41E604"
79" ILMN_2398159" DKK3" 27122" 2.813630734" 2.05E603"
80" ILMN_1806733" COL18A1" 80781" 2.805995674" 4.36E603"
81" ILMN_1751161" COL7A1" 1294" 2.781632841" 3.37E605"
82" ILMN_1682738" SMAD3" 4088" 2.779720994" 2.37E604"
83" ILMN_1775448" PFN2" 5217" 2.759654271" 4.66E604"
84" ILMN_1797776" PRSS23" 11098" 2.757678549" 2.62E603"




87" ILMN_1750181" TESC" 54997" 2.722550049" 2.21E602"
88" ILMN_1668052" FOXA2" 3170" 2.71790653" 1.86E603"
89" ILMN_1719883" CYP4F11" 57834" 2.717374821" 1.99E604"
90" ILMN_1779182" TMEM98" 26022" 2.709082152" 9.36E604"
91" ILMN_1717793" C19ORF33" 64073" 2.703267192" 1.48E603"
92" ILMN_1674620" SGCE" 8910" 2.702002622" 9.13E604"
93" ILMN_1788874" SERPINA3" 12" 2.693242883" 3.99E603"
94" ILMN_1700831" SLC27A2" 11001" 2.682760791" 2.38E603"
95" ILMN_2384122" GPR56" 9289" 2.673658047" 1.74E602"




98" ILMN_1792356" DPYSL4" 10570" 2.616251534" 1.39E603"
99" ILMN_1803073" DNAJC12" 56521" 2.6140289" 1.95E603"
100" ILMN_1682636" CXCL2" 2920" 2.602766696" 4.73E602"




103" ILMN_3263974" KRT18P13" 392371" 2.579487933" 3.65E603"
104" ILMN_1671971" LOC644743" 644743" 2.575612154" 2.66E603"
105" ILMN_2340259" PDE4B" 5142" 2.565843704" 6.61E604"
106" ILMN_2041788" PLS3" 5358" 2.564675393" 2.14E603"
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107" ILMN_2081087" HSPA12A" 259217" 2.544854302" 8.75E604"
108" ILMN_1791726" TUBB3" 10381" 2.498494504" 1.26E602"
109" ILMN_2363165" TACC2" 10579" 2.488810936" 1.90E602"
110" ILMN_1725485" RGS17" 26575" 2.482788011" 5.32E604"
111" ILMN_1782439" CNN3" 1266" 2.481581768" 3.58E603"
112" ILMN_1658289" WDR54" 84058" 2.4812945" 1.19E602"
113" ILMN_1712545" S100A3" 6274" 2.464671407" 2.13E603"
114" ILMN_1802808" LOC654103" 654103" 2.464293735" 1.66E603"
115" ILMN_1790778" PNMA2" 10687" 2.449448243" 1.47E603"
116" ILMN_1788416" FAM108C1" 58489" 2.441826607" 2.91E603"
117" ILMN_1761858" MID1" 4281" 2.441745142" 3.42E603"
118" ILMN_2120695" TSPAN7" 7102" 2.441264102" 2.22E603"
119" ILMN_1815500" ITPR3" 3710" 2.436990774" 1.20E603"
120" ILMN_1803348" EHBP1" 23301" 2.436051401" 3.65E603"
121" ILMN_2376263" SMARCA1" 6594" 2.436039283" 1.26E603"
122" ILMN_1672589" SEMA4B" 10509" 2.413716299" 2.89E603"
123" ILMN_1740555" SNAP25" 6616" 2.413199559" 3.86E602"
124" ILMN_2343774" XAGE1" 9503" 2.412778057" 4.00E604"
125" ILMN_1788955" PDLIM1" 9124" 2.405846652" 2.22E603"
126" ILMN_1716815" CEACAM1" 634" 2.398077381" 1.59E602"
127" ILMN_1729563" UGDH" 7358" 2.396282961" 1.83E603"
128" ILMN_1765574" TFAP2A" 7020" 2.386072134" 3.14E604"
129" ILMN_1756071" MFGE8" 4240" 2.37621973" 2.31E603"
130" ILMN_1695946" TRNP1" 388610" 2.369131319" 1.56E603"
131" ILMN_2068104" TFPI2" 7980" 2.365494779" 8.66E604"
132" ILMN_2163723" KRT7" 3855" 2.363897768" 1.20E603"
133" ILMN_1796074" C18ORF56" 494514" 2.353759842" 3.89E603"
134" ILMN_1782419" GNG11" 2791" 2.351761083" 6.33E603"
135" ILMN_1673113" F2RL1" 2150" 2.348551863" 5.63E603"
136" ILMN_1815673" DKK3" 27122" 2.342476532" 8.14E603"
137" ILMN_1720282" NQO1" 1728" 2.336109972" 4.66E604"
138" ILMN_2352097" GPR56" 9289" 2.335233727" 1.93E602"
139" ILMN_2128770" CDR2L" 30850" 2.333485176" 1.28E603"
140" ILMN_1705066" BTBD11" 121551" 2.326005325" 2.59E602"
141" ILMN_1787897" CXCL1" 2919" 2.32072426" 3.38E602"
142" ILMN_1663401" LARP6" 55323" 2.318288029" 5.87E604"
143" ILMN_1659913" ISG20" 3669" 2.312972634" 9.13E604"
144" ILMN_2113490" NTN4" 59277" 2.299948844" 1.18E603"
145" ILMN_1769201" ELF3" 1999" 2.295579746" 2.76E603"
146" ILMN_1701007" PON3" 5446" 2.294023766" 4.09E602"
147" ILMN_1658709" LAMB1" 3912" 2.291446499" 4.07E603"
148" ILMN_2093027" MYO1B" 4430" 2.287761696" 1.59E602"
149" ILMN_1709479" YAP1" 10413" 2.27276551" 1.56E603"
150" ILMN_1724658" BNIP3" 664" 2.263770441" 9.29E603"
" " " " " "
"




" " " "1" ILMN_1754121" CSK" 1445" 60.284140672" 4.61E602"
2" ILMN_3278157" LOC653156" 653156" 60.289716204" 4.36E602"
3" ILMN_1800543" SCFD1" 23256" 60.304810559" 4.27E602"
4" ILMN_1657148" C19ORF23" 148046" 60.31013655" 4.73E602"
5" ILMN_1755111" C6ORF199" 221264" 60.310393389" 4.56E602"
6" ILMN_1682711" LOC493754" 493754" 60.314521009" 3.79E602"
7" ILMN_2299843" ATP5S" 27109" 60.316489628" 3.71E602"
8" ILMN_3268564" C19ORF60" 55049" 60.319941584" 3.83E602"
9" ILMN_1670769" CENPQ" 55166" 60.325616473" 4.74E602"
! 196!
10" ILMN_3251501" SERF2" 10169" 60.326013676" 4.28E602"
11" ILMN_1651735" TGOLN2" 10618" 60.328636966" 4.14E602"
12" ILMN_2191720" ZNF471" 57573" 60.329571295" 4.36E602"
13" ILMN_1806483" ZWILCH" 55055" 60.33144606" 4.88E602"
14" ILMN_2389445" ARHGEF10L" 55160" 60.332162395" 3.46E602"
15" ILMN_2364700" ENSA" 2029" 60.332525146" 4.80E602"
16" ILMN_2321634" RAD17" 5884" 60.332830856" 4.47E602"
17" ILMN_1667737" DNAHL1" 284176" 60.333119929" 3.29E602"
18" ILMN_1751143" C7ORF23" 79161" 60.333236852" 4.41E602"
19" ILMN_1695357" CCDC99" 54908" 60.333947619" 3.86E602"
20" ILMN_1755937" ANXA2" 302" 60.335346044" 3.97E602"
21" ILMN_1754423" C3ORF23" 285343" 60.335614372" 3.55E602"




24" ILMN_1718610" ARHGAP17" 55114" 60.337066429" 4.52E602"
25" ILMN_1765500" NDUFV3" 4731" 60.338814072" 3.56E602"
26" ILMN_2130838" UTP11L" 51118" 60.338994387" 4.88E602"
27" ILMN_1770466" ATP5G3" 518" 60.339319257" 3.38E602"
28" ILMN_1657149" C8ORF46" 254778" 60.339629423" 3.58E602"
29" ILMN_1715908" NCAPH2" 29781" 60.340504933" 4.87E602"
30" ILMN_1808196" GSTO1" 9446" 60.343223371" 4.12E602"
31" ILMN_1656184" PI4KAP1" 728233" 60.344733433" 4.60E602"
32" ILMN_1727798" MOSPD1" 56180" 60.345252566" 3.90E602"
33" ILMN_3238623" LYRM7" 90624" 60.345538684" 4.42E602"
34" ILMN_1755983" NFATC3" 4775" 60.345576572" 4.03E602"
35" ILMN_1735075" PGBD2" 267002" 60.345582564" 4.16E602"
36" ILMN_1657144" C1ORF69" 200205" 60.346692673" 4.60E602"
37" ILMN_1684042" BET1" 10282" 60.346985652" 4.00E602"
38" ILMN_1715674" ITPK1" 3705" 60.347425688" 2.96E602"
39" ILMN_1782069" TRAK1" 22906" 60.347898996" 3.43E602"
40" ILMN_2130514" FAM76B" 143684" 60.348230266" 3.62E602"
41" ILMN_1789751" MFSD1" 64747" 60.348453256" 2.40E602"
42" ILMN_1710710" DEDD" 9191" 60.349986596" 4.50E602"
43" ILMN_1750101" S100A11" 6282" 60.350152543" 3.44E602"
44" ILMN_1788211" SNX19" 399979" 60.3524995" 4.91E602"
45" ILMN_1723793" PALB2" 79728" 60.352804557" 2.71E602"
46" ILMN_1767992" SLC12A6" 9990" 60.353666053" 3.78E602"
47" ILMN_1784523" ATP6V1G1" 9550" 60.353794014" 3.86E602"
48" ILMN_1725787" RFX1" 5989" 60.353817753" 3.00E602"
49" ILMN_1728676" KIAA0196" 9897" 60.354221015" 3.14E602"
50" ILMN_1755423" PTCRA" 171558" 60.354982709" 4.15E602"
51" ILMN_1654318" PTPN23" 25930" 60.35609997" 2.94E602"
52" ILMN_1714567" AHNAK" 79026" 60.356360855" 4.00E602"
53" ILMN_1758545" DNAJB12" 54788" 60.356660665" 2.87E602"
54" ILMN_1730416" CYCS" 54205" 60.357081055" 3.25E602"
55" ILMN_1670801" MTR" 4548" 60.357252811" 4.26E602"
56" ILMN_3236135" FAM86D" 692099" 60.357908036" 4.82E602"
57" ILMN_2193498" C1ORF25" 81627" 60.358174061" 2.69E602"
58" ILMN_1807662" IGF2R" 3482" 60.358436655" 2.35E602"
59" ILMN_3251312" TMEM69" 51249" 60.3589313" 4.65E602"
60" ILMN_1711383" STK4" 6789" 60.359812997" 2.67E602"
61" ILMN_2163732" ATG3" 64422" 60.360712855" 2.52E602"
62" ILMN_1655921" GTF2E1" 2960" 60.360754682" 2.83E602"
63" ILMN_1734895" SFT2D1" 113402" 60.361460601" 4.45E602"
64" ILMN_1658302" PIAS2" 9063" 60.361526306" 3.67E602"
65" ILMN_1662932" LCP1" 3936" 60.362144268" 4.96E602"
66" ILMN_2305544" DBI" 1622" 60.362395537" 4.61E602"
! 197!
67" ILMN_1719158" CTBP1" 1487" 60.3627983" 2.56E602"
68" ILMN_1658684" ATP9B" 374868" 60.363245972" 4.52E602"
69" ILMN_1792305" ZNF318" 24149" 60.363269288" 4.29E602"
70" ILMN_3178529" FAM108A2" 728917" 60.36377767" 4.21E602"
71" ILMN_2140990" CAMK1" 8536" 60.363949135" 3.03E602"
72" ILMN_2124386" RGL2" 5863" 60.36414336" 3.41E602"
73" ILMN_1804820" ZNF431" 170959" 60.364322664" 2.39E602"
74" ILMN_1668619" KIAA1467" 57613" 60.36462873" 4.60E602"
75" ILMN_1782851" TAPBP" 6892" 60.365616452" 3.18E602"
76" ILMN_1689518" PECAM1" 5175" 60.36666655" 4.08E602"
77" ILMN_1768640" CRNKL1" 51340" 60.367941707" 4.01E602"
78" ILMN_2408240" DTNBP1" 84062" 60.368480712" 2.91E602"
79" ILMN_2362346" TRPV4" 59341" 60.369235661" 3.35E602"
80" ILMN_1742224" SLTM" 79811" 60.369536331" 2.25E602"
81" ILMN_2052335" MYOC" 4653" 60.369698511" 2.53E602"
82" ILMN_1724230" LOC642236" 642236" 60.370196696" 4.55E602"
83" ILMN_2398587" ZNRD1" 30834" 60.370969239" 3.38E602"
84" ILMN_1754051" RMI1" 80010" 60.371029457" 2.96E602"




87" ILMN_2117171" LMO4" 8543" 60.373299982" 4.05E602"
88" ILMN_1716821" GORASP1" 64689" 60.374164704" 2.28E602"
89" ILMN_1679577" SETD3" 84193" 60.374257917" 3.48E602"
90" ILMN_1694504" RNF220" 55182" 60.374309152" 4.50E602"
91" ILMN_1786843" KCTD13" 253980" 60.374383445" 1.90E602"
92" ILMN_2043569" MOSPD2" 158747" 60.374412458" 3.24E602"
93" ILMN_2337789" Mar602" 51257" 60.375243592" 1.72E602"
94" ILMN_3266054" FLJ31306" 379025" 60.375795275" 2.21E602"
95" ILMN_1776109" ZNF622" 90441" 60.375806096" 2.74E602"
96" ILMN_1755909" C20ORF11" 54994" 60.37584411" 4.34E602"
97" ILMN_1670377" ZNF20" 7568" 60.376377013" 3.73E602"
98" ILMN_2411731" HPS5" 11234" 60.37685832" 1.88E602"
99" ILMN_1703573" DNAJC17" 55192" 60.378414542" 4.56E602"
100" ILMN_1717099" DSCR3" 10311" 60.378896129" 3.66E602"
101" ILMN_3201485" LOC644988" 644988" 60.378966844" 2.94E602"
102" ILMN_1745005" GGCT" 79017" 60.379093812" 2.63E602"
103" ILMN_1765746" SFT2D3" 84826" 60.379658216" 3.39E602"
104" ILMN_1802631" AGA" 175" 60.381106329" 3.10E602"
105" ILMN_1697024" LOC730432" 730432" 60.381114863" 2.39E602"
106" ILMN_1810289" FER1L3" 26509" 60.381350562" 3.62E602"
107" ILMN_1747598" PPP1R11" 6992" 60.381844513" 4.92E602"
108" ILMN_3199780" LOC401076" 401076" 60.38193012" 3.31E602"
109" ILMN_1801043" GSN" 2934" 60.382274799" 4.45E602"
110" ILMN_1797082" SNX13" 23161" 60.382606274" 1.82E602"
111" ILMN_1735788" TRIOBP" 11078" 60.382858751" 3.07E602"
112" ILMN_1801914" SH3BP2" 6452" 60.38340176" 3.10E602"
113" ILMN_2380967" DNASE1L1" 1774" 60.384582065" 2.17E602"
114" ILMN_1756910" PLA2G15" 23659" 60.38463456" 3.11E602"
115" ILMN_1745620" KRCC1" 51315" 60.38496145" 2.76E602"
116" ILMN_1733374" LOC642197" 642197" 60.385140183" 2.36E602"
117" ILMN_3247064" SNRNP40" 9410" 60.385323943" 2.16E602"
118" ILMN_1663664" MRPS10" 55173" 60.385798395" 3.48E602"
119" ILMN_2162234" NEK1" 4750" 60.387059473" 3.93E602"
120" ILMN_2367418" OSCAR" 126014" 60.387206692" 3.41E602"
121" ILMN_1653940" USP2" 9099" 60.388524838" 3.62E602"
122" ILMN_1744914" FUCA2" 2519" 60.389163905" 3.71E602"
123" ILMN_2365307" CD276" 80381" 60.389854692" 2.37E602"
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124" ILMN_2141807" C15ORF23" 90417" 60.389977963" 4.78E602"
125" ILMN_1738604" ADH5" 128" 60.389997431" 3.55E602"
126" ILMN_3243011" LOC641844" 641844" 60.390056305" 2.76E602"
127" ILMN_2389347" NR3C1" 2908" 60.390991345" 3.75E602"
128" ILMN_1688753" PTDSS1" 9791" 60.391244837" 3.34E602"
129" ILMN_1655734" RPF1" 80135" 60.393071157" 4.19E602"
130" ILMN_2088410" PSMG2" 56984" 60.393084781" 3.02E602"
131" ILMN_1721704" FNTA" 2339" 60.393170338" 1.90E602"
132" ILMN_1780618" TMEM192" 201931" 60.393413761" 4.06E602"
133" ILMN_1810228" TTF2" 8458" 60.393603248" 2.98E602"
134" ILMN_2151579" HMGN1" 3150" 60.394135477" 4.16E602"
135" ILMN_1765021" TOP3B" 8940" 60.394276259" 4.50E602"
136" ILMN_1766247" ZBTB2" 57621" 60.394414338" 2.88E602"
137" ILMN_1671981" FLJ44076" 401080" 60.395039178" 2.03E602"
138" ILMN_1783469" LOC642197" 642197" 60.395249021" 3.56E602"




141" ILMN_1655312" HPS5" 11234" 60.396474864" 2.83E602"
142" ILMN_1671387" C3ORF23" 285343" 60.396627456" 4.15E602"
143" ILMN_2276952" TSC22D3" 1831" 60.396830739" 3.38E602"
144" ILMN_2074258" BARD1" 580" 60.397066646" 4.93E602"
145" ILMN_3241758" POTEF" 728378" 60.398191381" 4.36E602"
146" ILMN_2167416" MR1" 3140" 60.399294339" 2.61E602"
147" ILMN_1733515" LOXL3" 84695" 60.39944334" 4.22E602"
148" ILMN_2178088" ZNF131" 7690" 60.399637066" 2.07E602"
149" ILMN_1768020" HAUS8" 93323" 60.399780033" 3.32E602"




DEPARAFFINIZATION+In! a! slide! staining! jar,! perform! the! following! procedures! to! remove! paraffin! and!rehydrate!tissues:!!XYLENE/HISTOCLEAR!S!Wash!3X,!3!min!each!wash!(replace!solution!in!jar!each!time)!100%!Ethanol!–!Wash!2X,!3!min!each!wash!!95%!Ethanol!–!Wash!1x,!2!min.!70%!Ethanol!–!Wash!1x,!2!min.!!Distilled!Water!–!Wash!1x,!2!min.!!PAP! Section!with! pen,! and! add! 1%! hydrogen! peroxide! in!water! (from#30%#stock),! 10!min.!to!quench!any!endogenous!peroxidase!in!tissue!! 10ml!=!333ul!30%!H2O2!into!9.7!ml!H20!Meanwhile,!prep!moisture!chamber!(wet!tissues!and!put!parafilm!on!top)!Turn!ON!steamer,!and!warm!antigen!retrieval!solution!! (3.75!ml!of!either!alkaline!or!citrateSbased!antigen!retrieval!solution!+!400!ml!of!water!(Vector#Labs,#H3300#or#H3301))!Wash!slides!with!PBS!at!least!3X,!3!min.!each!SSS!
ANTIGEN+RETRIEVAL+STEP+Put! slides! into! warmed! antigen! retrieval! solution! and! keep! in! closed! steamer! for! 30!minutes!Remove!steaming!basket,!and!let!cool!at!room!temperature!for!15S30!minutes!SSS!




DAB+SUBSTRATE+ADDITION+Prepare!ImmPACT!DAB!substrate!solution!(SKJ4105,#Vector#Labs)#Add!1!drop!of! ImmPACT!DAB!Chromogen! concentrate! to! 1ml! ImmPACT!DAB!Diluent.!Mix!well.!!Stable!for!14!days!at!2S8!deg!C.!!Incubate!slides!in!DAB!substrate!solution!for!5!minutes!(or!until!developed).!!Once!staining!intensity!is!achieved,!immediately!wash!with!cold!tap!water.!Rinse!slides!at!least!2x!with!cold!tap!water!5!min!each.!!
HEMATOXYLIN++QS+COUNTERXSTAIN+Use!Hematoxylin!QS! (QuickStain!–!HJ3404#Vector#Labs)!and!apply!on!sections!directly,!for!5S45!seconds.!!Wash!with!distilled!water!until!it!runs!clear.!!
DEHYRADATION+Follow!alcohol!series!in!reverse!from!deparaffinization!step:!!70%!Ethanol!–!1x,!2!minutes!95%!Ethanol!–!1x,!2!minutes!100%!Ethanol!–!2x,!3!minutes!Xylene/Histoclear!–!3x,!3!minutes!Mount!with!Cytoseal!XYL!(RichardJAllen#Scientific)!!!
